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V 
Summary 
 
In the last decades, increasing evidence suggests that inflammatory processes play an important 
role in the development of psychiatric disorders, such as anxiety and depression. Psychosocial 
stress – one of the main environmental factors contributing to these disorders – affects immune 
system activity through neuronal and endocrine signals. The endocannabinoid system (ECS) is a 
neuromodulatory system that regulates stress responses via the cannabinoid receptor 1 (CB1). 
Blockade of CB1 signalling, either pharmacologically or genetically, increases the sensitivity to 
stress and the risk to develop stress-related psychiatric pathologies. Whether this is based on a 
purely neuronal mechanism or whether it is accompanied or mediated by altered immune system 
regulation is, however, not known. The aim of this study was therefore to analyse how CB1 
signalling modulates behavioural, neuroendocrine, and immunological responses in a mouse 
model of chronic social defeat stress (CSDS).  
 
CB1-deficient (Cnr1-/-) mice were extremely sensitive to a standard protocol of CSDS, indicated by 
an increased mortality rate. Therefore, a mild CSDS protocol was established, which still induced 
a behavioural phenotype in highly susceptible Cnr1-/- mice. Molecular analysis showed that lack 
of CB1 receptors alters glucocorticoid levels after mild CSDS, supporting the hypothesis that CB1 
signalling regulates hypothalamic–pituitary–adrenal (HPA) axis activity and its adaptation during 
repeated stress exposure.  
 
In both humans and rodents, chronic stress is associated with elevated inflammatory signalling. 
This is indicated by increased numbers of circulating myeloid cells, which possibly infiltrate the 
brain, and the activation of microglia – the brain-resident immune cells. Mild CSDS induced weak 
myelopoiesis in the periphery, but did not induce recruitment of myeloid cells to the brain. In 
contrast, mild CSDS did affect microglial function in Cnr1-/- mice, indicated by increased surface 
expression of activation markers and altered morphology. Furthermore, microglial parameters 
were correlated with the severity of the behavioural phenotype in Cnr1-/- mice, thus implicating 
endocannabinoid-mediated modulation of microglia in the development of stress-related 
pathologies.  
 
In summary, the present study indicates that ECS/CB1 signalling is indeed essential to protect 
the organism from the physical and emotional harms of chronic stress. These protective 
mechanisms involve modulation of the HPA axis and microglial function.  
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1 
1 Introduction 
1.1 Stress and stress-related disorders 
1.1.1 Concepts of stress 
The concept of stress known today is largely based on observations of Claude Bernard, Walter B. 
Cannon, and Hans Selye in the late 19th and early 20th century (Goldstein and Kopin, 2007). Today, 
stress is defined as any threat to an organism’s homeostasis, a term introduced by Cannon to 
describe the maintenance of various physiological functions within an acceptable range. The 
threat, or stressor, can be external (e.g. exposure to cold, social conflicts) or internal (e.g. 
hypoglycaemia, infection) and can be consciously or unconsciously perceived. The body is 
equipped with mechanisms that can sense disturbances and activate effector systems that 
respond to the stressor and eventually restore homeostasis (Chrousos, 2009). These effector 
systems include the sympathetic nervous system (SNS), with noradrenaline as the main 
neurotransmitter, and the hypothalamic-pituitary-adrenal (HPA) axis, with glucocorticoids (GCs) as 
end product and main effector (see Figure 1). Based on Selye’s theories, it was long postulated 
that stress responses are nonspecific, meaning that stressors of different nature elicit the same 
set of responses. Today it is known that the responses can vary, at least to some degree, 
depending on the type, duration, intensity, and individual perception of the stressor (Childs et al., 
2014; Natelson et al., 1988; Sgoifo and Papi, 1995). It was also Selye, who postulated that severe 
or prolonged stress can cause physical and mental disorders – a concept widely accepted and 
scientifically proven today.  
 
1.1.2 Hypothalamic-pituitary-adrenal axis 
The main neuroendocrine stress response system is constituted by the HPA axis (Godoy et al., 
2018). Its activation is initiated by corticotrophin-releasing hormone (CRH)-expressing neurons in 
the paraventricular nucleus (PVN) of the hypothalamus. Release of CRH stimulates the production 
of adreno-corticotropic hormone (ACTH) by the pituitary gland and its release into circulation. ACTH 
then stimulates cells in the adrenal cortex to synthesise GCs (mainly cortisol in humans, 
corticosterone (CORT) in rodents). Circulating GCs in turn act on glucocorticoid receptors (GRs) in 
the hypothalamus and pituitary to inhibit further CRH and ACTH synthesis in a negative feedback 
loop. GCs are responsible for many of the physiological and psychological effects of stress by 
activating GRs in various target organs. Among others, GCs regulate immune system activity, 
metabolism, and cognitive functions (Kadmiel and Cidlowski, 2013). In the brain, GRs are not only 
expressed in the hypothalamus, but also in brain stem nuclei and limbic brain areas, such as the 
amygdala, hippocampus and prefrontal cortex (PFC). These brain regions also provide input to the 
PVN and can thereby modulate activity of the HPA axis (Godoy et al., 2018).  
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1.1.3 Sympathetic nervous system 
Along with the parasympathetic nervous system (PNS), the SNS is part of the autonomic nervous 
system that regulates unconscious body functions (McCorry, 2007). Sympathetic nerves arise in 
the spinal cord and innervate a variety of target organs, in most cases via two neurons that are 
connected within ganglia (pre- and postganglionic neuron). With a few exceptions (e.g. neurons 
innervating sweat glands), postganglionic neurons use catecholamines adrenaline or 
noradrenaline as neurotransmitter, which activate adrenergic receptors in the target organ. Both 
SNS and PSNS are active at baseline to maintain homeostasis, however, the SNS is also rapidly 
activated under stressful conditions (Ziegler, 2004). Activation of the SNS during stress leads, 
among others, to increased heart rate and contractile force, increased glucose production by the 
liver, and increased blood flow to muscles – all functions to prime the body for action and enhance 
the probability of survival. Sympathetic nerves also directly innervate the adrenal glands in a 
monosynaptic connection, also referred to as the sympathetic-adrenal-medullary (SAM) axis 
(McCorry, 2007). Release of acetylcholine (ACh) from preganglionic sympathetic fibres innervating 
the adrenal medulla stimulates the secretion of adrenaline, noradrenaline, and dopamine from 
chromaffin cells and thereby can potentiate stress effects.    
 
Furthermore, GCs and catecholamines are not only released in response to stress, but also under 
basal conditions, where their secretion follows a circadian rhythm (Dibner et al., 2010; Son et al., 
2011). Levels increase at the onset of an organism’s active phase (light phase in humans, dark 
phase in nocturnal animals, e.g. rodents). This provides a rhythmic signal to mobilise energy, 
increase alertness, and prime the immune system – all mechanisms to prepare the organism for 
potential challenges during the day (or night in nocturnal animals). 
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Figure 1. Overview of the two main stress response systems. Left panel: sympathetic nervous system (SNS). 
Sympathetic nerves arise in the spinal cord and innervate a variety of target organs, in most cases via two neurons that 
are connected within ganglia (pre- and postganglionic neurons are depicted in black and red, respectively). Most 
postganglionic neurons use adrenaline or noradrenaline as neurotransmitter, which activate adrenergic receptors in 
the target organ. Activation of the SNS has diverse functions, depending on the target organ. Right panel: hypothalamic-
pituitary-adrenal (HPA) axis. Activation of the HPA axis is elicited in the paraventricular nucleus (PVN) of the 
hypothalamus. Release of corticotrophin-releasing hormone (CRH) from PVN neurons stimulates the production of 
adreno-corticotropic hormone (ACTH) by the pituitary gland and its release into circulation. ACTH then stimulates cells 
in the adrenal cortex to synthesise glucocorticoids (GCs). Circulating GCs in turn act on glucocorticoid receptors (GRs) 
in the hypothalamus and pituitary to inhibit further CRH and ACTH synthesis in a negative feedback loop. 
 
1.1.4 Chronic stress and stress-related disorders 
While the activation of stress response systems provides an important benefit in situations of 
acute threat, prolonged or disturbed activity of these systems can have detrimental effects. 
Indeed, chronic stress is a major risk factor for various pathologies, ranging from psychiatric, to 
metabolic, cardiovascular, inflammatory, and autoimmune disorders (De Kloet et al., 2005; 
Yaribeygi et al., 2017). Among the most common consequences of chronic stress are negative 
emotional states and the development of affective disorders, including depression, anxiety, and 
posttraumatic stress disorder (PTSD). Symptoms of these disorders show considerable overlap, 
suggesting some common underlying pathology. The following section will exemplarily summarise 
the aetiology of depression, as one of the most common affective disorders. 
 
Depression, or major depressive disorder (MDD), affects up to 20% of the population throughout 
life. With more than 300 million people affected worldwide, depression is the leading cause of 
disability and substantially contributes to the overall disease burden (World Health Organization 
(WHO), 2018). Like other psychiatric disorders, depressive disorders are diagnosed according to 
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“The Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition“ (DSM-V) (American 
Psychiatric Association, 2013). For MDD diagnosis, patients must present at least five of the 
symptoms listed below over a period of at least two weeks (Table 1). Among those, one of the 
symptoms must be depressed mood or anhedonia (loss of interest or pleasure). Depression is 
caused by a complex interplay between biological (e.g. genetics, physical health) and external 
factors (e.g. social environment, adverse life events, trauma) (Lesch, 2004). And while there has 
been substantial research into the pathology of depression for many years, the underlying 
mechanisms still remain largely unknown. Classical pharmacological treatments are mainly based 
on the so-called monoamine hypothesis of depression, which postulates that depression is caused 
by a lack of monoamine neurotransmitters, such as serotonin, dopamine, and noradrenalin 
(Coppen, 1967; Schildkraut, 1995). However, anti-depressants that increase neurotransmitter 
levels in the brain (e.g. selective serotonin re-uptake inhibitors (SSRIs)) are ineffective in up to 
30% of patients (Nemeroff, 2007). Another hypothesis that has recently been receiving increasing 
interest is the inflammatory hypothesis of depression, which will be discussed in chapter 1.2.4.  
 
Table 1. DSM-V criteria for diagnosis of major depressive disorder  
Symptoms (≥ 5 have to be present for at least two weeks, one of them depressed mood or anhedonia) 
Depressed mood – most of the day 
Anhedonia: diminished interest or pleasure in all or most activities – most of the day 
Significant (> 5%) weight gain or loss, or reduced or increased appetite 
Insomnia or hypersomnia 
Psychomotor agitation or retardation (noticed by others) 
Fatigue or lack of energy  
Feelings of worthlessness or excessive or inappropriate guilt 
Diminished ability to think or concentrate, or indecisiveness 
Recurrent thoughts of death or suicide, suicide attempt or specific intention to commit suicide 
 
Next to psychiatric disorders, there is strong evidence linking chronic stress to an increased risk 
of metabolic and cardiovascular diseases (Dimsdale, 2008; Tamashiro et al., 2011). One major 
function of stress responses is the rapid mobilisation of energy and an increase in heart activity, 
which enables the organism to cope with the immediate threat (e.g. fleeing a predator). However, 
prolonged exposure to stressors will persistently disrupt metabolic homeostasis and eventually 
override regulatory systems (Ryan, 2014). Accordingly, chronic stress alters feeding behaviour 
and promotes obesity, which in turn is a known risk factor for diseases like type-2 diabetes and 
cardiovascular disease. Additionally, direct cardiovascular effects of elevated SNS activity (e.g. 
increased blood pressure) further increase the risk of cardiovascular complications like sudden 
death, myocardial infarction and ischemia (Dimsdale, 2008; Kivimaki and Steptoe, 2018). Finally, 
chronic stress is associated with an increased risk and exacerbated disease progression of 
inflammatory and autoimmune diseases, including inflammatory bowel disease, arthritis, and 
asthma (Evers et al., 2014; Mawdsley and Rampton, 2005; Wright, 2005). The connection 
between stress and immunity will be described in more detail in the following section.  
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1.2 Stress and the immune system 
One of the target systems of the HPA axis and SNS is the immune system. Peripheral immune 
cells are generally assigned to either the innate or the adaptive immune system (Parkin and 
Cohen, 2001). The innate immune system is considered the first line of defence against any 
pathogen or insult and mounts a rapid, but rather unspecific, immune response. It is comprised 
of myeloid cells, such as monocytes, macrophages, dendritic cells (DCs), and granulocytes as well 
as innate lymphocytes, such as natural killer (NK) cells. Adaptive immunity refers to the acquired, 
highly specific response to particular pathogens that is carried out by T- and B-lymphocytes, which 
also provide long-term protection against the encountered pathogen by developing immunological 
memory. Both cells of the innate and adaptive immune system are mainly generated from 
hematopoietic stem cell (HSC)-derived precursors in the bone marrow (Ng and Alexander, 2017). 
 
1.2.1 Myeloid cells: monocytes and microglia 
With regard to stress and stress-related disorders, a lot of research has been focused on myeloid 
cells, especially peripheral monocytes and microglia – the brain-resident immune cells.  
 
Monocytes are generated from myeloid progenitor cells in the bone marrow and are released into 
the circulation to eventually migrate to tissues throughout the body (Geissmann et al., 2010). This 
release is increased in response to inflammation or insults, such as injury. Monocytes can be 
differentiated into subsets of classical inflammatory and non-classical monocytes, which are 
characterized by differential expression of surface proteins, such as lymphocyte antigen 6 
complex (Ly6C), C-C chemokine receptor type 2 (CCR2), and fractalkine receptor (CX3CR1) 
(Gordon and Taylor, 2005). In the bone marrow, the vast majority of monocytes express high levels 
of Ly6C (Ly6Chi). Commonly, they are released into the circulation as Ly6Chi cells, where they either 
retain high Ly6C expression or differentiate into non-classical Ly6C low-expressing (Ly6Clo) 
monocytes that patrol the circulation. In tissues, monocytes usually differentiate into resident 
macrophages or DCs. The spleen serves as a reservoir for undifferentiated monocytes that can be 
rapidly mobilized in response to insults (Swirski et al., 2009). Monocytes fulfil several functions in 
innate immunity, including antigen presentation, phagocytosis, cytokine production, and tissue 
repair (Yang et al., 2014). Importantly, stress is associated with an increased blood monocyte 
count in both humans and animal models (see chapter 1.2.5).  
 
Microglia are the resident immune cells of the central nervous system (CNS) and fulfil various 
functions in both homeostasis and under pathological conditions (Gomez-Nicola and Perry, 2015). 
Microglia are derived from yolk-sac erythromyeloid progenitors that colonize the developing CNS 
early during embryogenesis (Ginhoux et al., 2013; Hoeffel and Ginhoux, 2015). This pool of 
microglia persists throughout life and maintains itself by proliferation, without substantial (or any) 
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replacement by infiltrating peripheral cells under normal circumstances (Askew et al., 2017). 
Microglia were long thought to remain in a resting state in the healthy brain and only become 
activated in response to pathological stimuli. By now it is known that “resting” microglia are highly 
dynamic cells that constantly scan their environment with many fine, mobile processes 
(Nimmerjahn et al., 2005). When brain homeostasis is disturbed (e.g. by injury, infection, or 
neurodegeneration) microglia undergo functional and morphological changes that aim at tissue 
defence and elimination of the insult – often termed “activation” (Colton and Wilcock, 2010; 
Kierdorf and Prinz, 2013). This state of “classical activation” is typically characterised by 
retraction of processes (amoeboid shape), increased phagocytic activity, increased surface 
expression of major histocompatibility complex (MHC) and costimulatory proteins (e.g. cluster of 
differentiation (CD)40, CD86) for antigen presentation, production of pro-inflammatory cytokines 
and chemokines (e.g. interleukin (IL)-6, IL-1b, tumor necrosis factor alpha (TNFa), chemokine C-C 
motif ligand 2 (CCL2)) and other inflammatory mediators, such as nitric oxide (NO) (Beins et al., 
2016; Boche et al., 2013). In order to restore homeostasis once the insult has been eliminated, 
microglia also contribute to the resolution of inflammation and tissue regeneration by acquiring 
an “alternative”, anti-inflammatory activation state. These activation states, however, are not a 
black or white situation but should rather be seen as a continuum (Martinez and Gordon, 2014; 
Murray et al., 2014).  
 
Next to those typical immune-related functions, microglia play important roles during brain 
development and homeostasis. In recent years, the interaction between microglia and neurons 
has been focus of many studies. As the major phagocyte of the brain, microglia are involved in 
phagocytosis of apoptotic cells (Sierra et al., 2010) as well as synaptogenesis and synaptic 
pruning (the elimination of unnecessary or non-functional synapses) and thus refinement of 
neuronal connections (Kettenmann et al., 2013; Tremblay, 2011; Wake et al., 2013). These 
processes are very important during development, when neuronal networks are generated, but 
also in the mature brain, where they play important roles in neuronal plasticity – the ability of 
neuronal connections to change over time in an activity-dependent manner.  
 
1.2.2 Glucocorticoid effects on the immune system 
Most immune cells express both GRs and adrenergic receptors and thus can sense and respond 
to the main signalling molecules released during stress (Miller et al., 1998; Scanzano and 
Cosentino, 2015). GCs are one of the body’s most potent immunosuppressants and are also 
commonly used as anti-inflammatory agents in the treatment of inflammatory or autoimmune 
diseases (Coutinho and Chapman, 2011). However, the mechanisms underlying the 
immunosuppressive actions are still not fully understood. Classically, the effects are mediated by 
cytoplasmic GRs expressed by immune cells. Upon GC binding, GRs are translocated to the 
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nucleus to induce or repress transcription of target genes, or to interact with other transcription 
factors (Coutinho and Chapman, 2011). One important target of GRs is the inflammation-related 
transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) (Bekhbat 
et al., 2017). The transcriptional activity of NFkB is inhibited upon interaction with GRs, which 
suppresses the expression of several pro-inflammatory genes. Pro-inflammatory cytokines, such 
as IL-1b, IL-6, and TNFa can further directly stimulate the HPA axis (Dunn, 2000). The release of 
GCs then suppresses the excessive expression of pro-inflammatory genes in a negative feedback 
loop. Thus, interaction between stress-response systems and the immune system is bidirectional. 
Additionally, GCs can differentially modulate other immune cell functions in a cell type-dependent 
manner, such as migration, adhesion, phagocytosis, antigen-presentation, differentiation, and 
survival (Oppong and Cato, 2015). For example, GCs have apoptotic actions on T-cells, but are 
anti-apoptotic in neutrophils (Brunetti et al., 1995; Liles et al., 1995). 
 
While GCs are generally powerful immunosuppressants, they can become pro-inflammatory under 
certain conditions. For example, it was repeatedly demonstrated that stress-induced GC 
production prior to an inflammatory stimulus increases pro-inflammatory responses of microglia 
(Fonken et al., 2016; Frank et al., 2010). Chronic stress is also associated with increased 
inflammation, both in the periphery and the brain. One explanation for this phenomenon is the 
development of GC resistance, i.e. the insufficient responsiveness of cells to GCs, both at the level 
of the HPA axis and of immune cells themselves (Pace et al., 2007; Raison and Miller, 2003). The 
lack of proper GC signalling may in turn lead to HPA axis hyperactivity and excessive inflammation. 
Thus, GC resistance can explain the seemingly paradox finding that many stress-related disorders 
are associated with HPA axis hyperactivity (hypersecretion of CRH and GCs) and a lack of GC-
mediated signalling at the same time. In fact, GC resistance at the level of the HPA axis is observed 
in up to 80% of depressed patients, as determined in the dexamethasone/CRH suppression test 
(Raison and Miller, 2003). Furthermore, peripheral immune cells isolated from the blood of 
depressed patients exhibit reduced responsiveness to the immunosuppressant actions of GCs 
(Carvalho et al., 2010, 2014; Pariante, 2017). Consistent with that, meta-analyses repeatedly 
showed that subsets of depressed patients exhibit higher levels of circulating pro-inflammatory 
cytokines, such as TNFa and IL-6 (Dowlati et al., 2010; Liu et al., 2012). Finally, both PTSD and 
MDD symptom severity is positively correlated with increased pro-inflammatory cytokine 
production and NFκB signalling in monocytes (Carvalho et al., 2014; Gola et al., 2013; Pace et al., 
2007).  
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1.2.3 Interaction between sympathetic nervous system and immune system 
Next to the HPA axis, the SNS provides the second important communication pathway between 
the brain and the immune system. Already in the early 20th century, it was found that a single 
injection of adrenaline into healthy human volunteers rapidly increases the number of circulating 
leukocytes (Loeper and Crouzon, 1904). These initial observations are supported by several 
studies showing that both acute and chronic psychological stress can increase HSC mobilisation 
from the bone marrow (Dhabhar et al., 2012; Heidt et al., 2014; Mckim et al., 2018). The bone 
marrow and other lymphoid organs, such as thymus and spleen, are heavily innervated by 
sympathetic nerve fibres that terminate in close proximity to stem cell niches (Katayama et al., 
2006; Yamazaki and Allen, 1990). In response to stress, release of noradrenaline and its 
interaction with adrenergic receptors on bone marrow stromal cells increases HSC proliferation 
and differentiation towards the myeloid cell lineage (Heidt et al., 2014). Furthermore, since most 
immune cells express adrenergic receptors, adrenaline and noradrenaline can also directly affect 
immune cell function (Scanzano and Cosentino, 2015).  
 
1.2.4 Inflammation and depression 
Already over two decades ago, the “inflammatory hypothesis of depression” was postulated by 
Michael Maes and has since received increasing interest in the scientific community (Maes, 
1995). Indeed, there are several lines of evidence suggesting that inflammatory responses 
contribute to the pathology of depression:  1) As mentioned above, depression is associated with 
elevated levels of pro-inflammatory cytokines in the blood, along with increased numbers of 
circulating leukocytes. 2) Many of the symptoms of depression resemble what is known as 
sickness behaviour – a generalised response to illness that includes low mood, lethargy, 
decreased appetite, social withdrawal, impaired concentration, pain, and fever (Dantzer, 2009). 
3) Chronic inflammatory disorders, such as cardiovascular disease, have a high co-morbidity with 
depression (Marrie et al., 2017). 4) Administration of pro-inflammatory mediators, such as 
interferon-a (IFNa) treatment in hepatitis C patients, induces depression in many patients 
(Dieperink et al., 2000). Furthermore, many studies using laboratory animals have by now 
confirmed the relevance of aberrant inflammatory signalling in depressive disorders.  
 
1.2.5 Animal models of depression and inflammation  
Exposure to psychosocial stress is one of the most reliable predictors of developing depression in 
humans and is a common experimental procedure to induce depressive-like behaviour in rodents 
(Björkqvist, 2001). Chronic social defeat stress (CSDS), the model applied in this study, is a 
resident-intruder paradigm, where the experimental mouse – the intruder – is exposed to 
repeated bouts of social defeat by a dominant aggressor mouse – the resident) (Golden et al., 
2011). This or similar models recapitulate many of the behavioural, endocrine, and immunological 
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responses that are observed in patients suffering from stress-related disorders, such as MDD, 
PTSD, and anxiety disorders. Mice that underwent CSDS typically show GC resistance, elevated 
plasma cytokines, and increased production and mobilization of myeloid cells from the bone 
marrow. In the brain, CSDS increases neuronal and microglial activity in stress-responsive regions 
and increases cell adhesion molecule expression on neurovascular endothelial cells. This in turn 
recruits inflammatory monocytes to the brain, which are said to play a causative role in the 
development of stress-related behavioural pathology (Weber et al., 2017; Wohleb et al., 2015).  
 
So while there is increasing evidence for a role of neuroimmune mechanisms in the pathology of 
depression and other stress-related disorders, the treatment is still largely based on directly 
modulating neurotransmitter systems in the brain. However, the low efficacy of available anti-
depressant treatments prompts the need for more research and identification of other drug 
targets. One such potential target is the so-called endocannabinoid system (ECS), which will be 
discussed in the following sections. It is well known for its role in regulating neuronal signalling, 
stress responses, and inflammation and thus constitutes a promising target for the treatment of 
stress-related disorders.   
 
1.3 The endocannabinoid system 
Preparations of the plant Cannabis sativa, commonly known as cannabis, have been used for 
medicinal and recreational purposes for centuries and are well known for their mood-elevating 
and stress-relieving properties (Murray et al., 2007). Its main psychoactive ingredient, Δ9-
tetrahydrocannabinol (THC), was discovered in 1964 by Raphael Mechoulam and colleagues 
(Gaoni and Mechoulam, 1964), who is today considered the “father of cannabinoid research”. It 
then took over two decades until THC’s molecular target – the first cannabinoid receptor (CB1) – 
was identified in the late 1980s (Devane et al., 1988; Matsuda et al., 1990), followed by the 
second cannabinoid receptor (CB2) (Munro et al., 1993) and their two main endogenous ligands 
N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) (Devane et al., 
1992; Mechoulam et al., 1995). These discoveries initiated extensive research into the ECS and 
its role in health and disease. Today, it is known that the ECS is widely expressed in mammalian 
tissues and is involved in a multitude of physiological and pathological processes (Pacher et al., 
2006). The following section will briefly describe the main components of the ECS and its 
signalling mechanisms in the CNS, where it is best characterised.  
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1.3.1 Endocannabinoid system components: receptors, ligands, and enzymes 
Both of the two main cannabinoid receptors, CB1 and CB2, are G protein-coupled receptors 
(GPCR), but their expression pattern varies substantially. CB1 receptors are highly expressed in 
the CNS (Matsuda et al., 1990), while CB2 receptors are mainly found in the periphery, with high 
expression on immune cells (Galiegue et al., 1995; Munro et al., 1993). In recent years, this 
segregation of the “central” and “peripheral” cannabinoid receptor was, however, challenged by 
the identification of CB2 expression by different brain cells, including neurons (Li and Kim, 2015; 
Onaivi et al., 2006; Stempel et al., 2016) and studies showing that CB1 receptors also act in 
peripheral, non-neuronal cells (Cota et al., 2003; Teixeira-Clerc et al., 2006). Next to CB1 and CB2, 
several other receptors (e.g. GPR55, GPR18) are considered cannabinoid or cannabinoid-like 
receptors, since they can be activated by cannabinoid compounds, be it endogenous, plant-
derived, or synthetic (McHugh, 2012; Stella, 2010).  
 
The main functions of CB1 and CB2 are attributed to the two well-documented endocannabinoids 
(eCBs), 2-AG and AEA. Although AEA and 2-AG possess distinct properties and binding affinities 
for the receptors, both are derived from lipid precursors and are produced on-demand in response 
to increased intracellular calcium (Ca2+) concentrations. Due to their lipophilic nature, eCBs 
cannot be stored in intracellular vesicles like neurotransmitters. The synthesis and degradation 
of 2-AG and AEA are catalysed by a set of specific enzymes that complete the main components 
of the ECS. In brief, 2-AG is primarily produced by the hydrolysis of diacylglycerol (DAG) by the 
enzyme DAG lipase (DAGL) (Prescott and Majerus, 1983; Sugiura et al., 1995). DAGL exists in two 
isoforms – DAGLa and DAGLb, which display distinct expression patterns with respect to the type 
of tissue and developmental stage (Bisogno et al., 2003). In the adult brain, DAGLa seems to be 
the main source of 2-AG. Degradation of 2-AG is mainly mediated by monoacylglycerol lipase 
(MAGL) that cleaves 2-AG into arachidonic acid (AA) and glycerol (Sugiura et al., 2006). While 
DAGLa and MAGL constitute the primary metabolic pathways for 2-AG, other less abundant 
pathways have been described, such as hydrolysis by the enzymes ABHD6 and ABHD12 
(Blankman et al., 2007). For AEA, several pathways have been described for its synthesis. The 
most direct one involves the hydrolysis of N-acyl-phosphatidylethanolamine (NAPE) by NAPE-
specific phospholipase D (NAPE-PLD) (Hansen et al., 2000; Okamoto et al., 2007). Degradation 
of AEA is mediated by fatty acid amino hydrolase (FAAH), which hydrolyses AEA into AA and 
ethanolamine (Cravatt et al., 1996). AEA and 2-AG can further both be metabolised by several 
other enzymes, including cyclooxygenase-2 (COX-2), lipoxygenases (LOX), and cytochrome P450 
(CYPs) enzymes (Zelasko et al., 2015). 
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1.3.2 Retrograde endocannabinoid signalling in the central nervous system  
In the brain, CB1 receptors are one of the most widely-expressed receptors from the GPCR family, 
suggesting an essential role of CB1 signalling in brain function (Herkenham et al., 1991; Kano et 
al., 2009; Mackie, 2005). CB1 receptors are localized at the presynaptic neuron of both excitatory 
and inhibitory synapses and are activated by eCBs produced by the postsynaptic neuron (Katona 
et al., 1999, 2006). CB1 signalling thus acts as a retrograde feedback system. Since 2-AG 
concentrations are approximately 800 times higher than AEA in the brain, 2-AG is considered the 
primary mediator of eCB signalling in the CNS (Sugiura et al., 1995). Therefore, the following 
section will exemplify CB1 signalling via 2-AG (see Figure 2). Nonetheless, it should be noted that 
AEA also contributes to eCB signalling.  
 
The classical eCB retrograde signalling usually starts with excessive neurotransmitter release from 
the presynaptic neuron (Kano et al., 2009). The consequent strong depolarization of the 
postsynaptic neuron causes increased cytoplasmic Ca2+ concentrations and/or activated 
Gq/11 protein-coupled receptors, which induces the production of 2-AG by DAGLa. Subsequently, 
2-AG is released into the synaptic cleft and activates presynaptic CB1 receptors. Gi/o proteins 
coupled to the CB1 receptor then suppress further release of neurotransmitter from the 
presynaptic neuron by inhibiting Ca2+ influx through voltage-gated Ca2+ channels. CB1 signalling 
is terminated by the rapid uptake and subsequent degradation of 2-AG primarily by presynaptic 
MAGL (Murataeva et al., 2014). Depending on whether the synapse uses glutamate (excitatory) 
or g-aminobutyric acid (GABA) (inhibitory), retrograde CB1 signalling thus mediates depolarisation-
induced suppression of excitation (DSE) or inhibition (DSI), respectively (Kreitzer and Regehr, 
2001a, 2001b; Ohno-Shosaku et al., 2001; Wilson et al., 2001).  
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Figure 2. Retrograde signalling of the endocannabinoid system in the brain. Exemplarily illustrated for 2-AG, the most 
abundant brain eCB. Left: inhibitory, GABAergic synapse; right: excitatory, glutamatergic synapse. High frequency 
stimulation of a presynaptic neuron leads to influx of Ca2+ into the presynaptic terminal, triggering the release of 
neurotransmitter into the synaptic cleft (GABA or glutamate, respectively), which activate postsynaptic receptors. Strong 
depolarization of the postsynaptic neuron causes influx of Ca2+ through voltage-gated Ca2+ channels (and/or NMDA 
receptors in glutamatergic synapses). The increase in Ca2+ induces the production of 2-AG from DAG through DAGL 
activity. In glutamatergic synapses, 2-AG production can further be triggered via activation of metabotropic glutamate 
receptors (mGluR5) coupled to Gq/11 proteins, which induce DAG production from membrane phosphatidylinositol (PI) 
by phospholipase Cb (PLCb). 2-AG is released into the synaptic cleft and activates presynaptic CB1 receptors. 
Associated Gi/o proteins suppress the influx of Ca2+ through voltage-gated Ca2+ channels – among others – thus 
inhibiting further neurotransmitter release. 2-AG is taken up into the presynaptic terminal and degraded by MAGL. 
Additionally, astrocytes close to the synapse can actively contribute to synaptic transmission and endocannabinoid 
(eCB) signalling, since they are able to detect and produce both neurotransmitters and eCBs. Microglia, the resident 
immune cells of the brain, are equipped with components of the ECS as well and thus can respond to or modulate eCB 
signalling. Abbreviations: AA: arachidonic acid, AMPA: a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(ionotropic glutamate receptor), Ca2+: calcium ion, DAG: diacylglycerol, DAGL: DAG lipase, GABA: γ-aminobutyric acid 
(inhibitory neurotransmitter), Glu: glutamate (excitatory neurotransmitter), NMDA receptor: N-methyl-D-aspartate 
receptor (ionotropic glutamate receptor).  
 
1.3.3 CB1 receptors – beyond retrograde signalling  
While this retrograde signalling at synapses is the best described mechanism of endocannabinoid 
actions, recent years have provided evidence that eCB/CB1 signalling is much more diverse. CB1 
activation can modulate several intracellular signalling cascades, such as the adenylyl cyclase 
(AC)/cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway, or several 
mitogen-activated protein kinases (MAPKs) (Turu and Hunyady, 2010). Thereby, CB1 signalling 
can also have other, longer-lasting effects on synaptic transmission - one example being long-term 
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depression (LTD), a process crucially involved in neuronal plasticity. Furthermore, CB1 receptors 
are also located on mitochondrial membranes (mtCB1), where they can regulate mitochondrial 
activity and thus energy supply of the cell (Bénard et al., 2012; Hebert-Chatelain et al., 2014). In 
the brain, mtCB1 signalling was shown to regulate cannabinoid effects on memory formation, a 
process long-thought solely dependent on presynaptic plasma membrane CB1 receptors (Hebert-
Chatelain et al., 2016). So far, mtCB1 expression has been demonstrated for neurons and 
astrocytes in the brain. CB1 receptors, as well as other components of the ECS, are thus not only 
expressed by neurons, but also other cell types within the CNS, including astrocytes and microglia 
(Metna-Laurent and Marsicano, 2015; Stella, 2010). The ECS can therefore act as a 
communication system between the different cells of the CNS.  
 
1.3.4 CB1 signalling in the periphery 
Next to its well-described functions in the CNS, the ECS regulates a plethora of peripheral 
processes, ranging from reproductive-, gastrointestinal-, and cardiovascular-function to bone 
metabolism, immunity and the endocrine system (Chiurchiu et al., 2015; Idris and Ralston, 2012; 
Izzo and Sharkey, 2010; Meccariello et al., 2014; Montecucco and Di Marzo, 2012). The next 
section will briefly outline how CB1 signalling can regulate peripheral systems relevant to this 
study.   
 
1.3.4.1 Sympathetic nervous system  
CB1 receptors are expressed on adrenergic and noradrenergic neurons both in the brain and 
peripheral nerves that innervate various target organs (Lowin and Straub, 2015; Mackie, 2005; 
Oropeza et al., 2007; Sanudo-Pena et al., 1999). Similar to the retrograde feedback signalling 
described above, activation of CB1 receptors on sympathetic nerve terminals inhibits the release 
of noradrenaline (Ishac et al., 1996; Pfitzer et al., 2005; Szabo et al., 2001). For example, it was 
demonstrated that the lack of CB1 signalling increases noradrenaline levels in the bone and 
thereby influences bone formation and absorption (Bab and Zimmer, 2008; Tam et al., 2008). 
Similarly, blocking CB1 receptors on sympathetic nerves that innervate the spleen can increase 
adrenergic signalling and thereby modulate immune processes (Mnich et al., 2010). 
 
1.3.4.2 Hypothalamic-pituitary-adrenal axis 
CB1 receptors are also found at all levels of the HPA axis, namely within the hypothalamus, the 
pituitary, and the adrenal glands (Hillard et al., 2017). In fact, CB1 signalling is essential for the 
GC-mediated fast feedback inhibition of the HPA axis. In vitro and in vivo studies showed that GCs 
can rapidly induce the production of 2-AG by CRH neurons in the hypothalamus via non-genomic 
GR signalling (Di et al., 2003; Evanson et al., 2010; Hill et al., 2010b). Activation of CB1 receptors 
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on presynaptic glutamatergic neurons by 2-AG then suppresses the excitatory input onto CRH 
neurons and thus inhibits HPA axis activity. Furthermore, GCs can modulate eCB levels and CB1 
signalling in other brain regions that provide input to the PVN (hippocampus, PFC, amygdala) (Hill 
et al., 2010a, 2011; Rademacher et al., 2008; Sumislawski et al., 2011; Wang et al., 2012; Zoppi 
et al., 2011). For example, CB1 signalling via AEA and 2-AG in the basolateral amygdala (BLA) 
appears to be important for HPA axis initiation during acute stress exposure and its habituation 
to repeated stress, respectively.  Since CB1 receptors are also expressed by cells of the pituitary 
and adrenal gland, they can also directly regulate HPA axis activity at these levels (Cota et al., 
2007).  
 
1.3.5 CB1 signalling and depression  
As described above, CB1 signalling is involved in the regulation of many aspects that are affected 
in psychiatric disorders, such as mood, stress responses, and cognitive function. Accordingly, lack 
of CB1 signalling is associated with an increased risk to develop these disorders. A prominent 
example is the drug rimonabant (SR141716), an inverse agonist selective for CB1 receptors 
(Rinaldi-Carmona et al., 1994). It was developed by Sanofi-Aventis and approved as an anorectic 
drug for obese patients in Europe in 2006. However, its approval was eventually withdrawn 
worldwide in 2008 due to serious psychiatric side effects. In about 10% of subjects, blocking CB1 
receptors with rimonabant caused mood alterations or depressive symptoms and even suicidal 
ideation in about 1% (Christensen et al., 2007). Other side effects included anxiety, irritability, 
sleep disorders, fatigue, gastrointestinal problems (nausea, diarrhoea, vomiting), spasms, 
respiratory tract infections and flu-like symptoms (Aagaard, 2014; Christensen et al., 2007). 
Similarly, mice with a genetic deletion of the gene encoding CB1 (Cnr1) show phenotypes similar 
to clinical symptoms of depressive disorders (see Table 2) (Valverde and Torrens, 2012).  
 
Table 2. Phenotype of CB1 knockout (Cnr1-/-) mice and symptoms of depression (from Valverde & Torrens, 2012) 
Phenotype of Cnr1-/- mice Clinical symptoms of depressive disorders 
Increased anxiety-like behaviour  Increased anxiety  
Higher sensitivity to develop depressive-like symptoms 
after stress  
Impaired stress-coping 
Cognitive impairments, e.g. in the extinction of aversive 
memories 
Cognitive dysfunction in MDD, impaired extinction of 
traumatic experiences in PTSD 
Decreased rewarding effects of natural rewards and 
altered responses to drugs of abuse 
Anhedonia; co-morbidity with substance use disorders 
Decreased locomotor activity Low energy and psychomotor retardation 
Changes in baseline and higher stress-induced CORT 
levels  
Enhanced cortisol response to stress, hyperactivity of 
HPA axis in depression 
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1.3.6 ECS/CB1 signalling and inflammation 
Most of the studies on CB1 and its role in depressive disorders have focused on CB1-mediated 
regulation of neuronal function, such as serotonergic signalling or neurogenesis (Aso et al., 
2008a, 2009; Steiner et al., 2008). However, the ECS  in general also has well-documented 
immunomodulatory functions (Chiurchiu et al., 2015). These are mainly attributed to CB2 
receptors, which are expressed by most immune cells, including microglia (Galiegue et al., 1995; 
Munro et al., 1993). In microglia, eCBs can reduce the production of pro-inflammatory mediators 
and increase anti-inflammatory cytokine production via CB2 receptors (Correa et al., 2010; 
Eljaschewitsch et al., 2006; Puffenbarger et al., 2000). Furthermore, 2-AG stimulates microglial 
proliferation and migration, which seems to be mediated by both CB1 and CB2 (Carrier et al., 
2004; Eljaschewitsch et al., 2006; Walter et al., 2003). Furthermore, there are a few studies 
showing that also CB1 receptors can regulate immune function. For example, blocking CB1 
signalling in peripheral organs appears to be protective under inflammatory conditions (e.g. liver 
fibrosis), mediated by reducing macrophage migration, reactive oxygen species (ROS) production, 
and pro-inflammatory activation (Mai et al., 2015; Mnich et al., 2010; Tian et al., 2017). In the 
CNS, lack of CB1 receptors on GABAergic forebrain neurons alters neuroinflammatory processes 
and microglial activation at baseline and in response to pro-inflammatory stimuli as well as during 
ageing (Albayram et al., 2011; Ativie et al., 2018).  
 
However, the contribution of CB1 signalling to immune function has never been studied in the 
context of stress. In a recent study, it was shown that pharmacological treatment with a 
cannabinoid agonist can reverse social stress-induced myelopoiesis, neuroinflammation, and 
anxiety (Lisboa et al., 2018). Whether these effects were mediated by CB1 or CB2 receptors is, 
however, not known, since a non-selective agonist was used. Considering the prominent role of 
CB1 in stress-related pathologies, its presence in most – if not all – systems that are involved in 
neuroimmune communication, and the increasing evidence linking inflammation to psychiatric 
disorders, it is tempting to speculate that CB1 signalling provides a connection between 
behavioural, neuroendocrine, and immunological responses to stress (see Figure 3).  
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Figure 3. Neuroimmune communication systems during chronic stress and their possible regulation by CB1 signalling. 
Stress activates stress responses, including the hypothalamic–pituitary–adrenal (HPA) axis, which leads to the 
secretion of glucocorticoids (GCs) by the adrenal glands. GC acting via glucocorticoid receptors (GR) expressed by 
immune cells (e.g. macrophages, monocytes) usually exert strong immunosuppressant functions. During chronic stress, 
this immunosuppressive function is often lost, eventually leading to enhanced production of inflammatory mediators 
(e.g. pro-inflammatory cytokines) and thus chronic low-grade inflammation. Cytokines, such as interleukin 6 (IL-6), IL-
1b, or tumor necrosis factor alpha (TNFa) can signal to the brain and act on microglia – the resident immune cells of 
the brain. High levels of pro-inflammatory cytokines and microglial activation trigger neuroinflammation, which can 
affect neuronal function. A second system activated by stress is the sympathetic nervous system (SNS). During chronic 
stress, increased release of noradrenaline (norepinephrine, NE) from nerves innervating the bone marrow induces the 
production of myeloid cells (monocytes, neutrophils). Downregulation of retention factor C-X-C motif chemokine 12 
(CXCL12), mediated by NE and GCs, increases the release of myeloid cells into the circulation and subsequent 
trafficking to different organs, including the spleen and possibly the brain. In the brain, infiltrated monocytes are thought 
to contribute to neuroinflammatory processes and thereby drive the development of stress-related pathologies, such 
as depression and anxiety. The CB1 receptor is expressed in all systems involved in this neuroimmune communication 
during stress and known to regulate them in different contexts. Whether CB1 signalling also regulates these processes 
during chronic stress and whether they contribute to the increased stress-susceptibility in the absence of CB1 signalling 
is however not known. 
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1.4 Aim of this study 
As described above, there is increasing evidence linking inflammatory processes to psychiatric 
disorders. Chronic stress, a major environmental factor contributing to the development of these 
disorders, affects immune system activity through neuronal and endocrine signals. The link 
between CB1 signalling, stress-reactivity, and psychiatric disorders is well established. However, 
it is not known whether this is a purely neuronal effect or whether it is accompanied or mediated 
by altered immune system regulation. The aim of this study was therefore to analyse how CB1 
signalling modulates behavioural, neuroendocrine, and immunological responses in a mouse 
model of chronic social defeat stress (CSDS). The model recapitulates many of the symptoms that 
are observed in patients suffering from stress-related disorders, such as depression, PTSD, and 
anxiety disorders and previous studies suggest that these stress effects are driven by altered 
myeloid cell function. To elucidate the role of CB1 signalling in these processes, CSDS was 
performed in mice with a genetic deletion of CB1 receptors (Cnr1-/-).  
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2 Materials and methods 
2.1 Equipment 
 
Technical instrument Identifier, company 
Analytical balance BP 121 S, Sartorius 
Liquid handling platform Janus®, Perkin Elmer 
Cell culture incubator Binder GmbH 
Centrifuges Biofuge fresco, Heraeus Instruments 
Megafuge 1.0R, Heraeus Instruments 
Multifuge 3 S-R, Heraeus Instruments 
Cryostat CM3050S, Leica 
Digital gel documentation ChemiDoc MP imaging system, Bio-Rad Laboratories 
Electrophoresis chamber  Sub-Cell GT System, Bio-Rad Laboratories 
Flow cytometer FACS Canto II, BD Bioscience 
Home cage activity measurement Mouse-E-Motion, Infra-e-motion 
Laminar flow hood Herasafe, Kendro 
Magnetic stirrer MR 3001 K, Heidolph, Fisher  
Microplate reader MRX TC II, Dynex Technologies 
Microscope Leica TCS SP8, Leica  
Animal video-tracking-system EthoVision XT, Noldus Information Technology 
PCR cycler iCycler, Bio-Rad Laboratories 
pH meter inoLab, WTW 
Real-time PCR cycler LightCycler 480, Roche 
Spectrophotometer NanoDrop 1000, Thermo Scientific 
Sterilizing oven Varioklav 25T, H+P Labortechnik 
Tissue homogeniser Precellys 24, Bertin Technologies 
Vacuum concentrator SpeedVac SPD111V, Thermo Fisher 
Vortexer Vortex-Genie 2, Scientific Industries 
Mouse telemetry implants Data Science International 
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2.2 Chemicals and reagents 
2.2.1 Chemicals/enzymes 
 
Chemical/enzyme  Company (catalog #) 
1-bromo-3-chloropropane (BCP) Sigma-Aldrich (B9673) 
100 bp DNA ladder  Life Technologies (15628-050) 
10x red blood cell (RBC) lysis buffer BioLegend (420301) 
2-Methylbutan/isopentane Sigma-Aldrich (320404) 
2-Propanol/isopropanol Carl Roth (6752.4) 
4’,6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich (10236276001) 
Ammonium hydroxide Sigma-Aldrich (221228) 
Carprofen (Rimadyl®) Pfizer (30601241) 
Citric acid Promega (H526a) 
Collagenase/Dispase (for brain tissue) Roche (11097113001) 
Collagenase type VIII (for spleen tissue) 
DNase I from bovine pancreas (for spleen tissue) 
Sigma-Aldrich (C2139-1g) 
Sigma-Aldrich (DN-25-100mg) 
DNase I from bovine pancreas (for brain tissue) Roche (11284932001) 
DNase I recombinant, RNase-free (+ 10x incubation buffer) Sigma-Aldrich (4716728001) 
DNase/RNase-free distilled water Gibco (10977015) 
dNTP mix (10 mM) Sigma-Aldrich (D7295) 
Dulbecco's Modified Eagle Medium (DMEM), high glucose Gibco (11965-092) 
Ethanol (EtOH) absolute  VWR (20821.330) 
Ethidium bromide solution (10 mg/ml) Sigma-Aldrich (E1510) 
Ethylenediaminetetraacetic acid (EDTA), disodium salt  Calbiochem (324503) 
Fetal calf serum (FCS) PAA (A15-108) 
Fluoromount-G® SouthernBiotech (0100-01) 
Hydrochloric acid (HCl) 37% Carl Roth (X942.1) 
Isoflurane Piramal (30372.00.00) 
Ketamine hydrochloride Inresa Arzneimittel GmbH (30101021) 
L-glutamine (200 mM) Gibco (25030081) 
Lipopolysaccharide (LPS) from E. coli 0127:B8   Sigma-Aldrich (L4516) 
Normal donkey serum Abcam (ab7475) 
Normal goat serum Abcam (ab7481) 
Oligo(dT) primer (50 µM) Invitrogen (18418012) 
Paraformaldehyde (PFA) Sigma-Aldrich (P6148) 
Penicillin-Streptomycin (10,000 U/ml) Gibco (15140122) 
Percoll™  GE Healthcare (17-0891-01) 
Phosphate-buffered saline (PBS) tablets Gibco (18912014) 
Phosphoric acid (H3PO4) Sigma Aldrich (43.808) 
Proteinase K NEB (P8107S) 
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Chemical/enzyme  Company (catalog #) 
RPMI 1640 medium Gibco (21875-034) 
Sodium azide Sigma-Aldrich (S8032) 
Sodium chloride (NaCl) Carl Roth (9265) 
Sodium dodecyl sulphate (SDS) Carl Roth (2326) 
Sucrose, for microbiology Sigma-Aldrich (84100) 
SuperScript™ II reverse transcriptase  
(+ 5x first-strand buffer and DTT (0.1M)) 
Invitrogen (18064014) 
Taq Polymerase (+ 10x ThermoPol buffer) NEB (M0267X) 
TaqMan® Gene Expression Assays Applied Biosystems (4331182) 
TaqMan® Gene Expression Master Mix  Applied Biosystems (4370074) 
Tissue-Tekâ O.C.T. Compound VWR (4583) 
Tris-(hydroxymethyl)aminomethane (Tris) Carl Roth (5429) 
Tris-HCl Carl Roth (9090.3) 
Triton™ X-100 detergent Sigma-Aldrich (T9284) 
TRIzol® reagent Life technologies (15596026) 
TWEEN® 20 Sigma-Aldrich (P9416) 
UltraPure™ agarose Invitrogen (15510-027) 
Xylazin hydrochloride (Rompunâ) Bayer (03406) 
 
 
2.2.2 Solutions and buffers (general) 
If not stated otherwise, solutions were prepared with ultrapure distilled water (MilliQ H2O).  
 
Solution/buffer   Composition  
Phosphate-buffered saline (PBS), pH 7.4 
500 ml MilliQ H2O  
+ 1 PBS tablet  
Tris-buffered saline (TBS), pH 7.5 
MilliQ H2O 
+ 50 mM Tris-HCl 
+ 150 mM NaCl 
Tris-EDTA (TE) buffer, pH 7.4 
MilliQ H2O 
+ 10 mM Tris 
+ 1 mM EDTA, pH 8.0 
Tris-acetate-EDTA (TAE) buffer  
MilliQ H2O 
+ 40 mM Tris-acetate 
+ 1 mM EDTA pH 8.0 
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2.2.3 Genotyping 
 
Solution/buffer Composition 
Mouse tail lysis buffer 
MilliQ H2O 
+ 100 mM Tris/HCl pH 8.0 
+ 5 mM EDTA 
+ 200 mM NaCl 
+ 0.2% (w/v) SDS  
+ Proteinase K (1 mg/ml) (added later)  
Ethidium bromide bath solution  
TAE buffer 
+ 1.5 µg/ml ethidium bromide  
 
2.2.4 Immunohistochemistry 
 
Solution/buffer Composition 
4% Paraformaldehyde (PFA) PBS + 4% (w/v) PFA, sterile filtered 
Decalcification solution for bone tissue 
PBS  
+ 14% (w/v) EDTA  
+ 3% (v/v) ammonium hydroxide 
Cryoprotection solution 
PBS  
+ 30% (w/v) sucrose 
Citrate buffer pH 6.0 for antigen retrieval 
MilliQ H2O 
+ 10 mM citric acid 
+ 0.05% (v/v) Tween 20 
PBS-Triton X-100 (PBS-T)/ 
TBS-Triton X-100 (TBS-T) 
PBS/TBS 
+ 0.025 – 0.5% (v/v) Triton X 100  
Blocking solution 
PBS-T 0.5% or TBS-T 0.5% 
+ 5 – 10% (v/v) normal serum  
(of host species of 2nd antibody) 
Antibody solution 
PBS-T 0.025 – 0.1% or TBS-T 0.25% 
+ 2.5 – 5% (v/v) normal serum  
(of host species of 2nd antibody) 
 
2.2.5 Cell culture 
 
Solution/buffer Composition  
Culture medium for splenocytes 
RPMI 1640  
+ 10% (v/v) FCS  
+ 1% (v/v) Penicillin-Streptomycin (10,000 U/ml) 
+ 1% (v/v) L-glutamine (200 mM) 
Lipopolysaccharide (LPS)  
Stock: 5 mg/ml LPS  
from Escherichia coli 0127:B8  in sterile dH2O 
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2.2.6 Flow cytometry  
 
Solution buffer Composition  
FACS buffer 
PBS  
+ 2% (v/v) FCS 
Red blood cell (RBC) lysis buffer 
MilliQ H2O 
+ 10% (v/v) 10x RBC lysis buffer 
Medium CNS mononuclear cells 
 DMEM, high glucose 
+ 10% (v/v) FCS 
Digestion mix for brain tissue 
Medium 
+ 1 mg/ml Collagenase/Dispase  
+ 1 mg/ml DNase I  
Stock isotonic Percoll (SIP)  
Percoll™  
+ 10% (v/v) PBS (10X) 
Digestion mix for spleen tissue 
PBS 
+ 1 mg/ml Collagenase type VIII 
+ 120 KU/ml DNase I  
 
2.2.7 Enzyme-linked Immunosorbent Assay (ELISA) Kits 
 
Assay Company  Solutions prepared (not provided by Kit) 
Mouse IL-1β  
Ready-SET-Go! 
eBioscience 
 
Wash buffer (0.05% TWEEN® 20 in PBS) 
Stop solution (1 M H3PO4) 
Mouse IL-6  
Ready-SET-Go! 
eBioscience 
 
Wash buffer (0.05% TWEEN® 20 in PBS) 
Stop solution (1 M H3PO4) 
Mouse TNFα  
Ready-SET-Go! 
eBioscience 
 
Wash buffer (0.05% TWEEN® 20 in PBS) 
Stop solution (1 M H3PO4) 
Mouse CCL2 (MCP-1)  
Ready-SET-Go! 
eBioscience 
 
Wash buffer (0.05% TWEEN® 20 in PBS) 
Stop solution (1 M H3PO4) 
DetectX® Corticosterone 
Enzyme Immunoassay Kit 
Arbor Assays  
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2.3 Methods 
2.3.1 Mice 
In this study, the following mouse lines were used for behavioural and molecular analysis: 
C57BL/6J wild type (WT) and B6.cgCnr1tm1Zim (constitutive CB1 knockout). C57BL/6J mice 
were originally obtained from a commercial breeder (Charles River) and bred at the animal facility 
of the University of Bonn. B6.cgCnr1tm1Zim mice were generated by disrupting the Cnr1 coding 
region with a neomycin cassette, using homologous recombination in embryonic stem cells 
(Zimmer et al., 1999). Mutant mice were backcrossed to C57BL6/J mice for more than ten 
generations. For this study, B6.cgCnr1tm1Zim mice were bred mainly using heterozygous 
breeding pairs (Cnr1+/- x Cnr1+/-) that generate offspring with the following genotypes: homozygous 
wild type (Cnr1+/+), heterozygous CB1 knockout (Cnr1+/-), and homozygous CB1 knockout (Cnr1-/-). 
Cnr1+/+ and Cnr1-/- littermates were used for most experiments. In early experiments (standard 
CSDS), WT and Cnr1-/-mice were derived from separate homozygous breeding pairs. For clarity, 
WT mice will be referred to as Cnr1+/+ in this case as well. If not stated otherwise, mice were group-
housed (3-5 animals per cage) in standard laboratory cages under specific-pathogen-free (SFP) 
conditions, with a normal light-dark cycle (lights on from 07:00 am to 07:00 pm) with ad libitum 
access to food and water. Male CD1 mice (6 months old retired breeders), used as aggressor mice 
for CSDS, were obtained from a commercial breeder (Janvier) and single-housed in standard 
laboratory cages with a reversed light-dark cycle (lights on from 09:00 pm to 09:00 am) with ad 
libitum access to food and water. All experiments followed the guidelines of the German Animal 
Protection Law and the Local Committee for Animal Health, LANUV NRW, approved the 
experiments (84-02.04.2015.A192). 
2.3.1.1 Genotyping – DNA isolation  
For mouse genotyping, DNA was isolated from mouse tail biopsies. The tissue was incubated 
overnight in 200 µl mouse tail lysis buffer and proteinase K (1 mg/ml) at 50°C with shaking (550 
rpm). After lysis, samples were centrifuged (12000 x g, 10 min, 4°C) and the supernatant 
transferred to a fresh tube. DNA was precipitated by adding 200 µl isopropanol and inverting the 
tube several times. Afterwards, the DNA pellet was washed twice with 70% ethanol, air-dried and 
dissolved in 100 µl TE buffer. 
2.3.1.2 Genotyping – DNA amplification by polymerase-chain reaction  
Sequence specific amplification of DNA fragments for genotyping was performed using 
polymerase-chain reaction (PCR). Each PCR reaction was specifically adapted to the temperature 
requirements of the oligonucleotides (primer) and the length of the desired PCR product. PCR was 
performed using Taq Polymerase, 10x ThermoPol buffer, dNTPs, and respective primer pairs. 
Established PCR conditions and corresponding primer sequences are listed below. 
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PCR reaction for B6.cgCnr1tm1Zim genotyping 
15.4 µl Sterile water 
2.1 µl 10x ThermoPol buffer 
0.5 µl dNTP mix (10mM) 
0.3 µl Primer WT: 5´-TGT GTC TCC TGC TGG AAC CAA CGG-3´ 
0.7 µl Primer KO: 5´-TCT CTC GTG GGA TCA TTG TTT TTC TCT TGA-3´ 
0.5 µl Primer COM: 5’-CTC CTG GCA CCT CTT TCT CAG TCA-3’ 
0.5 µl Taq Polymerase 
1 µl Mouse tail DNA (100 - 150 ng/µl) 
Cycling parameter Temp. Time 
  1 x  Initial denaturation 94°C 4 min 
35 x        
Denaturation 94°C 45 s 
Annealing 65°C 45 s 
Elongation 68°C 60 s 
  1 x  Final elongation 68°C 7 min 
  Cooling 4°C   ∞ 
 
2.3.1.3 Genotyping – agarose gel electrophoresis 
DNA fragments from PCR reactions were separated using agarose gel electrophoresis. Gels were 
prepared by dissolving 1 - 2% agarose in TAE buffer. Electrophoresis was run in chambers filled 
with TAE buffer at 120 V for 60 - 120 min. A 100 bp DNA ladder was used for estimating the size 
of the DNA fragments. DNA fragments in the gel were stained in an ethidium bromide bath for 
10 – 20 min and visualised using a ChemiDoc MP imaging system.  
2.3.2 Chronic social defeat stress (CSDS) 
Chronic stress is a main cause of depression in humans (De Kloet et al., 2005; Lupien et al., 
2009). Several chronic stress models have been established to investigate stress-induced 
depressive-like behaviour and molecular changes in rodents, including CSDS. In humans, chronic 
social defeat, like bullying in schools or workplaces, can lead to sociophobia, the loss of self-
esteem, anxiety and depression (Björkqvist, 2001). The animal model CSDS is based on a 
resident-intruder paradigm, in which a young male C57BL6/J mouse (intruder) is placed into the 
home cage of an older, more aggressive male CD1 mouse (resident). The defeated animal is 
considered to experience social stress. 
2.3.2.1 Screening for aggressive CD1 mice 
Reproducible and successful application of CSDS is strongly dependent on consistent levels of 
aggressive behaviour of the CD1 mice. Single-housed, male retired breeders exhibit the strongest 
territoriality and aggressiveness against foreign males and are therefore the most recommended 
aggressors. Nevertheless, aggression levels can vary greatly between individuals and a screening 
procedure is essential. In this study, a screening procedure described by Golden et al. (2011) was 
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applied. Screening was performed on three consecutive days in the home cage of the CD1 mouse. 
Each day, a novel 7-9 weeks old C57BL6/J mouse was placed into the home cage of the aggressor 
for up to 5 min and the latency until the first aggression was recorded. Only CD1 mice that 
attacked within 60 s in at least two of the three screening days were selected. 
2.3.2.2 Chronic social defeat stress protocol 
At least one week before starting the CSDS paradigm, male C57BL6/J mice were habituated to a 
reversed light-dark cycle (lights on from 09:00 pm to 09:00 am). Depending on the experiment, 
mice were single- or group-housed before CSDS, with ad libitum access to food and water. Social 
defeat sessions were carried out during the active phase of the animals (lights off), between 
10:00 am – 01:00 pm. In the standard CSDS paradigm, 8 - 10 weeks old male C57BL6/J mice 
were subjected to repeated bouts of social defeat by a CD1 aggressor mouse for 5 - 10 min daily 
on 10 consecutive days (Golden et al., 2011). A mild CSDS paradigm was established later, with 
only 1 - 2 min defeat per day. After the daily defeat session, animals were separated by a 
perforated plastic glass wall, which allowed sensory but no physical contact for the following 24 h. 
In order to prevent habituation between resident and intruder, C57BL6/J mice were exposed to a 
novel CD1 aggressor every day. Subsequent to the last defeat session, animals were single-
housed and tested in different anxiety- and depression-related behavioural tests. Control 
C57BL6/J mice were housed with two unfamiliar mice per cage, constantly separated by a 
perforated wall. 
2.3.3 Behavioural tests 
If not stated otherwise, all behavioural tests were performed during the animal’s active phase 
(lights off). 
2.3.3.1 Social avoidance test 
Social avoidance behaviour was analysed after CSDS. A metal grid cage containing a foreign CD1 
mouse (male retired breeder) was placed close to one wall of an open field box. The test mouse 
was placed into a corner of the box and its movement recorded for 5 min using the EthoVision XT 
software. Interaction was measured as the time spent in close proximity to the cage (nose-point). 
The less time the test mouse spent interacting with the CD1 mouse, the higher the social 
avoidance behaviour. In later experiments, the test was divided into two trials. During the first half 
(2.5 min), the metal cage was empty and then replaced by a cage containing a CD1 mouse for the 
second half (2.5 min). Test mice were shortly removed from the open field box in between trials. 
The social interaction (SI) ratio was calculated as the interaction with the CD1 mouse divided by 
the interaction with the empty cage. Thereby, changes in exploratory behaviour can be excluded 
from the social avoidance behaviour. The lower the ratio, the higher the social avoidance 
behaviour. 
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2.3.3.2 Open field test 
Anxiety behaviour and locomotor activity were analysed using the open field test. Animals were 
tested in a sound-isolated room in an open field box (44 cm x 44 cm). Depending on the 
experiment, the room was differently illuminated (20 or 150 lux for a non-aversive or aversive 
environment, respectively). The mice were allowed to explore the box freely and their behaviour 
was recorded for 10 min, using the EthoVision XT software. The time spent in the centre of the 
open field box (25% of the whole area) is considered a measure of anxiety. Rodents usually avoid 
open lit-up areas and increased anxiety is associated with decreased time spent in the centre of 
the open field. Additionally, locomotor activity and exploratory behaviour were determined as the 
total distance travelled. 
2.3.3.3 Sucrose preference test 
Anhedonia, the inability to experience pleasure, is a common symptom of affective disorders, such 
as depression. In rodents, anhedonia can be analysed using the sucrose preference test. Rodents 
generally prefer sweet solutions to water with a preference up to 95% in C57BL/6 mice (Pothion 
et al., 2004) and a reduction of this preference is considered a measure of depressive-like 
behaviour (Katz, 1981). Mice were single-housed and had free access to two bottles, one 
containing water and the other one containing 1% sucrose solution. Consumption of each solution 
was measured by weighing the bottles before and after the test. During the test, positions of the 
bottles were changed at least once to avoid side-bias. Preference was calculated as the 
percentage of sucrose consumption of the total fluid consumption. 
2.3.3.4 Nestlet test 
When provided with suitable material, mice build a nest that provides shelter and camouflage 
from predators and helps conserving body temperature (Bult and Lynch, 1997). In laboratory mice, 
nest building is further considered a home-cage activity related to social behaviour (Moretti et al., 
2005). In the nestlet test, single-housed mice were provided with a pre-weighed nestlet made of 
compressed cotton. After 1 h, the remaining intact nestlet was removed and weighed to calculate 
the amount of nesting material used.  
2.3.3.5 Home cage activity measurements 
Home cage activity was recorded for four days using an infrared system (Mouse-E-Motion, Infra-e-
motion GmbH). An infrared sensor was attached to the cage lid to record movements in the home 
cage every 30 s. Movements were sampled and averaged over 1 h. 
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2.3.3.6 Zero-maze test 
Anxiety-related behaviour was also tested in the zero-maze (height 40 cm, internal diameter 46 
cm, width 5.6 cm) in a sound-isolated room. The maze was divided into four equal quadrants, with 
non-transparent walls enclosing the two opposite quadrants. Animals were placed in the open 
area of the zero-maze and their movements were recorded for 5 min with 600 - 700 lux 
illumination. Time spent in the different areas and distance travelled was analysed using 
EthoVision XT software. 
2.3.3.7 Forced swim test 
Mice were tested for behavioural despair in the forced swim test. This test is based on the 
assumption that mice try to escape an aversive (stressful) stimulus, such as water. Mice were 
placed individually into a glass cylinder (height 28 cm, diameter 20 cm) containing water (height 
14 cm, 24 - 25°C) and their movements observed and videotaped for 6 min. Immobility, i.e. the 
lack of any movements other than those necessary to balance the body and keep the head above 
the water, was recorded during the last 4 min of the 6 min testing period and is considered a 
measure of helpless behaviour (Porsolt et al., 1977). 
2.3.4 Telemetric measurement of heart activity 
To record cardiac activity of mice during CSDS, electrocardiograms were recorded in cooperation 
with Prof. Dr. med. J. Schrickel and Dr. med. T. Beiert (Department of Internal Medicine II, 
University Hospital Bonn). Two weeks before starting the CSDS paradigm, mice were implanted 
with telemetric ECG-transmitters specifically made for small rodents. For implantation, mice were 
anaesthetised by i.p. injection of xylazin hydrochloride (16 mg/kg) and ketamin hydrochloride 
(100 mg/kg) and received s.c. injections of the analgesic carprofen (5 mg/kg) once during and for 
3 days after the surgery. Anaesthetised mice were fixed on a warming plate (37°C) and eyes were 
protected from drying with eye ointment (Bepanthen®). After shaving the fur, a small incision of 
the skin was prepared between the scapulae and the transmitter implanted subcutaneously. 
Additionally, two electrode wires were implanted subcutaneously at the left-lateral and anterior 
thoracic wall. The wound was closed with prolene threads. After this type of surgery, mice behave 
normally with respect to circadian rhythm, feeding, and grooming. The wound is usually healed 
after approximately one week, but since mice were exposed to physical contact with CD1 
aggressor mice during CSDS, a recovery period of two weeks was applied in this study. Mice were 
subjected to the standard CSDS paradigm and heart activity was recorded during the 10-day 
period (no recording during the 10 min of stress exposure). Measurements were performed by 
telemetric recording plates that are placed below the cages of the mice and thus do not require 
any further manipulation on the animal. The ECG recordings were analysed by Dr. med. Beiert. In 
ECG traces, ventricular and atrial depolarisation are represented by the QRS-complex and P-wave, 
respectively (see Figure 4).  
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Figure 4. A typical electrocardiogram (ECG) trace of the cardiac cycle. The signal of one cardiac cycle (heartbeat) 
consists of three events: atrial depolarisation (P wave), ventricular depolarization (QRS complex), and repolarisation of 
ventricles (T wave). In a healthy heart, these events follow each other in an orderly progression. Figure from Elgendi et 
al. (2014). 
 
2.3.5 Transcardial perfusion and tissue processing 
For organ isolation, mice were deeply anaesthetised by isoflurane inhalation. Abdomen and thorax 
were opened and mice were transcardially perfused through the left ventricle with approximately 
25 ml of ice-cold PBS at a flow rate of approximately 4 ml per min. In some cases, blood was 
withdrawn from the right ventricle before starting the perfusion. Organs were isolated and 
processed depending on the subsequent analysis.  
For flow cytometric analysis, organs were transferred into PBS, FACS buffer, or corresponding 
medium and kept on ice until further processing. For RNA or protein isolation, organs were snap-
frozen in isopentane on dry ice and stored at -80°C until use. For immunohistochemistry, organs 
were post-fixed overnight in 4% paraformaldehyde (PFA) at 4°C, followed by 2 - 3 days incubation 
in 30% (w/v) sucrose solution for cryoprotection. Organs were then snap-frozen in isopentane on 
dry ice and stored at -80°C until use. For immunohistochemistry of bone marrow, tibias were post-
fixed in 4% PFA for 3 days at 4°C, decalcified for 4 days at 4°C in EDTA solution (14% EDTA, 3% 
ammonium hydroxide, pH = 7.1), cryoprotected in 30% sucrose solution for 24 h at 4°C, 
embedded in TissueTek, and stored at-80°C until further processing. 
2.3.6 Preparation of blood plasma 
Blood was collected from the heart or the submandibular vein into EDTA-treated micro tubes (red 
caps) to prevent coagulation. Blood was centrifuged at 1000 - 2000 x g for 30 min at 4°C. Plasma 
(supernatant) was transferred into a fresh tube, snap-frozen in liquid nitrogen and stored at -80°C 
until analysis.  
2.3.7 Isolation of cells for flow cytometry 
2.3.7.1 Bone marrow 
Bone marrow cells were isolated from tibias and/or femurs. The bone was cleared from 
surrounding tissue using scissors and gauze. The bone was opened on both ends and the bone 
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marrow flushed out into a fresh petri dish, using a 10 ml syringe with 27G cannula filled with 10 
ml ice-cold PBS or FACS buffer. Single cell suspensions were prepared by pipetting cells up and 
down and transferring them into 50 ml tubes through a cell strainer (70 µm pore size). Petri dish 
and cell strainer were rinsed with FACS buffer to harvest all remaining cells. Cells were centrifuged 
(300 x g, 7 min, 4°C) and resuspended in FACS buffer. For gene expression analysis of bone 
marrow, cells were stored at-80°C as a pellet or dissolved in 500 µl TRIzol® reagent.   
2.3.7.2 Brain  
For isolation of CNS mononuclear cells (resident microglia and infiltrating peripheral cells), brains 
were harvested and stored in medium (DMEM, high glucose + 10% FCS) on ice. Brains (or one 
hemisphere) were placed in a petri dish, the cerebellum removed and the remaining tissue cut 
into small pieces using a scalpel. Tissue was further homogenised in 4 ml medium using a syringe 
with 20G cannula. When all samples were homogenised, 1 ml digestion mix (DNase 
I/Collagenase/Dispase) was added and samples incubated at 37°C for 45 min. Single cell 
suspensions were prepared and filtered through a cell strainer (70 µm pore size) into a 50 ml 
tube. Petri dish and cell strainer were rinsed with medium. Tubes were filled up to 50 ml with 
medium and centrifuged (300 x g, 7 min, 4°C). Separation of leukocytes from other cells and 
debris was performed using Percoll gradient centrifugation. Stock isotonic Percoll (SIP) was 
prepared by diluting 9 parts of Percoll with one part of 10x PBS. 40% and 80% Percoll solutions 
were prepared by diluting SIP with either medium (40%) or FACS buffer (80%). Cell pellets were 
resuspended in 8 ml of 40% Percoll, transferred to a 15 ml tube and carefully sublayered with 5 
ml 80% Percoll using a Pasteur pipette. Cells were then centrifuged (2100 rpm, 25 min, RT, slow 
acceleration, without break). After centrifugation, myelin accumulated at the surface was carefully 
aspirated before collecting the leukocytes at the interface between 40% and 80% Percoll. 
Approximately 2 ml were collected, transferred into a 50 ml tube, washed with 20 ml medium, 
and centrifuged (300 x g, 7 min, 4°C). Cells were resuspended in 1 ml medium and transferred 
into FACS tubes through gauze to remove remaining fat and cell doublets. Cells were washed once 
more with medium. 
2.3.7.3 Spleen 
Spleens (or half spleens) were placed in a petri dish and cells flushed out by injecting 1 ml 
digestion mix (DNase I/Collagenase type VIII). Tissue was cut into small pieces before adding 
additional 4 ml or 8 ml digestion mix for one half or one full spleen, respectively. Tissue was 
digested at 37°C for 45 min and then homogenised with a syringe to prepare a single cell 
suspension. Homogenates were filtered through a cell strainer (70 µm pore size) into a 50 ml tube 
and petri dish and cell strainer were rinsed with FACS buffer. The cell suspension was filled up to 
25 or 50 ml with FACS buffer, centrifuged (300 x g, 7 min, 4°C), and washed once more with FACS 
buffer. Alternatively, cells were isolated from spleens without digestion by directly mincing the 
tissue through the cell strainer using the back of a 10 ml syringe.  
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2.3.8 Cell culture of splenocytes 
Isolated splenocytes were resuspended in splenocyte culture medium (RPMI 1640, supplemented 
with 10% FCS, 1% penicillin/streptomycin, 1% L-glutamine), counted in a Neubauer chamber, and 
seeded in 12-well plates at a density of 1 x 106 cells/ml. Cells were either untreated or stimulated 
with 100 – 1000 ng/ml lipopolysaccharide (LPS) from Escherichia coli O127:B8 overnight. After 
overnight culture, cells and medium were collected and centrifuged (300 x g, 5 min, 4°C). 
Supernatants were transferred to a fresh tube, snap-frozen in liquid nitrogen and stored at -20°C. 
Cells were resuspended in FACS buffer and stained for flow cytometric analysis.   
2.3.9 Flow cytometry/fluorescence-activated cell sorting (FACS) 
Flow cytometry is a technique to measure physical and chemical properties of thousands of 
individual cells or particles, commonly used for the analysis of immune cells. The technique is 
based on three components – fluidics, optics, and electronics. Cells are suspended in a fluid and 
hydrodynamically focused in a stream that allows cells to pass a laser beam one at a time. The 
light scattered by the cell passing the laser is detected by specific detectors and corresponds to 
physical properties of the cell, such as cell size (detected by forward scatter, FSC) and internal 
complexity/granularity (detected by side scatter, SSC). Furthermore, fluorescent staining of cell 
surface markers is used to identify cells based on their specific pattern of marker expression or 
to quantify the expression of surface proteins. By using fluorophores with different 
excitation/emission spectra and appropriate lasers and detectors, many markers can be 
measured simultaneously. In this study, the flow cytometer (BD FACSCanto II) was equipped with 
three lasers for excitation and eight filters for detection of different emission wavelengths.  
Flow cytometry was used to analyse cell surface marker expression on immune cells from whole 
blood or cells isolated from bone marrow, spleen, and brain. To ensure cell viability, cells were 
kept at 4°C during the whole procedure. Cells were transferred to FACS tubes and filtered through 
gauze to exclude cell aggregates. Cells were centrifuged (300 x g, 7 min, 4°C) and supernatants 
removed. Cell pellets were resuspended in 50 µl Fc-block (anti-mouse CD16/32), diluted 1:100 
in FACS buffer, to block unspecific binding of antibodies to Fc-receptors. After 5 min incubation, 
50 µl primary antibody solution was added and incubated for 30 min in the dark. Antibodies and 
corresponding dilutions are listed in the table below. Cells were washed with 3 ml FACS buffer, 
followed by centrifugation. Cells were then incubated with 100 µl secondary antibody solution for 
15 min. After another washing step, erythrocytes were lysed in 1 - 3 ml 1x RBC-lysis buffer for 5 
min at RT (depending on the tissue of origin). Cells were washed once more and dead cells stained 
using DAPI or DRAQ7™. To avoid fading of the fluorescent signal, cells were kept in the dark 
whenever possible. Flow cytometric analysis was performed using the BD FACSCanto II and the 
BD FACSDiva Software. Resulting files were analysed using FlowJo version 10.0.6 (Tree Star Inc.). 
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List of antibodies used for flow cytometry 
Antigen Conjugate Host  Clone Dilution Company  Catalog # 
CD115 (CSF-1R) PerCP/Cy5.5 Rat AFS98 1:100 BioLegend 135526 
NK1.1 Biotin Rat PK136 1:200 BioLegend 108704 
TER-119  Biotin Rat TER-119 1:200 BioLegend 116204 
Ly-6G Biotin Rat 1A8 1:200 BioLegend 127604 
Ly-6G PE/Cy7 Rat 1A8 1:200 BD 560601 
CD3 Biotin Rat 17A2 1:200 BioLegend 100244 
CD45  BV 510 Rat 30-F11 1:200 BioLegend 103137 
CD11b PE/Cy7 Rat M1/70 1:200 BioLegend 101216 
CD11b FITC Rat M1/70 1:200 BD 553310 
Ly-6C APC Rat HK1.4 1:200 BioLegend 128016 
CD19 APC/Cy7 Rat 1D3 1:200 BD  557655 
CCR2 (CD192) BV 421 Rat SA203G11 1:200 BioLegend 150605 
MERTK (Mer) PE Rat 2B10C42 1:400 BioLegend 151505 
MHCII (I-A/I-E) PerCP/Cy5.5 Rat M5/114.15.2 1:200  BioLegend 107625 
CD11c FITC Hamster N418 1:200 BioLegend 117306 
CD40 PE Rat 1C10 1:200 eBioscience 12-0401 
Streptavidin APC/Cy7     1:200  BioLegend 405208 
 
2.3.10 RNA-isolation  
Total RNA from cells or frozen tissue was extracted using TRIzol® reagent. Cells were resuspended 
in 0.5 – 1 ml TRIzol® and homogenated by vortexing. Frozen tissue was transferred into 2 ml 
tubes containing 1.4 mm zirconium oxide beads and homogenised in TRIzol® (1 ml TRIzol®/100 
mg tissue) by vigorous shaking in a tissue homogeniser. After centrifugation (12,000 x g, 10 min, 
4°C), the homogenate was transferred into a fresh tube. For phase separation, 1-bromo-3-
chloropropane (BCP) (1:5) was added. After vortexing for 30 s and 3 min incubation at RT, samples 
were centrifuged (12,000 x g, 10 min, 4°C) and the RNA containing aqueous phase transferred 
into a fresh tube. RNA was precipitated by isopropanol (1:1). Samples were mixed, incubated at 
RT for 10 min and centrifuged at 12,000 x g, 10 min, 4°C. The supernatant was discarded and 
the pellet was washed twice with 500 µl 75% EtOH. RNA was dried at 50°C for 5 – 10 min and 
dissolved in 15 – 50 µl RNase-free water. After dissolving, RNA was digested with approximately 
1 U of recombinant DNase I per 1 µg of RNA at 37°C for 20 min to remove any remaining genomic 
DNA. The reaction was stopped by heat inactivation of DNase at 75°C for 10 min. Concentration 
and purity of RNA was determined by optical density (OD) measurements at 260 and 280 nm, 
using a NanoDrop 1000. The absorbance of 1 unit at 260 nm is equivalent to a RNA concentration 
of 40 µg/ml. Purity of RNA was confirmed by A260/A280 values close to 2. RNA was stored at-80°C 
until further processing.  
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2.3.11 Reverse transcription PCR 
Messenger RNA (mRNA) was reverse transcribed into complementary DNA (cDNA) using 
SuperScript™ II Reverse Transcriptase. Up to 3 µg of RNA in a total volume of 11 µl RNAse-free 
H2O were used per sample. The reaction conditions and cycling parameters are summarised in 
the table below. After reverse transcription, cDNA was diluted appropriately and stored at -20°C. 
 
Reaction and cycling parameters for cDNA synthesis 
Reaction Cycling parameters 
 11 µl RNA (0.5 – 3 µg) 
+ 1 µl Oligo(dT) primers 
+ 1 µl dNTP mix (10mM) 
  Temp. Time 
  65°C  5 min 
  4°C  3 min 
+ 4 µl 5 x first strand buffer   
+ 2 µl DTT (0.1 M)   
  42°C 2 min 
  4°C  3 min 
+ 1 µl SuperScriptTM II    
  42°C 50 min 
  70°C  15 min 
  4°C ∞ 
 
2.3.12 Quantitative real-time PCR (qPCR) 
Expression levels of mRNA were analysed using TaqMan® Gene Expression Master Mix and Gene 
Expression Assays. TaqMan® gene expression analysis is one option for real-time qPCR using the 
fluorescence resonance energy transfer (FRET) technology. FRET is based on an energy transfer 
between two fluorophores. For qPCR, a short gene-specific oligonucleotide probe, fluorescently 
labelled at the 5’ end (FAM™ or VIC®) and quenched by a non-fluorescent tag (MGB = minor 
groove binder) at the 3’ end, is added to the cDNA sample together with an unlabelled pair of 
primers. Due to sequence complementarity, the probe hybridises with the target cDNA and is 
cleaved during the PCR reaction through the 5’ - 3’ exonuclease activity of the polymerase. The 
fluorescent signal is therefore no longer quenched and increases with each PCR cycle, in 
proportion to the amount of available cDNA. For relative quantification of gene expression, the 
expression level of the target gene is normalised to the expression level of a constitutively 
expressed reference gene. In this study, hypoxanthine-guanine phosphoribosyltransferase (Hprt) 
was used as a reference gene. Expression of target and reference genes was either measured 
within the same reaction, using two different fluorescent dyes (VIC® + FAM™, dual colour 
analysis), or measured in separate reactions (FAM™, mono colour analysis). Reactions were 
pipetted in triplicates into 384-well plates by a JANUS® automated workstation. qPCR was 
performed using the LightCycler 480 and parameters listed in the table below. Data was analysed 
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using the 2-ΔΔCq method (Livak and Schmittgen, 2001). The quantification cycle (Cq), i.e. the cycle 
at which fluorescence from amplification exceeds the background fluorescence, was determined 
for each gene and ΔCq calculated as the difference between the Cq of the target gene and the Cq 
of the reference gene. Relative expression levels were calculated as 2-ΔCq. For calculating the fold 
change from control samples, data was normalised to the mean 2-ΔCq of the respective control 
group.  
 
Reaction and cycling parameters for qPCR  
Reaction (dual colour analysis) Reaction (mono colour analysis) 
4 µl cDNA  4 µl cDNA  
5 µl TaqMan® Gene Expression Master Mix 5 µl TaqMan® Gene Expression Master Mix 
0.5 µl 
TaqMan® Assay for target gene  
(dye: FAM-MGB) 
0.5 µl 
TaqMan® Assay for target or reference 
gene (dye: FAM-MGB) 
0.5 µl 
TaqMan® Assay for reference gene  
(dye: VIC-MGB) 
0.5 µl H2O 
Cycling parameters Cycling parameters 
 Temp. Time Quantification  Temp. Time Quantification 
1x  95°C 10 min None 1x  95°C 10 min None 
45x 
95°C  
60°C 
15 s 
1 min 
Dual colour  
(FAM + VIC) 
45x 
95°C  
60°C 
15 s 
1 min 
Mono colour  
(FAM) 
1x 4°C ∞ None 1x 4°C ∞ None 
 
 
List of TaqMan® Gene Expression Assays used for qPCR 
Target mRNA  TaqMan® assay ID Target mRNA TaqMan® assay ID 
Arg1 Mm00475988_m1 Hprt Mm00446968_m1 
Ccl2 Mm00441242_m1 Il10 Mm99999062_m1 
Cnr1 Mm00432621_s1 Il1b Mm01336189_m1 
Cnr2 Mm00438286_m1 Il6 Mm0446190_m1 
Fkbp5 Mm00487406_m1 Mgll Mm00449274_m1 
Crh Mm01293920_s1 Napepld Mm00724596_m1 
Crhr1 Mm00432670_m1 Nos2a Mm00440485_m1 
Faah Mm00515684_m1 Nr3c1 Mm00433832_m1 
Dagla Mm00813830_m1 Ptgs2 Mm00478374_m1 
Daglb Mm00523381_m1 Tnf Mm00443258_m1  
 
2.3.13 Enzyme-linked immunosorbent assay (ELISA) 
Levels of cytokines/chemokines IL-1b, IL-6, TNFa, and CCL2 in blood plasma or cell culture 
supernatants were determined using indirect sandwich ELISAs. ELISAs are antibody-based assays 
to detect and quantify proteins or other small molecules. In indirect sandwich ELISAs, the target 
protein is captured by antibodies immobilised on a plate and subsequently detected by a second 
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antibody. The detection antibody is then bound by a secondary antibody that is coupled to an 
enzyme that can catalyse a colour reaction, such as horseradish peroxidase (HRP). The amount 
of target protein thus correlates with the intensity of the colour reaction and can be quantified by 
applying appropriate standard curves. Respective ELISA assays were used according to the 
manufacturer’s instructions. Briefly, Nunc MaxiSorp flat-bottom 96-well plates were coated with 
50 µl corresponding capture antibodies, diluted 1:250 in coating buffer, overnight at 4°C. The 
next day, plates were washed 3 - 5 times with 200 µl wash buffer per well, followed by blocking 
with 100 µl assay diluent for 1 h at RT. After blocking, 50 µl of standard and samples were 
incubated for 2 h at RT. Samples were tested in duplicates and diluted in assay diluent, if 
necessary. After washing, 50 µl of corresponding detection antibodies (coupled to biotin), diluted 
1:250 in assay diluent, were added and incubated for 1 h at RT. After another washing step, 50 
µl of avidin-HRP, diluted 1:250 in assay diluent, were incubated for 30 min at RT. Plates were 
washed again, followed by 15 min incubation with 50 µl TMB substrate solution. The reaction was 
stopped by adding 25 µl 1 M H3PO4. Absorbance was measured at 450 nm using a microplate 
reader.  
2.3.14 Measurement of corticosterone 
Plasma and faecal CORT levels were measured using the DetectX® Corticosterone Enzyme 
Immunoassay (EIA) Kit. Plasma samples were incubated with dissociation reagent provided by the 
kit and diluted with assay buffer. To extract steroids from frozen faeces (stored at-80°C), samples 
were dried for 2 h at 37°C. Subsequently, 200 – 300 mg of dried faeces were transferred into a 
5 ml microcentrifuge tube and 1 ml 100% EtOH per 100 mg of solid was added. For extraction, 
samples were incubated for 30 min at RT in a shaking incubator. Subsequently, samples were 
centrifuged at 4500 rpm for 15 min and 600 µl of the supernatant was transferred into a 1.5 ml 
microcentrifuge tube. Samples were evaporated to dryness in a SpeedVac for 1 h at 35°C. 
Extracted samples were kept at -20°C overnight. On the next day, samples were dissolved in 
100 µl EtOH, followed by addition of 400 µl assay buffer, and vortexed and incubated for 5 min at 
RT. The vortexing and incubation steps were repeated for three times. Afterwards, samples were 
diluted 1:2 with assay buffer, since the final EtOH concentration should be lower than 5% for the 
measurements. The CORT immunoassay was performed according to the manufacturer ́s protocol. 
After incubation of all kit reagents for 30 min at RT, the CORT standards were prepared with a 
concentration range of 78.128 pg/ml to 10000 pg/ml. Subsequently, 50 µl of diluted samples or 
standards were pipetted in duplicates into the wells of a clear microtiter plate coated with an 
antibody to capture sheep antibodies, followed by 25 µl DetectX® Corticosterone (Peroxidase-) 
Conjugate and 25 µl DetectX® Corticosterone Antibody. After 1 h shaking at RT, wells were 
aspirated and washed 4 times with 300 µl wash buffer, followed by 100 µl TMB substrate per 
well. After 30 min incubation at RT, 50 µl stop solution was added to each well. Absorbance was 
measured at 450 nm using a microplate reader. 
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2.3.15 Immunohistochemistry (IHC), image acquisition and analysis 
2.3.15.1 Brain  
2.3.15.1.1  IBA1, ICAM-1, CD45 staining 
For microglia analysis, frozen brain hemispheres were cut into coronal 60 µm free-floating 
sections and stored in PBS + sodium-azide at 4°C. For immunohistochemical staining, sections 
were blocked in 10% normal donkey serum (NDS) in PBS-T 0.5% for 4 h, followed by overnight 
incubation at 4°C with primary antibodies, diluted in 5% NDS in PBS-T 0.1%. Antibodies used were 
rabbit anti-ionized calcium-binding adapter molecule 1 (IBA1) (1:1000), goat anti-intercellular 
adhesion molecule 1 (ICAM-1) (1:1000), and rat anti-CD45 (1:500). Negative controls were 
incubated in diluent without primary antibody. After antibody incubation, sections were washed 
three times in PBS for 10 min. After washing, sections were stained with secondary antibodies, 
diluted 1:1000 in 5% NDS in PBS-T 0.1%. Secondary antibodies used were donkey anti-rabbit 
AlexaFluor®594, donkey anti-goat AlexaFluor®647, and donkey anti-rat AlexaFluor®488. For 
details on antibodies, see table below. Nuclei were stained with DAPI (0.1 µg/ml in PBS) for 15 
min at RT, followed by another washing step. Sections were shortly washed in MilliQ H2O and 
embedded in Fluoromount-G®. Sections were covered by cover glasses of 170± µm (No. 1.5H) 
and edges closed with nail polish. Stained sections were stored at 4°C in the dark.    
2.3.15.1.2  IBA1, TMEM119, CD68 staining 
Free-floating sections (see above) were permeabilised in TBS-T 0.5% for 30 min, followed by two 
10 min wash steps in TBS. Sections were then incubated in citrate buffer pH = 6 for 20 min at 
65°C for heat-mediated antigen retrieval. Sections were washed again and blocked in 10% NDS 
in TBS-T 0.5% for 2 h, followed by 48 h incubation at 4°C with primary antibodies, diluted in 5% 
NDS in TBS-T 0.25%. Antibodies used were goat anti-IBA1 (1:1000), rabbit anti-Transmembrane 
protein 119 (TMEM119) (1:1000, 0.614 µg/ml), and rat anti-CD68 (1:1000). Negative controls 
were incubated in diluent without primary antibody. After antibody incubation, sections were 
washed three times in TBS-T 0.25% for 15 min. After washing, sections were stained with 
secondary antibodies, diluted 1:1000 in 5% NDS in TBS-T 0.25%. Secondary antibodies used were 
donkey anti-rabbit AlexaFluor®594, donkey anti-goat AlexaFluor®647, and donkey anti-rat 
AlexaFluor®488. For details on antibodies, see table below. Nuclei were stained with DAPI (0.1 
µg/ml in PBS) for 15 min at RT, followed by another washing step. Sections were shortly washed 
in MilliQ H2O and embedded in Fluoromount-G®. Sections were covered by cover glasses of 170± 
µm (No. 1.5H) and edges closed with nail polish. Stained sections were stored at 4°C in the dark.    
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List of antibodies used for immunohistochemistry 
Antigen Conjugate Host  Clone Dilution Company  Catalog # 
CD45 unconjugated Rat IBL-3/16 1:500 abcam ab23910 
CD68 unconjugated Rat FA-11 1:1000 AbD Serotec MCA1957 
IBA1 unconjugated Rabbit Polyclonal 1:1000 Wako 019-19741 
IBA1 unconjugated Goat Polyclonal 1:1000 abcam ab5076 
ICAM-1/CD54 unconjugated Goat Polyclonal 1:1000 R&D systems AF796 
TH unconjugated Rabbit Polyclonal 1:1000 abcam ab112 
TMEM119 unconjugated Rabbit 28-3 1:1000 abcam ab234501 
Anti-rabbit 
IgG 
Alexa FluorÒ 594 Donkey  1:1000 Invitrogen A21207 
Anti-rat IgG Alexa FluorÒ 488  Donkey  1:1000 Invitrogen A21208 
Anti-goat IgG Alexa FluorÒ 647 Donkey  1:1000 Invitrogen A21447 
 
2.3.15.1.3  Image acquisition  
Sections were imaged using a Leica TCS SP8 confocal microscope. For excitation of fluorophores, 
the microscope was equipped with a UV diode (405 nm), a pulsed argon ion laser with several 
wavelengths (458, 476, 488, 514 nm), a yellow-green diode-pumped solid-state (DPSS) laser 
(561 nm), a yellow helium-neon (HeNe) laser (594 nm), and a red HeNe laser (633 nm). For 
detection of emitted light, two photomultiplier tubes (PMT) and two hybrid photodetectors (HyD) 
were available. DAPI was excited at 405 nm, AlexaFluor®488 at 488 nm, AlexaFluor®594 at 594 
nm, and AlexaFluor®647 at 633 nm.  
For overview pictures, images were acquired with a 20x objective (numerical aperture (NA) = 
0.75), pinhole = 1 AU, 0.28 µm/pixel. Z-stacks of 9 µm were acquired at a step size (voxel depth) 
of 3.0 µm. Two - three sections were imaged per animal for each region. For higher resolution, 
images were acquired with a 40x objective (NA = 1.1), pinhole = 1 AU, 0.19 µm/pixel. Five single 
plane images were acquired within the 60 µm section at a distance of 5 µm. Two - three sections 
were imaged per animal for each region. For three-dimensional (3D) morphological analysis of 
microglia, z-stacks of 40 - 50 µm were acquired using the 63x objective (NA = 1.2), pinhole = 1 
AU, voxel depth 0.5 µm, 0.18 µm/pixel. Two z-stacks were acquired per animal per region.  
2.3.15.1.4  Image analysis 
Images were analysed using Fiji (ImageJ 2.0.0). For measurement of IBA1-positive (IBA1+) area, 
an appropriate threshold was applied to exclude background signal. IBA1+ area was quantified 
as area fraction of either the whole image or within a region of interest (ROI). In the same images, 
IBA1+ cells were manually counted and cell number normalised to the area of the ROI. Similarly, 
ICAM-1+ area was quantified. To determine neurovascular ICAM-1 expression, a threshold was 
applied that excluded ICAM-1 immunoreactivity on microglia, which was considerably lower than 
neurovascular ICAM-1. To measure ICAM-1, CD68, and TMEM119 immunoreactivity on microglia, 
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IBA1+ area was determined as described above and used as a ROI. ICAM-1+, CD68+, or 
TMEM119+ area and mean grey intensity were then measured within the IBA1+ ROI.  
For 3D analysis of microglia, mages were pre-processed using ImageJ functions for smoothing and 
background subtraction (rolling ball). Images were then analysed using automated custom-written 
ImageJ plug-ins, written by Jan Niklas Hansen (Institute of Innate Immunity, University of Bonn) 
(Plescher et al., 2018). Binary images were obtained by application of an intensity threshold, 
which was determined in a 50% downscaled maximum projection of the original z-stack image 
using ImageJ's implemented threshold algorithm “MinError.” Individual cells were automatically 
traced in the z-stack by overlap. Particles smaller than 12,000 voxel were removed from the 
image. Correct tracing of cells was visually verified and incorrectly traced cells (e.g. incomplete or 
clustered) excluded from analysis. Surface area, volume, convex hull, and ramification index were 
automatically reconstructed based on the size-filtered binary image. The microglial ramification 
index is the ratio of cell surface area and surface area of a perfect sphere with the same volume 
as the analysed cell and thus calculated using the equation: cell surface area/(4p x ((3 x cell 
volume)/(4p))2/3. The ramification index is a unit-free parameter for the complexity of the cellular 
shape. A ramification index of 1 corresponds to a perfectly round cell without processes. The more 
the cell differs from a perfectly round shape, i.e. the more branches the cell possesses, the higher 
is its 3D ramification index. For quantification of branch number, junctions, and tree length, 
skeleton parameters were obtained by Gauss-filtering (sigma = 0.5) of the size-filtered binary 
image and subsequent skeleton generation and analysis using the plugins by Arganda-Carreras 
et al. (2010). On average, 10 cells were analysed per animal, giving a total of 60 – 90 cells per 
group.  
2.3.15.2 Bone marrow  
2.3.15.2.1 Tissue preparation and IHC staining 
Frozen, fixed and decalcified bones were cut into 10 µm sections using a cryostat and stored at -
80°C until further processing. To analyse SNS innervation of the bone marrow, tyrosine 
hydroxylase (TH) positive (TH+) nerve endings were stained. Therefore, sections were washed in 
PBS  for 5 min, permeabilised in PBS-T 0.5% for 30 min, followed by washing in PBS (3x 5 min) 
and incubation in blocking solution (5% NGS in PBS-T 0.025%) for 1 - 2 h. Sections were then 
incubated with primary antibody rabbit anti-TH (1:1000), diluted in antibody solution (2.5% NGS 
in PBS-T 0.025%), overnight at 4°C. On the next day, sections were washed (3x 10 min), followed 
by 2 h incubation with secondary antibody goat anti-rabbit AlexaFluor®594 (1:1000). Nuclei were 
stained with DAPI (0.1 µg/ml in PBS) for 10 min. After washing in PBS (3x 10 min), sections were 
washed in MilliQ H2O once and embedded in Fluoromount-G®. Sections were covered by cover 
glasses of 170± µm (No. 1.5H) and edges closed with nail polish. Stained sections were stored at 
4°C in the dark.  
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2.3.15.2.2  Image acquisition 
Bone marrow sections, stained for TH+ nerve endings, were imaged using a Leica TCS SP8 
confocal microscope. Z-stacks of 10 µm were acquired using the 63x objective (NA = 1.2), pinhole 
= 1 AU, voxel depth 1 µm, 0.10 µm/pixel). Next to TH and DAPI, a transmitted light picture was 
taken for identification of blood vessels within the bone. Five – seven images were acquired per 
animal. 
2.3.15.2.3  Image analysis 
Images were analysed using Fiji (ImageJ 2.0.0). For the analysis of bone marrow SNS innervation, 
maximum projections of z-stacks (TH channel) were used. Signal in the TH channel was 
thresholded to limit the analysis to TH+ nerve endings. Within this threshold, TH immunoreactivity 
was measured as mean grey intensity.  
2.4 Statistical analysis 
Statistical analysis was performed using the GraphPad Prism 6 software. Datasets with only two 
groups were analysed using unpaired Student’s t-test. Datasets containing more than two groups, 
but only one independent variable (e.g. stress) were analysed by one-way analysis of variance 
(ANOVA). Datasets containing two independent variables (e.g. stress and genotype) were analysed 
using two-way ANOVA. The ANOVA was considered significant at a 95% confidence interval (p < 
0.05). P-values between 0.05 and 0.1 were considered a tendency. Results for main effects and 
interactions in the two-way ANOVA are stated in the corresponding figure (significant effects are 
indicated by + for stress effect, * for genotype effect, # for stress x genotype interaction). Detailed 
results (F ratio and p-value) for relevant main effects are stated in the figure legends. The ANOVA 
was followed by Bonferroni post-hoc comparisons. Non-parametric datasets were analysed using 
the Kruskal-Wallis test, followed by Dunn’s multiple comparisons. If not stated otherwise, data are 
presented as mean values ± standard error of the mean (SEM). Significances in post-hoc 
comparisons are depicted in the graphs (+ for p < 0.05 compared to controls of the same 
genotype; * for p < 0.05 compared to Cnr1+/+ mice of the same group). Correlation analysis was 
performed either using Pearson correlation (parametric) or Spearman correlation (non-
parametric). The correlation was considered significant at a 95% confidence interval (p < 0.05).  
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3 Results 
3.1 Standard chronic social defeat stress (CSDS) 
In the first sets of experiments, Cnr1+/+ and Cnr1-/- mice were exposed to a standard protocol of 
CSDS – a common rodent model of social stress and based on a resident-intruder paradigm. In 
brief, male Cnr1+/+ and Cnr1-/- mice were single-housed for two weeks before starting the CSDS 
paradigm, during which mice were exposed to 5 – 10 min of daily defeat sessions by a CD1 
aggressor mouse on 10 consecutive days. Standard CSDS experiments were performed in four 
separate cohorts of mice, with slight adaptations to the experimental setup, such as a different 
timeline for behavioural tests and organ retrieval. For clarity, results of behavioural analysis will 
only be shown for the last two cohorts of mice, where the experimental setup most closely 
resembled later experiments with mild CSDS (see chapter 3.2). The respective experimental setup 
and timeline for behavioural analysis is shown below (Figure 5). Experimental setups and 
behavioural data for the other two cohorts can be found in the appendix. Results for physiological 
and molecular effects of standard CSDS shown here are derived from different cohorts of mice. 
When applicable, data was pooled from different cohorts (e.g. for body weight).   
 
 
Figure 5. Experimental setup for standard CSDS. C57BL/6J intruder mice were single-housed for two weeks prior to 
stress exposure. During CSDS, male Cnr1+/+ or Cnr1-/- mice were individually introduced into the home cage of a CD1 
aggressor mouse. Mice were allowed to physically interact for 5 – 10 minutes, during which the intruder is exposed to 
repeated bouts of social defeat by the CD1 aggressor. After the physical defeat, mice were separated by a perforated 
Plexiglas wall to allow sensory, but not physical contact for the following 24 hours. C57BL/6J intruder mice were 
exposed to a new CD1 aggressor for 10 consecutive days. Control mice were housed in pairs of two, unfamiliar to each 
other and separated by a perforated Plexiglas wall. Combinations of control mice were not alternated during the 10-day 
period. After standard CSDS, social avoidance behaviour and sucrose preference was analysed. One day after the last 
stress exposure, mice were sacrificed and organs harvested for analysis.   
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3.1.1 Increased mortality of Cnr1-/- mice during standard CSDS 
CSDS consists of physical defeat sessions that are highly demanding for the defeated mice. 
Occasionally, this protocol results in injuries due to physical attacks of the CD1 mouse, however 
this is rare and leads to the direct exclusion of the injured mouse. Cnr1-/- mice are known to be 
stress-sensitive and to have an increased spontaneous mortality rate (Zimmer et al., 1999). 
Surprisingly, nearly 50% of Cnr1-/- mice died during the first days of standard CSDS or had to be 
excluded from the experiments because they reached exclusion criteria (e.g. loss of more than 
20% of body weight). In contrast, mortality rates of Cnr1+/+ mice reached only 10%. Deaths usually 
occurred during the first days of stress exposure and mice died without any signs of injuries. In 
most, but not all cases the death was preceded by substantial body weight loss. Mice never died 
during the 10-minute stress exposure, but rather during the following period of sensory contact. 
Due to the high mortality rate, the group size of stressed Cnr1-/- for behavioural and molecular 
analysis after standard CSDS was lower than for Cnr1+/+ mice (seven Cnr1+/+, four Cnr1-/- mice).  
 
3.1.2 Social avoidance after standard CSDS 
The social avoidance test is commonly used to determine the susceptibility of mice to CSDS. In 
the first trial of the test, movements of mice are recorded in the presence of an empty metal cage 
(no target), while in the second trial the cage contains an unknown CD1 aggressor (target) (Figure 
6A). Thereby, behavioural changes specifically induced by the presence of the CD1 mouse can be 
distinguished from generally altered exploratory behaviour. The social interaction (SI) ratio is 
calculated as the ratio between interaction time with a CD1 mouse and an empty cage. SI ratios 
higher than one are commonly used as a threshold for stress resilience (Golden et al., 2011).  
After standard CSDS, all stressed mice showed SI ratios below 0.5 and were thus classified as 
stress susceptible (Figure 6B). Statistical analysis showed a clear stress effect that was significant 
in post-hoc comparisons for both genotypes. Detailed analysis of the mice’s movement revealed 
that all mice behaved rather similarly when no CD1 target was present (Figure 6 left panel). There 
was no difference in the time spent in the interaction zone after stress, but a tendency for a 
genotype effect (Figure 6C). Furthermore, a tendency for a stress effect as well as stress x 
genotype interaction was detected for the time spent in corners (Figure 6D). Post-hoc comparison 
showed that these effects were due to stressed Cnr1-/- mice spending more time in corners 
compared to control Cnr1-/- mice. Stress had a significant effect on locomotion, slightly reducing 
total distances moved during the first trial (Figure 6E). In the second trial, movements of mice 
were traced in the presence of an CD1 target (Figure 6 right panel). Highly significant stress effects 
were seen for interaction time (Figure 6F) and time spent in corners (Figure 6G). For both 
genotypes, stress significantly reduced interaction with the CD1 target and increased the time 
spent in corners. Furthermore, stress caused a significant reduction of locomotion in Cnr1-/- mice 
(significant stress effect and stress x genotype interaction) (Figure 6H).  
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Figure 6. Standard CSDS induces strong social avoidance behaviour in both Cnr1+/+ and Cnr1-/- mice. Mice were 
subjected to the social avoidance test after standard CSDS. (A) Experimental setup and representative heatmap 
visualization of movement of mice during the two trials of the test. First trial (no target): the cage on one side of the 
arena is empty. Second trial (target): cage containing an unfamiliar CD1 aggressor mouse. After all mice had completed 
the first trial, empty cages were replaced by cages with CD1 mice. (B) Social interaction (SI) ratio, calculated from the 
interaction time in the first (C) and second trial (F). A ratio > 1 (red line) is usually used to identify stress-resilient mice 
(stress: F(1,16) = 46.10, p < 0.0001). (C - E) Quantification of the first trial of the test (no target). (C) Interaction with 
empty cage (genotype: F(1,16) = 4.09, p = 0.060). (D) Time spent in any of the four corners (stress: F(1,16) = 3.93, p = 
0.065; stress x genotype interaction: F(1,16) = 4.02, p = 0.062). (E) Locomotion, total distance moved (stress: F(1,16) = 
5.39, p = 0.034). (F - H) Quantification of the second trial (target). (F) Interaction with an unfamiliar CD1 aggressor 
(stress: F(1,16) = 54.43, p < 0.0001). (G) Time spent in corners (stress: F(1,16) = 33.43, p < 0.0001). (H) Total distance 
moved (stress: F(1,16) = 41.69, p < 0.0001; stress x genotype interaction: F(1,16) = 7.07, p = 0.017). Data was analysed 
by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same 
group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 
0.05, ++ p < 0.01, +++ p < 0.001.   
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3.1.3 Anhedonia after standard CSDS 
After ten days of standard CSDS, hedonic behaviour was measured in the sucrose preference test. 
Mice usually prefer sweet solutions and a reduction in this preference is associated with 
anhedonia, the inability to experience pleasure. Quantification of the fluid consumption after 
standard CSDS showed that stress had a significant effect on sucrose preference, calculated as 
the percentage of sucrose consumed in relation to total fluid consumption (Figure 7A). A tendency 
for a genotype effect was observed as well. Post-hoc comparisons revealed no significant 
differences between the groups, probably due to small group sizes. Total fluid intake was 
significantly affected by stress, with stressed Cnr1+/+ mice drinking significantly more compared 
to their control group (Figure 7B).  
 
 
Figure 7. Standard CSDS induces mild anhedonia and increases fluid intake. Anhedonia was analysed after standard 
CSDS using the sucrose preference test. (A) Sucrose preference, i.e. the percentage of sucrose solution consumed in 
relation to the total fluid intake (stress: F(1,15) =  7.31, p = 0.016; genotype: F(1,15) =  4.31, p = 0.056). (B) Total fluid 
intake over 24 h (stress: F(1,15) =  10.27, p = 0.006). Data was analysed by 2way ANOVA, followed by Bonferroni post-
hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 
0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
 
3.1.4 Physiological changes after standard CSDS  
Body weight was monitored throughout the standard CSDS paradigm. Overall, Cnr1-/- mice were 
leaner than Cnr1+/+ mice, which was independent from stress (Figure 8A). On average, stressed 
mice lost approximately 10 - 20% body weight (1 - 2 g) during the first days of stress exposure, 
but recovered completely within the remaining days. Over the 10-day period, stress had a 
significant effect on body weight change, with stressed animals of both genotypes gaining 
significantly more weight than control mice (Figure 8B).  
 
After the CSDS paradigm, mice were sacrificed and organs isolated for further analysis. Adrenal 
glands were weighed as a measure for HPA axis activity, since continuous activation of the system 
is associated with enlargement of the adrenal glands. Indeed, stress increased adrenal weight 
(Figure 8C), reaching significance in post-hoc comparisons in Cnr1+/+ mice. Chronic stress has 
also been reported to induce splenomegaly, which was also observed after standard CSDS (Figure 
8D). Post-hoc comparison showed a significant stress-induced increase in spleen weight in Cnr1-/-, 
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but not Cnr1+/+ mice. To account for the reduced body weight of Cnr1-/- mice, adrenal and spleen 
weight was further normalised to body weight (Figure 8E - F). The main effect of stress remained 
significant in both cases. Additionally, a significant genotype effect and a tendency were found for 
adrenal glands and spleen, respectively.  
 
 
Figure 8. Standard CSDS affects body weight and leads to adrenal enlargement and splenomegaly. (A) During standard 
CSDS, body weight was monitored daily for stressed mice and every second day for control mice (analysis for day 10 - 
genotype: F(1,38) =  21.17, p < 0.0001). (B) Body weight change after standard CSDS, compared to day one (stress: F(1,37) 
=  18.69, p = 0.0001). (C - F) Organs were isolated and weighed approximately 24 h after the last stress exposure. 
Organ weight is shown as absolute weight and normalised to body weight, since Cnr1-/- mice weighed less than Cnr1+/+ 
mice. (C) Absolute adrenal weight (stress: F(1,16) = 7.07, p = 0.017). (D) Absolute spleen weight (stress: F(1,16) =  13.67, 
p = 0.002). (E) Relative adrenal weight (stress: F(1,16) = 4.84, p = 0.043; genotype: F(1,16) =  5.19, p = 0.037). (F) Relative 
spleen weight (stress: F(1,16) =  13.34, p = 0.002; genotype: F(1,16) =  3.96, p = 0.064). Data was analysed by 2way 
ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * 
p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p 
< 0.01, +++ p < 0.001.   
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3.1.5 Glucocorticoid signalling after standard CSDS 
Corticosterone, the main GC in rodents, is produced by the adrenal glands at baseline and in 
response to stress. Basal CORT levels follow a diurnal rhythm, with a peak at the beginning of the 
active (dark) phase and low concentrations during the inactive (light) phase (Son et al., 2011). 
After standard CSDS, blood was collected at the beginning of the active phase, approximately 24 
hours after the last stress exposure, and plasma CORT measured using an EIA kit. Although not 
statistically significant, there was a tendency for a genotype effect, with Cnr1-/- mice showing 
slightly increased plasma CORT levels (Figure 9A). In another cohort of mice (cohort 1), cumulative 
CORT was measured in faecal samples collected from a 24-hour period of single-housing after the 
last stress exposure, but no significant effects on faecal CORT levels were observed (Figure 9B). 
 
 
Figure 9. Corticosterone levels are not significantly altered after standard CSDS. Corticosterone (CORT) was measured 
after standard CSDS in blood plasma and faecal extracts using a CORT enzyme immunoassay (EIA). (A) Blood was 
collected approximately 24 h after the last stress exposure, at the beginning of the active phase (genotype: F(1,18) = 
3.89, p = 0.064; stress x genotype interaction: F(1,14) = 3.78, p = 0.072). (B) In another cohort of mice, faeces were 
collected from a 24 h period after standard CSDS. Steroids were extracted from faecal samples using ethanol extraction 
and used for CORT measurements (no significant main effects). Data was analysed by 2way ANOVA, followed by 
Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 
0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 
0.001. 
 
3.1.6 Effects of standard CSDS on peripheral myeloid cells 
Chronic stress is associated with an increased production of myeloid cells in the bone marrow 
that are released into the circulation and migrate to different organs, including the spleen (Wohleb 
et al., 2015). Therefore, leukocytes from blood and spleen were isolated after standard CSDS 
approximately 24 hours after the last stress exposure and myeloid cell populations analysed by 
flow cytometry.   
In the blood, a significant stress effect was detected for myeloid (CD11b+) cells, with stressed 
mice of both genotypes showing elevated numbers (Figure 10B). Due to some variance and small 
group sizes, these differences did not reach significance in post-hoc comparisons. Separation of 
myeloid cells into neutrophils (Ly6G+) and monocytes (Ly6G-) revealed that this increase in myeloid 
cells was mainly driven by an increase in inflammatory, Ly6Chi monocytes (Figure 10D). In contrast, 
there were no significant differences in neutrophil (Figure 10C) and Ly6Clo monocytes 
(Figure 10E).  
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Figure 10. Standard CSDS increases circulating inflammatory monocyte frequencies. After standard CSDS, whole 
blood was collected by cardiac puncture and analysed by flow cytometry. (A) Gating strategy for blood cells. DAPI was 
used for staining dead cells. Neutrophils were identified as CD11b+ Ly6G+. Monocytes were identified as CD11b+ Ly6G- 
and divided into Ly6Chi and Ly6Clo subsets. (B) Frequency of CD11b+ myeloid cells (stress: F(1,15) = 5.24, p = 0.037). (C) 
Neutrophil frequency (no significant main effects). (D) Ly6Chi monocyte frequency (stress: F(1,15) = 5.81, p = 0.029). (E) 
Ly6Clo monocyte frequency (no significant main effects). Data was analysed by 2way ANOVA, followed by Bonferroni 
post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 
0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
 
In the same cohort of mice, spleen cells were isolated and cultured ex vivo overnight, with or 
without stimulation with LPS, which elicits a pro-inflammatory response. Flow cytometric analysis 
of unstimulated splenocytes revealed significant stress effects for overall myeloid cell frequencies 
(Figure 11B) and Ly6Chi monocytes (Figure 11C). In both cases, stressed Cnr1+/+ mice showed 
significantly higher values compared to their control group. For Cnr1-/- mice, only the increase in 
Ly6Chi monocytes reached statistical significance.  
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Figure 11. Standard CSDS increases splenic monocyte frequencies and increases pro-inflammatory responses to ex 
vivo stimulation. After standard CSDS, spleens were collected and isolated splenocytes cultured overnight and 
stimulated with LPS or vehicle (PBS). Afterwards, cells were harvested for flow cytometric analysis and supernatants 
collected for cytokine measurements. (A) Gating strategy for unstimulated splenocytes. DAPI was used for staining dead 
cells. (B) Frequency of CD11b+ myeloid cells (stress: F(1,15) = 32.3, p = 0.003). (C) Ly6Chi monocyte frequency (stress: 
F(1,15) = 24.9, p = 0.0002). (D) IL-6 released from splenocytes treated with 0.1 µg/ml LPS (stress x genotype interaction: 
F(1,13) = 3.99, p = 0.067). (E - G) Cytokine measurements from another cohort of mice that underwent standard CSDS. 
Splenocytes were stimulated with 1 µg/ml LPS. (E) IL-6 (stress: F(1,14) = 14.12, p = 0.002). (F) IL-1b (stress: F(1,13) = 3.46, 
p = 0.085). (G) TNFa (stress: F(1,14) = 12.76, p = 0.003). Data was analysed by 2way ANOVA, followed by Bonferroni 
post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 
0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
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Supernatants from cultured splenocytes were collected for the measurement of cytokines 
released in response to LPS stimulation. Without LPS stimulation, cytokine levels were generally 
very low and mostly below the detection limit of the respective ELISA (data not shown). When cells 
were treated with 0.1 µg/ml LPS, IL-6 was detectable in the supernatant and a tendency for a 
stress x genotype interaction was observed (Figure 11D). In Cnr1+/+ mice, stress slightly enhanced 
the release of IL-6, while this effect was not observed in Cnr1-/- mice. However, due to small group 
sizes and high variances between the samples, the differences did not reach significance. In 
another cohort of mice that underwent standard CSDS (cohort 2), splenocytes were stimulated 
with 1 µg/ml LPS. In this case, significant stress effects were detected for IL-6 and TNFa as well 
as a tendency for IL-1b (Figure 11E - G). Similar to the previous observation, prior stress exposure 
exaggerated the pro-inflammatory response of splenocytes to LPS stimulation. This effect was 
more pronounced in Cnr1+/+ mice, where it reached significance in post-hoc comparisons for IL-6 
and TNFa. In contrast, no significant differences were observed for splenocytes of Cnr1-/- mice.  
 
3.1.7 Reduction of stress exposure during standard CSDS 
In the following cohort of mice, defeat sessions were reduced to a maximum of 5 minutes daily 
and mice were not single-housed before CSDS to reduce baseline stress levels. Nonetheless, six 
out of nine Cnr1-/- mice died during the first four days of stress exposure. Therefore, all remaining 
Cnr1-/- mice were excluded and experiments were carried out only with Cnr1+/+ mice. Behavioural 
analysis showed that this protocol was still sufficient to affect stress-related behaviours (Figure 
12). Stressed mice displayed increased anxiety in the open field (Figure 12C) and a mild, albeit 
not significant, reduction in sucrose preference (Figure 12D). In the social avoidance test, 
stressed mice spent more time in the corners (Figure 12B). Furthermore, 8 out of 11 stressed 
mice showed an SI ratio below one and were thus classified as susceptible, while the remaining 
three mice with SI ratios above one were classified as resilient (Figure 12A). Separate analysis of 
behavioural data for these two sub-groups showed that this classification was able to differentiate 
mice in the social avoidance test, but not in other tests. In more detail, susceptible mice spent 
significantly more time in corners during the social avoidance test, compared to both control and 
resilient mice (Figure 12E). However, susceptible and resilient mice spent comparable amounts 
of time in the centre of the open field and the variance within the susceptible group was rather 
high (Figure 12F). In the sucrose preference test, resilient mice even seemed to have lower 
preferences than susceptible ones (Figure 12G). This suggests that the classification of mice into 
stress susceptible and resilient mice based on one behavioural readout (the SI ratio) does not 
reflect the overall stress-related phenotype.  
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Figure 12. Social avoidance behaviour of Cnr1+/+ mice does not correlate with other stress-related behaviour. 
Behavioural analysis of Cnr1+/+ mice after standard CSDS with reduced stress exposure (max. 5 minutes daily). Due to 
substantial mortality, Cnr1-/- mice were completely excluded from the experiment after four days. (A - D) Quantification 
of behaviour of control versus all stressed mice. (A) Social interaction (SI) ratio, calculated from the interaction time 
during the two trials of the social avoidance test (p = 0.13, t = 1.61, df = 13). According to the SI ratio, stressed mice 
were classified as resilient (SI ratio > 1) or susceptible (SI ratio < 1). (B) Time spent in corners during trial two of the 
social avoidance test (CD1 target present) (p = 0.04, t = 2.30, df = 13). (C) Anxiety measured as time spent in the centre 
of the open field test (p = 0.02, t = 2.61, df = 13). (D) Anhedonia measured as sucrose preference (p = 0.24, t = 1.23, 
df = 11). (E - G) Analysis of the same data sets with separation of mice into stress resilient and susceptible. (E) Time 
spent in corners during the social avoidance test (F = 10.71, p = 0.002). (F) Time spent in the centre of the open field 
(F = 3.35, p = 0.07). (G) Sucrose preference (F = 2.75, p = 0.11). Data was analysed by unpaired Student’s t-test (two 
groups) or 1way ANOVA, followed by Bonferroni post-hoc comparisons (three groups). Significant differences in the t-
test or post-hoc comparisons are shown in the graph, * p < 0.05, ** p < 0.01. 
 
3.1.8 Effect of standard CSDS on plasma interleukin-6  
Stress-induced IL-6 release by circulating leukocytes has been shown to correlate with stress-
susceptibility in social defeat models (Hodes et al., 2014). Therefore, blood was collected from 
submandibular veins one hour after the first stress exposure for quantification of plasma IL-6 
levels. Stress significantly increased IL-6 concentrations in both genotypes (Figure 13A). Since 
Cnr1-/- mice had to be excluded from the experiment after four days, correlation of IL-6 with 
behavioural stress-susceptibility could only be performed in Cnr1+/+ mice. However, there was no 
correlation of plasma IL-6 levels with later social avoidance behaviour (Figure 13B). Interestingly, 
one stressed Cnr1-/- mouse showed very high plasma IL-6 levels (608 pg/ml; mean = 191 pg/ml) 
and this particular animal was found dead on the following day (Figure 13A).  
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Figure 13. Circulating interleukin-6 is increased after the first exposure to standard CSDS. One hour after the first 
defeat session, blood was collected from submandibular veins. Plasma was prepared and levels of interleukin-6 (IL-6) 
measured by ELISA. (A) Plasma IL-6 levels (stress: F(1,26) = 14.98, p = 0.0007). Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, 
** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, 
+++ p < 0.001.  (B) Pearson correlation analysis of plasma IL-6 levels in stressed Cnr1+/+ with later social avoidance 
behaviour (SI ratio) (R2 = 0.014, p = 0.743). For correlation, only Cnr1+/+ mice could be used, since Cnr1-/- mice were 
excluded from the experiments due to a very high mortality rate. 
 
3.1.9 Measurement of cardiac activity in Cnr1-/- mice during standard CSDS 
In order to determine if the increased mortality of Cnr1-/- during standard CSDS was due to 
cardiovascular events, heart activity was monitored using ECG recordings. Therefore, Cnr1-/- mice 
were equipped with telemetric ECG chips that were implanted subcutaneously and did not require 
any further manipulation of the animal after surgery. Two weeks after the surgery, mice were 
subjected to 5 - 10 minutes of daily defeat sessions and cardiac activity was measured starting 
on the first day of stress exposure (Figure 14A). Out of seven Cnr1-/- mice analysed, three mice 
died during the recordings, on day three to five of CSDS exposure. All mice were bradycardic on 
the day of death (Figure 14B - C) and developed atrio-ventricular (AV) blocks (Figure 14C - F). In a 
healthy heart, depolarisation spreads from the atria to ventricles in a controlled sequence, which 
is visible as a 1:1 pattern in the ECG traces (one P wave followed by one QRS complex). An AV 
block of third degree indicates a complete dissociation of atrial and ventricular signal 
transmission, as seen for the examined Cnr1-/- mice (Figure 14D). Furthermore, mice might have 
had seizures or convulsions during the development of the AV block, indicated by high amplitude 
disturbances in the ECG trace, possibly caused by strong muscle contractions (Figure 14E - F).  
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Figure 14. Signs of cardiac arrhythmias in Cnr1-/- mice that died during standard CSDS. Cardiac activity of Cnr1-/- mice 
was monitored during standard CSDS by long-term telemetric electrocardiogram (ECG) recording. Experiments were 
performed in cooperation with Dr. med. Thomas Beiert, Department of Internal Medicine II, University Hospital Bonn. 
(A) Timeline of experiments: ECG chips were implanted subcutaneously two weeks before starting the standard CSDS 
paradigm, to allow complete healing of the surgical wounds. (B - F) Representative ECG traces of two Cnr1-/- mice that 
died during the experiments (red and blue traces each correspond to one mouse). (B) Comparison of the heart beat on 
day one versus the day of death. (C) Example of a mouse with initial sinus rhythm (beat 1 - 2) with development of a 
short period of 2:1 atrio-ventricular (AV) block (beat 3 – 5), devolving into sinus bradycardia. (D) Example of a mouse 
developing total AV block (third degree, III°). Note the complete dissociation of atrial (P wave, indicated by stars) and 
ventricular (QRS complex) signals. (E - F) Extended time frames showing the development of persistent AV blocks of 
higher degree, with intermittent sinus arrest in one case and the possible occurrence of seizures or convulsions. 
 
3.2 Mild chronic social defeat stress 
In order to prevent mortality of Cnr1-/- mice during stress exposure, the CSDS paradigm was 
adapted to a much milder version, with only one - two minutes of daily defeat sessions (Figure 
15). Thereby, survival rates could be increased to 100%. After mild CSDS, anxiety- and depressive-
like behaviour was analysed in the open field, social avoidance, sucrose preference, and the 
nestlet test. Experiments were carried out in three separate cohorts of mice, with four - nine 
animals per group. In total, 29 Cnr1+/+ mice (15 control, 14 stress) and 29 Cnr1-/- mice (12 control, 
16 stress) were tested. All three cohorts were confronted with the same group of CD1 aggressor 
mice and experiments were performed within a time frame of eight weeks. Therefore, behavioural 
data was pooled from all cohorts. Two control cages (i.e. two Cnr1+/+ and two Cnr1-/- mice) had to 
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be excluded from the analysis, due to highly deviant baseline behaviour. After completion of all 
behavioural tests, mice from the different cohorts where used for analysis of different cellular and 
molecular parameters. When applicable, data was pooled from two or all cohorts.  
 
 
Figure 15. Experimental setup for mild CSDS. Male Cnr1+/+ or Cnr1-/- mice were individually introduced into the home 
cage of a CD1 aggressor mouse. Mice were allowed to physically interact for 1 - 2 minutes, during which the intruder is 
exposed to repeated bouts of social defeat by the CD1 aggressor. After the physical defeat, mice were separated by 
perforated Plexiglas wall to allow sensory, but not physical contact for the following 24 h. C57BL/6J intruder mice were 
exposed to a new CD1 aggressor for 10 consecutive days. Control mice were housed in pairs of two, unfamiliar to each 
other and separated by a perforated Plexiglas wall. Combinations of control mice were not alternated during the 10-day 
period. After mild CSDS (starting on day 9), anxiety- and depressive-like behaviour was analysed in the open field, social 
avoidance, sucrose preference, and nestlet test. One day after the last stress exposure, mice were sacrificed and organs 
harvested for analysis. Faeces were collected from the 24 h period of single-housing after the last stress exposure.  
 
3.2.1 Social avoidance after mild CSDS 
Approximately three hours after the last stress exposure, social avoidance behaviour was 
analysed (Figure 16). In the first trial without a CD1 target, there was no difference in the time 
spent in the interaction or corner zones (Figure 16C - D). Locomotion during this trial was 
significantly affected by stress and genotype (Figure 16E). Cnr1-/- mice generally moved less and 
stress significantly reduced locomotion in Cnr1+/+ mice. In the second trial, significant stress 
effects were detected for both interaction with the CD1 target and time spent in corners (Figure 
16F - G). Post-hoc comparisons showed that stressed Cnr1-/- mice spent significantly less time in 
interaction zones and more time in corners compared to control Cnr1-/- mice. Similar directions 
were also seen in Cnr1+/+ mice, however, they did not reach significance. Furthermore, both stress 
and genotype had a strong effect on locomotion in the presence of a CD1 target (Figure 16H), with 
stressed mice of both genotypes moving significantly less compared to their corresponding 
unstressed controls, and Cnr1-/- mice moving significantly less than Cnr1+/+ mice.   
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Figure 16. Mild CSDS induces social avoidance behaviour in Cnr1-/- mice. Mice were subjected to the social avoidance 
test after mild CSDS. (A) Experimental setup and representative heatmap visualization of movement of mice during the 
two trials of the test. First trial (no target): the cage located on one side of the arena is empty. Second trial (target):  
cage containing an unfamiliar CD1 aggressor mouse. In between trials, mice were briefly transferred to their home cage 
and the empty cages replaced by cages with CD1 mice. (B) Social interaction (SI) ratio, calculated from the interaction 
time in the first and second trial (stress: F(1,45) = 6.15, p = 0. 017). (C - E) Quantification of the first trial of the test (no 
target). (C) Interaction with empty cage (no significant main effects). (D) Time spent in any of the four corners (no 
significant main effects). (E) Locomotion, total distance moved (stress: F(1,48) = 7.68, p = 0.008; genotype: F(1,48) = 3.42, 
p = 0.071). (F - H) Quantification of the second trial of the test (target). (F) Interaction with an unfamiliar CD1 aggressor 
(stress: F(1,45) = 8.50, p = 0.006). (G) Time spent in corners (stress: F(1,46) = 19.23, p < 0.0001). (H) Total distance 
moved (stress: F(1,45) = 33.28, p < 0.0001; genotype: F(1,45) = 13.73, p < 0.0006). Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, 
** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, 
+++ p < 0.001.   
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3.2.2 Locomotion and anxiety after mild CSDS 
On day nine of the mild CSDS paradigm, exploratory and anxiety-like behaviour of mice was 
analysed in the open field test (Figure 17A). The test was performed under aversive, brightly 
illuminated conditions (150 lux). For all parameters analysed – locomotion (total distance moved) 
and anxiety (time spent in the centre and frequency to enter the centre) – a significant genotype 
effect was detected. Stress, on the other hand, only slightly reduced the frequency to enter the 
centre (Figure 17D). Post-hoc comparisons showed that control Cnr1-/- mice moved significantly 
less than control Cnr1+/+ mice (Figure 17B). Furthermore, control and stressed Cnr1-/- mice 
entered the centre area less frequently and spent significantly less time in the centre of the open 
field compared to corresponding Cnr1+/+ mice (Figure 17C - D), suggesting that Cnr1-/- mice were 
generally more anxious, independent from stress. 
  
 
Figure 17. Cnr1-/- mice are hypoactive and more anxious in the open field test, independent from stress. Locomotion 
and anxiety-like behaviour was analysed on day nine of the mild CSDS paradigm in the open field test. (A) Mice were 
placed in a brightly illuminated open field arena and allowed to explore for 10 minutes. (B) Locomotion was measured 
as total distance moved (genotype: F(1,47) = 9.70, p = 0.003). (C) Anxiety was measured as time spent in the centre area 
of the arena (genotype: F(1,46) = 29.96, p < 0.0001) and (D) frequency to enter the centre (genotype: F(1,47) = 18.63, p 
< 0.0001; stress: F(1,47) = 5.67, p < 0.021). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc 
comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. 
For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
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3.2.3 Anhedonia after mild CSDS 
While standard CSDS slightly induced anhedonia in mice, mild CSDS had no effect on sucrose 
preference (Figure 18A). A significant genotype effect was detected, caused by a general reduction 
in sucrose preference in Cnr1-/- mice independent from stress. In post-hoc comparisons, the 
differences did not reach significance. Similar to standard CSDS, also mild CSDS increased fluid 
intake (Figure 18B), with stressed Cnr1-/- mice drinking significantly more than Cnr1-/- controls.  
 
 
Figure 18. Mild CSDS has no effect on sucrose preference but increases fluid intake. Anhedonia was analysed after 
mild CSDS using the sucrose preference test. Mice had free access to two bottles, one containing H2O and the other 
one 1% sucrose solution, and consumption of fluid was measured after 24 h. (A) Sucrose preference, i.e. the percentage 
of sucrose consumption in relation to the total fluid intake (genotype: F(1,44) = 5.82, p = 0.020). (B) Total fluid intake 
over 24 h (stress: F(1,44) =  9.48, p = 0.004). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc 
comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. 
For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
 
3.2.4 Nest building behaviour after mild CSDS 
As a final behavioural readout for stress-sensitivity, nest building was analysed after mild CSDS. 
Therefore, mice were provided with pre-weighed nesting material and left undisturbed for one 
hour (Figure 19). Qualitatively, it was apparent that stressed mice did not build nests as well as 
control mice. Furthermore, Cnr1-/- mice generally had deficits in nest building behaviour and none 
of the stressed Cnr1-/- mice started using the nesting material at all (Figure 19A). Since the 
variability between individual mice was very high and data points were not distributed normally, 
data was analysed by a non-parametric Kruskal-Wallis test. The test revealed a significant 
variation of medians between the groups and Dunn’s post-hoc comparisons showed that stressed 
Cnr1-/- mice used significantly less nesting material compared to Cnr1-/- control mice (Figure 19B). 
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Figure 19. Mild CSDS reduces nest-building behaviour in Cnr1-/- mice. Nest-building behaviour was analysed as a 
measure of self-care after mild CSDS. Mice were provided with pre-weighed nestlet material and the amount of material 
used was measured after one hour. (A) Representative pictures of nests build by mice of the different groups. (B) 
Quantification of nestlet material used within one hour (Kruskal-Wallis statistic = 14.43, p = 0.006). Since data points 
were not normally distributed, data was analysed by non-parametric Kruskal-Wallis test, followed by Dunn’s multiple 
comparisons and are presented as box and whiskers plots (Min to Max, line indicates median). For stress effects 
(compared to control of the same genotype) + p < 0.05.   
 
3.2.5 Calculation of behavioural stress scores 
To obtain an overall estimate of the stress-related behavioural phenotype, values from each 
behavioural test were transformed into a score ranging from zero (no phenotype) to three (strong 
phenotype). The score for each parameter was determined based on the deviation from the mean 
performance of Cnr1+/+ control mice (within SD = score 0; > 1x SD = score 1; > 2x SD = score 2; 
> 3x SD = score 3). The overall stress score was then calculated as the mean of all individual 
parameters (Figure 20). Thereby, mice that had to be excluded from a certain test (e.g. due to a 
leaky bottle in the sucrose preference test) could still be assigned an overall stress score from the 
remaining tests. Non-parametric analysis confirmed that mild CSDS had a more pronounced effect 
in Cnr1-/- mice, with stressed Cnr1-/- mice showing significantly higher scores than both control 
Cnr1-/- mice and stressed Cnr1+/+ mice. Mild CSDS increased the scores of Cnr1+/+ mice to levels 
comparable to those of control Cnr1-/- mice, which were already increased under control 
conditions (not significant in post-hoc comparisons).   
 
 
Figure 20. Mild CSDS increases overall stress-related behaviour in Cnr1-/- mice. Behavioural stress scores were 
calculated for individual mice based on their performance in all behavioural tests, ranging from zero (no phenotype) to 
three (strong phenotype), see text above for details (Kruskal-Wallis statistic = 25.1, p < 0.0001). Data was analysed by 
non-parametric Kruskal-Wallis test, followed by Dunn’s multiple comparisons and are presented as box and whiskers 
plots (Min to Max, line indicates median). For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05. For 
stress effects (compared to control of the same genotype) + p < 0.05.  
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3.2.6 Physiological effects of mild CSDS 
During mild CSDS, body weight was monitored on a daily basis. Stress overall had no effect on 
body weight (Figure 21). In contrast, the genotype significantly affected body weight gain during 
mild CSDS, as control and stressed Cnr1-/- gained significantly less weight compared to the 
respective Cnr1+/+ groups (Figure 21B). Unlike standard CSDS, which induced adrenomegaly and 
splenomegaly, mild CSDS had no effect on adrenal or spleen weight (Figure 21C - D). The genotype 
did also not influence these parameters. For adrenal glands, there was a significant stress x 
genotype interaction, however no differences between the groups in post-hoc comparisons.  
 
 
Figure 21. Mild CSDs has no effect on body weight, adrenal glands and spleen weight. (A) During mild CSDS, body 
weight was monitored daily for both stressed and control mice (analysis for day 10 – genotype: F(1,47) = 25.78, p < 
0.0001). (B) Body weight change after mild CSDS, compared to day one (genotype: F(1,44) = 13.51, p = 0.0006). (C - D) 
Organs were isolated and weighed approximately 24 h after the last stress exposure. Organ weight was normalised to 
body weight, since Cnr1-/- mice generally weigh less than Cnr1+/+ mice. (C) Relative adrenal weight (stress x genotype 
interaction: F(1,43) = 4.74, p = 0.035). (D) Relative spleen weight (no significant main effects). Data was analysed by 
2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same 
group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 
0.05, ++ p < 0.01, +++ p < 0.001.   
 
3.2.7 Glucocorticoid signalling after mild CSDS 
After mild CSDS, blood was collected at the beginning of the active phase approximately 24 hours 
after the last stress exposure and plasma CORT was measured using an EIA kit (Figure 22A). A 
significant stress x genotype interaction was detected and post-hoc comparisons showed that 
stressed Cnr1-/- mice had higher plasma levels compared to stressed Cnr1+/+ mice. Additionally, 
cumulative CORT was measured in faecal samples collected from a 24-hour period of single-
housing after the last defeat (Figure 22B). Faecal CORT was significantly affected by genotype and 
stress, and a tendency for a stress x genotype interaction was detected. In more detail, stress 
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induced a significant increase in 24-hour faecal CORT in Cnr1+/+, but not in Cnr1-/- mice. Stressed 
Cnr1-/- mice thus had significantly lower CORT levels compared to stressed Cnr1+/+ mice. To test 
whether CORT responses were associated with the individual behavioural susceptibility, data was 
correlated with the behavioural stress scores (see chapter 3.2.5). Only in Cnr1+/+ mice, plasma 
CORT levels were negatively correlated with stress scores, as mice with high behavioural deficits 
showed the lowest CORT levels (Figure 22C). In contrast, there was no correlation in Cnr1-/- mice. 
For faecal CORT, no correlation was detected for any genotype (Figure 22D).  
 
 
Figure 22. Mild CSDS increases cumulative corticosterone levels in Cnr1+/+, but not in Cnr1-/- mice. Corticosterone 
(CORT) was measured after mild CSDS in blood plasma and faecal extracts using an enzyme immunoassay (EIA). (A) 
Blood was collected approximately 24 h after the last stress exposure. Measurement of CORT in plasma was performed 
for two cohorts of mice (stress x genotype interaction: F(1,17) = 6.41, p = 0.022). (B) Faeces were collected from a 24 h 
period after mild CSDS in three cohorts of mice and steroids were extracted from faecal samples using ethanol 
extraction (stress: F(1,47) = 3.56, p = 0.065; genotype: F(1,47) = 7.91, p = 0.010). Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, 
** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, 
+++ p < 0.001. (C - D) CORT levels were correlated to the behavioural stress scores. Spearman correlation was 
performed for each genotype. (C) Plasma CORT vs. stress scores (Cnr1+/+: r = -0.78, p = 0.004; Cnr1-/-: r = 0.146, p = 
0.686). (D) Faecal CORT vs. stress scores (Cnr1+/+: r = 0.20, p = 0.317; Cnr1-/-: r = -0.22, p = 0.276).  
 
GCs secreted by the adrenal glands give feedback to brain regions that regulate activity of the 
HPA axis directly or indirectly, such as the PVN, or the amygdala, hippocampus and mPFC (Godoy 
et al., 2018). To analyse whether the altered CORT levels after mild CSDS resulted in changes of 
HPA axis components in these brain regions, expression of the genes encoding GR (Nr3c1), CRH 
(Crh), and CRHR1 (Crhr1) was analysed by qPCR in one cohort of mice (Figure 23). However, no 
significant differences were observed for Nr3c1, Crh, or Crhr1 expression in any of the brain 
regions analysed. 
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Figure 23. Gene expression of HPA axis-related genes is not altered in the brain after mild CSDS. Brain regions were 
isolated approximately 24 h after the last stress exposure in one cohort of mice. RNA was isolated, reverse transcribed 
into cDNA and gene expression analysed by qPCR. Expression of target genes was normalised to the expression of 
reference gene Hprt and is presented as 2-DCp. (A - B) Nr3c1 and Crh mRNA levels in the PVN (no significant main 
effects). (C - D) Nr3c1 and Crhr1 mRNA levels in the amygdala (no significant main effects). (E - F) Nr3c1 and Crhr1 
mRNA levels in the dorsal hippocampus (no significant main effects). Data was analysed by 2way ANOVA, followed by 
Bonferroni post-hoc comparisons. 
 
3.2.8 Sympathetic innervation of the bone marrow after mild CSDS 
Next to the HPA axis, another system activated by stress is the SNS. Sympathetic nerves innervate 
the bone marrow and release noradrenaline in response to stress (Ziegler, 2004). Noradrenaline 
is synthesised downstream of TH, the rate-limiting enzyme during catecholamines synthesis. To 
analyse whether mild CSDS altered sympathetic innervation of the bone marrow, tibia sections 
were stained for TH and imaged using confocal microscopy. TH+ nerve endings could clearly be 
identified in close proximity to blood vessels within the bone marrow (Figure 24A). Quantification 
of TH immunoreactivity within TH+ nerve endings showed that stress significantly increased TH 
levels in sympathetic nerve endings, indirectly suggesting increased production of noradrenaline 
(Figure 24B). It also seemed like the number of TH+ nerve endings was increased after stress, 
however this could not be reliably quantified, since the area of blood vessels varied strongly 
between samples, depending on the cutting angle of the sections.  
 
Results  59 
 
Figure 24. Mild CSDS increases tyrosine hydroxylase immunoreactivity in sympathetic nerves innervating the bone 
marrow. Tibias were collected after mild CSDS in one cohort of mice. Frozen, fixed and decalcified bones were cut into 
10 µm longitudinal sections. Tyrosine hydroxylase (TH) was stained to identify noradrenergic nerve terminals innervating 
the bone marrow. Images were acquired using confocal microscopy using a 63x objective. Z-stacks of 10 µm were taken 
with a step size of 1 µm. (A) Representative images of maximum projections of z-stacks, showing TH-positive (TH+) 
nerve endings surrounding blood vessels within the bone marrow. Upper panels show overviews of a transmitted light 
(TM) image and TH signals (magenta). Black boxes indicate areas shown in higher magnification in the lower panels 
(middle: TM + TH signal; bottom: only TH signal for better visualisation); scale bar = 10 µm. (B) TH+ nerve endings were 
identified by applying an appropriate threshold and TH immunoreactivity (mean grey) was quantified within TH+ nerve 
endings (stress: F(1,13) = 4.94, p = 0.045). AU = arbitrary unit. Data was analysed by 2way ANOVA, followed by Bonferroni 
post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 
0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
 
3.2.9 Regulation of CXCL12 in the bone marrow after mild CSDS 
During chronic stress, both noradrenaline and GCs facilitate the egress of myeloid cells from the 
bone marrow into circulation via regulation of the chemokine stromal cell-derived factor 1, also 
known as C-X-C motif chemokine 12 (CXCL12) (Heidt et al., 2014; Niraula et al., 2018). CXCL12 
is expressed by bone marrow stromal cells (among others) and functions as a retention factor for 
HSCs and myeloid cells within the bone marrow by interacting with its receptor CXCR4 expressed 
by those cells (Ding and Morrison, 2013; Eash et al., 2010). Therefore, Cxcl12 gene expression 
was analysed in bone marrow cells isolated after mild CSDS using qPCR (Figure 25). A significant 
stress effect was detected, with stressed mice showing reduced Cxcl12 expression. Although not 
significant in post-hoc comparisons for both genotypes, the reduction was slightly more 
pronounced in Cnr1+/+ mice.   
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Figure 25. Mild CSDS reduces Cxcl12 gene expression in the bone marrow. Bone marrow cells were isolated 
approximately 24 h after the last stress exposure in three cohorts of mice. RNA was isolated, reverse transcribed into 
cDNA and gene expression analysed by qPCR. Expression of target genes was normalised to the expression of reference 
gene Hprt and is presented as fold change from Cnr1+/+ controls (2-DDCp). Cxcl12 mRNA levels in the bone marrow 
(stress: F(1,45) = 5.97, p = 0.019). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For 
genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects 
(compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
 
3.2.10 Effects of mild CSDS on peripheral myeloid cells 
As described above, chronic stress is associated with an increased production of myeloid cells in 
the bone marrow that are subsequently released into the circulation and migrate to different 
organs, including the spleen (Wohleb et al., 2015). In the spleen, they remain as a myelopoietic 
depot that provides persistent production of splenic monocytes even after cessation of the 
stressor (Mckim et al., 2018). Therefore, leukocytes from bone marrow, blood, and spleen were 
isolated after mild CSDS approximately 24 hours after the last stress exposure and myeloid cell 
populations analysed by flow cytometry.  
 
3.2.10.1 Bone marrow 
In the bone marrow, there was a clear stress effect on CD11b+ myeloid cells (Figure 26B). 
Separation of the myeloid cell population into neutrophils (Ly6G+ Ly6Cint) and monocytes (CD115+) 
showed that the stress-induced increase in myeloid cells was mainly driven by neutrophils (Figure 
26C). In Cnr1-/- mice, stress caused a significant increase in neutrophil frequencies compared to 
their control group and also compared to stressed Cnr1+/+ mice. In contrast, mild CSDS had no 
significant effect on total CD115+ bone marrow monocytes (Figure 26D). However, there was a 
small tendency for Cnr1-/- mice showing higher monocyte frequencies. Similar to total monocytes, 
mild CSDS had no effect on bone marrow Ly6Chi monocytes (Figure 26E), but Cnr1-/- mice had 
slightly higher frequencies (not significant). A significant stress effect was observed for Ly6Clo 
monocytes, which were lower in stressed mice (Figure 26G), although the differences were not 
significant in post-hoc comparisons. Furthermore, Cnr1-/- mice showed slightly reduced CCR2 
surface expression on Ly6Chi monocytes (significant genotype effect) (Figure 26F).  
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Figure 26. Mild CSDS increases neutrophil frequencies in the bone marrow of Cnr1-/- mice. After mild CSDS, bone 
marrow cells were isolated and analysed by flow cytometry in two cohorts of mice. (A) Gating strategy for bone marrow 
myeloid cells. Lineage stain included antibodies against CD3, CD19, NK1.1, TER-119, Ly6G, and DRAQ7™ for staining 
dead cells. Neutrophils were identified as CD11b+, Lineage/Ly6G+, Ly6Cint. Monocytes were identified as CD11b+, 
Lineage/Ly6Gneg, CD115+ and divided into Ly6Chi and Ly6Clo subsets. A CD115+/- CCR2- population was excluded from 
the CD115+ monocyte gate (possibly eosinophils). (B) Frequency of all CD11b+ myeloid cells (stress: F(1,27) = 18.2, p = 
0.0002; genotype: F(1,27) = 2.99, p = 0.095). (C) Neutrophil frequency (stress: F(1,27) = 15.58, p < 0.0005). (D) Total 
CD115+ monocyte frequency (genotype: F(1,27) = 2.12, p = 0.156). (E) Ly6Chi monocyte frequency (genotype: F(1,27) = 
2.47, p = 0.128). (F) CCR2 surface expression on Ly6Chi monocytes, measured as geometric mean fluorescence 
intensity (gMFI) (genotype: F(1,27) = 4.57, p = 0.042). (G) Ly6Clo monocyte frequency (stress: F(1,27) = 7.91, p = 0.009). 
Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to 
Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same 
genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
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3.2.10.2 Blood 
In the same cohorts of mice, blood was collected for analysis of circulating leukocytes (Figure 27). 
Analysis of myeloid cell populations showed that stress had no significant effect on overall CD11b+ 
myeloid cells (Figure 27C), but slightly increased circulating neutrophils, with a tendency for a 
stress effect (Figure 27D). Mild CSDS did not significantly affect circulating monocytes, neither 
total CD115+ monocytes, nor the Ly6Chi or Ly6Clo subtypes (Figure 27F - G). In Cnr1+/+ mice, stress 
increased the variance in Ly6Chi monocytes, but did not overall increase their numbers. With the 
exception of two mice, stressed Cnr1-/- mice mostly showed lower Ly6Chi frequencies than 
stressed Cnr1+/+, however this was not significant (Figure 27F). In the blood, Cnr1-/- mice generally 
had less patrolling Ly6Clo monocytes (significant genotype effect) (Figure 27G).   
 
3.2.10.3 Spleen 
After mild CSDS, overall CD11b+ myeloid cells were not changed in the spleen (Figure 28A), but a 
significant stress effect was observed for Ly6Chi monocytes and Ly6Clo monocytes/macrophages 
(Figure 28D - E). In post-hoc comparisons, this stress effect reached significance for Ly6Chi 
monocytes in Cnr1-/- mice, where the amplitude of the stress effect was higher than in Cnr1+/+ 
mice. Neutrophil frequencies were also significantly increased by stress in Cnr1-/- mice (significant 
stress x genotype interaction) (Figure 28C). Compared to the effects of standard CSDS on splenic 
myeloid cells (see Figure 11), the effects of mild CSDS were comparatively small. It should also 
be noted that the quality and quantity of splenocytes was not optimal for flow cytometry, possibly 
due to a rather long time-lag between cell isolation and analysis.  
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Figure 27. Mild CSDS has no major effect on circulating myeloid cell populations. After mild CSDS, whole blood was 
collected by cardiac puncture and analysed by flow cytometry in two cohorts of mice. (A) Gating strategy for blood cells. 
Lineage stain included antibodies against CD3, CD19, NK1.1, TER-119, Ly6G, and DRAQ7™ for staining dead cells. 
Neutrophils were identified as CD11b+, Ly6Cint, Lineage/Ly6G+. Monocytes were identified as CD11b+ CD115+ and 
divided into Ly6Chi and Ly6Clo subsets. (B) Frequency of CD11b+ myeloid cells (no significant main effects). (C) 
Neutrophil frequency (stress: F(1, 28) = 3.08, p = 0.090). (D) Ly6Chi monocyte frequency (no significant main effects). (E) 
Ly6Clo monocyte frequency (genotype: F(1,28) = 6.16, p = 0.019). Data was analysed by 2way ANOVA, followed by 
Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 
0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 
0.001.   
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Figure 28. Mild CSDS slightly increases splenic myeloid cell frequencies in Cnr1-/- mice. After mild CSDS, spleens were 
collected and isolated splenocytes analysed by flow cytometry in two cohorts of mice. (A) Gating strategy for spleen 
cells. Lineage stain included antibodies against CD3, CD19, NK1.1, TER-119, Ly6G, and DRAQ7™ for staining dead 
cells. Neutrophils were identified as CD11b+, CD11c/MHCIIlo, Ly6Cint, Lineage/Ly6G+. Monocytes/macrophages were 
identified as CD11b+, CD11c/MHCIIlo and divided into Ly6Chi and Ly6Clo subsets. (B) Frequency of CD11b+ myeloid cells 
(no significant main effects). (C) Neutrophil frequency (stress x genotype interaction: F(1, 26) = 5.97, p = 0.022). (D) Ly6Chi 
monocyte frequency (stress: F(1,26) = 7.67, p = 0.010). (G) Ly6Clo monocyte/macrophage frequency (stress: F(1,26) = 5.54, 
p = 0.026). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects 
(compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to 
control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
 
Correlation analysis of peripheral myeloid cell populations with the behavioural phenotype of mice 
showed that overall there was no clear association of myeloid cells with stress-susceptibility 
(Figure 29). The only significant correlation was found between splenic neutrophil frequencies and 
the stress score of Cnr1+/+ mice (Figure 29E). However, neutrophil frequencies were generally not 
altered in these mice after mild CSDS, making it difficult to draw a valid conclusion. For Ly6Chi 
monocytes, no significant correlations with the stress scores were found in any of the tissues 
analysed.  
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Figure 29. Overall, changes in peripheral myeloid cells do not correlate with behavioural susceptibility to mild CSDS. 
Results from flow cytometric analysis of peripheral myeloid cell populations were correlated to behavioural stress scores 
of individual mice. (A) Spearman correlation of bone marrow (BM) neutrophils vs. stress score (Cnr1+/+: r = -0.23, p = 
0.66; Cnr1-/-: r = 0.40, p = 0.11; both genotypes: r = 0.29, p = 0.09). (B) BM Ly6Chi monocytes vs. stress score (Cnr1+/+: 
r = 0.45, p = 0.11; Cnr1-/-: r = -0.09, p = 0.74; both genotypes: r = 0.33, p = 0.05). (C) Circulating neutrophils vs. stress 
score (Cnr1+/+: r = -0.43, p = 0.08; Cnr1-/-: r = 0.43, p = 0.07; both genotypes: r = 0.08, p = 0.66). (B) Circulating Ly6Chi 
monocytes vs. stress score (Cnr1+/+: r = 0.001, p = 0.99; Cnr1-/-: r = -0.004, p = 0.99; both genotypes: r = -0.07, p = 
0.70). (D) Splenic neutrophils vs. stress score (Cnr1+/+: r = -0.56, p = 0.049; Cnr1-/-: r = 0.14, p = 0.58; both genotypes: 
r = 0.11, p = 0.57). (E) Splenic Ly6Chi monocytes vs. stress score (Cnr1+/+: r = 0.03, p = 0.93; Cnr1-/-: r = 0.12, p = 0.64; 
both genotypes: r = 0.07, p = 0.70). 
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Taken together, analysis of peripheral myeloid cell populations suggests that even mild CSDS 
induces myelopoiesis in the bone marrow (mainly neutrophils) and some accumulation of Ly6Chi 
monocytes in the spleen. However, the effects were generally small and no significant differences 
were seen in circulating myeloid cells. In contrast, elevated blood Ly6Chi monocytes were observed 
after standard CSDS (see Figure 11). Furthermore, lack of CB1 signalling seems to affect 
monocyte distribution in the periphery. Although the differences were minor, it seemed like 
Cnr1-/- mice generally had fewer circulating monocytes, especially of the Ly6Clo subtype. This could 
possibly be related to reduced egress from the bone marrow, where monocyte frequencies were 
slightly higher in Cnr1-/- mice and CCR2 expression on monocytes was reduced. 
 
3.2.11 Effects of mild CSDS on CNS myeloid cells  
It has been reported in several studies that myeloid cells, especially inflammatory monocytes, are 
recruited to the brain during chronic stress, where they contribute to neuroinflammatory 
processes and the development of anxiety- and depressive-like behaviour (Reader et al., 2015; 
Wohleb et al., 2015). Therefore, brain mononuclear cells were isolated after mild CSDS from two 
cohorts of mice using Percoll density gradient centrifugation (Figure 30). In flow cytometric 
analysis, brain-resident microglia and infiltrated peripheral cells can be distinguished based on 
their expression of the leukocyte common antigen CD45 and the myeloid marker CD11b. While 
both microglia and peripheral myeloid cells are positive for CD11b, CD45 expression is higher on 
infiltrated cells (CD45hi) than on microglia (CD45int). Based on their expression of Ly6G and Ly6C, 
infiltrated cells can further be separated into neutrophils (Ly6G+), inflammatory monocytes 
(Ly6Gneg Ly6Chi), and macrophages/DCs (Ly6Gneg Ly6Clo).  
 
After mild CSDS, there was no apparent infiltration of peripheral cells into the brain parenchyma, 
irrespective of the cell type (Figure 30B - G). There was no change in microglia frequencies (CD45int 
CD11b+) and also no difference in total peripheral myeloid cells (CD45hi CD11b+). When 
separating those myeloid cells into neutrophils (Ly6G+) and monocytes/macrophages/DCs 
(Ly6G-), it seemed like Cnr1-/- mice had marginally reduced numbers of infiltrated 
monocytes/macrophages/DCs, but this did not reach significance. Further separation of cells into 
monocytes and macrophages/DCs did not provide any further information and cell numbers were 
overall too low to draw valid conclusions.    
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Figure 30. Mild CSDS does not cause infiltration of peripheral myeloid cells into the brain. After mild CSDS, brain 
mononuclear cells were isolated by Percoll gradient centrifugation and analysed by flow cytometry in two cohorts of 
mice. (A) Gating strategy for brain myeloid cells. Dead cells were stained with DRAQ7™. CD45 expression was used to 
differentiate between brain-resident microglia (CD45int) and infiltrated peripheral cells (CD45hi). Neutrophils were 
identified as CD45hi CD11b+ Ly6G+. Monocytes/macrophages/DCs were identified as CD45hi CD11b+ Ly6G- and divided 
into Ly6Chi and Ly6Clo subsets. Microglia were identified as CD45int CD11b+ (B - C) Frequency of infiltrated non-myeloid 
(CD11b-) and myeloid (CD11b+) cells (no significant main effects). (D - F) Myeloid cells were further separated into 
neutrophils, monocytes/macrophages/DCs and Ly6Chi monocytes (no significant main effects). (G) Frequency of brain-
resident microglia (no significant main effects). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc 
comparisons.  
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Next to the infiltration of peripheral myeloid cells, activation of brain-resident microglia is 
commonly observed after chronic stress (Stein et al., 2017). Therefore, surface expression of 
activation markers CD11b, CD40, and MHCII was quantified on microglia, by measuring the gMFI 
or the percentage of microglia expressing the respective marker (Figure 31A). For all three 
markers, the highest values were measured on microglia of stressed Cnr1-/- mice. For CD11b, a 
significant stress effect was found that was driven by upregulation of CD11b gMFI after stress in 
Cnr1-/- mice (Figure 31B). For CD40 and MHCII, the percentage of positive cells was quantified, 
since these markers are not expressed by all microglia. Significant stress and genotype effects 
were detected for CD40, with stressed Cnr1-/- mice showing significantly more CD40+ microglia 
compared to their controls (Figure 31D), while the stress effect did not reach significance for 
Cnr1+/+ mice. Similar results were also found for MHCII+ microglia (significant stress effect), but 
the differences did not reach significance in post-hoc comparisons (Figure 31F). Correlation 
analysis of microglial surface marker expression with the behavioural stress scores revealed a 
positive correlation for all three markers (Figure 31C, E and G). Thus, microglia activation marker 
expression was highest in those mice that showed the strongest stress-related behaviour. The 
directions of correlations were similar in both genotypes, however, they only reached significance 
in Cnr1-/- mice (for CD11b and CD40) or when mice of both genotypes were analysed together (for 
MHCII).  
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Figure 31. Surface expression of microglial activation markers is increased after mild CSDS in Cnr1-/- mice. After mild 
CSDS, brain mononuclear cells were isolated by Percoll gradient centrifugation and analysed by flow cytometry in two 
cohorts of mice. (A) Representative dot plots and histograms of surface marker expression on brain-resident microglia 
(CD45int CD11b+ cells). (B) Geometric mean fluorescent intensity (gMFI) of CD11b on microglia (stress: F(1, 22) = 6.24, p 
= 0.021). (C) Spearman correlation of CD11b gMFI vs. behavioural stress scores (Cnr1+/+: r = 0.47, p = 0.082; Cnr1-/-: 
r = 0.69, p = 0.008; both genotypes: r = 0.63, p = 0.0002). (D) Frequency of CD40+ microglia (stress: F(1, 22) = 8.21, p 
= 0.009; genotype: F(1, 22) = 4.89, p = 0.038). (E) Spearman correlation of CD40+ microglia vs. behavioural stress scores 
(Cnr1+/+: r = 0.34, p = 0.216; Cnr1-/-: r = 0.78, p = 0.001; both genotypes: r = 0.65, p = 0.0001). (F) Frequency of 
MHCII+ microglia (stress: F(1, 22) = 6.36, p = 0.019). (E) Spearman correlation of MHCII+ microglia vs. behavioural stress 
scores (Cnr1+/+: r = 0.05, p = 0.851; Cnr1-/-: r = 0.36, p = 0.207; both genotypes: r = 0.38, p = 0.04). Data was analysed 
by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same 
group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 
0.05, ++ p < 0.01, +++ p < 0.001. 
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3.2.12 Effects of mild CSDS on microglia density and neurovascular ICAM-1 expression  
Several studies showed that chronic stress leads to microglial rearrangements in stress-related 
brain areas, such as increased proliferation or altered morphology (Stein et al., 2017). It was also 
shown that chronic social stress increases neurovascular expression of adhesion molecule 
ICAM-1 in brain regions associated with stress-responses and emotional behaviour (Sawicki et al., 
2015). Increased ICAM-1 enables adhesion of peripheral cells to blood vessels and thereby 
facilitates their interaction with the brain and possibly their entry into the brain parenchyma. 
Therefore, ICAM-1 and IBA1 (which stains microglia and macrophages/monocytes) 
immunoreactivity was analysed in the brain after mild CSDS using immunohistochemistry and 
confocal microscopy. IBA1+ area was quantified in thresholded images to determine the density 
of the microglial network in different brain regions. For quantification of neurovascular ICAM-1+ 
area, an appropriate threshold was applied to exclude ICAM-1 expression on microglia or 
macrophages, which was considerably lower than vascular ICAM-1.  
 
3.2.12.1 Hippocampus  
In the dentate gyrus (DG) of the hippocampus, IBA1+ area was significantly increased by stress in 
Cnr1+/+, but not in Cnr1-/- mice (significant stress x genotype interaction) (Figure 32B). In contrast, 
the number of IBA1+ cells in the same area was not affected by stress or genotype (Figure 32C), 
suggesting that the difference in IBA1+ area was caused by altered morphology of microglia or 
altered expression levels of IBA1 itself. Similarly, a significant stress effect and a stress x genotype 
interaction was detected for neurovascular ICAM-1 expression in the DG, since ICAM-1+ area was 
significantly increased by stress in Cnr1+/+ mice, but not in Cnr1-/- mice (Figure 32D). To further 
exclude that the observed changes in ICAM-1+ area were caused by altered ICAM-1 expression on 
microglia, ICAM-1 immunoreactivity was quantified in IBA1+ cells in images taken with higher 
resolution within the molecular layer of the DG (Figure 32A, right panel). No difference between 
the groups was observed for ICAM-1 mean grey intensity within the IBA1+ area (Figure 32E).  
 
Correlation analysis with the behavioural stress score revealed a significant positive correlation in 
Cnr1+/+ mice between stress score and IBA1+ area (Figure 33A) as well as ICAM-1+ area (Figure 
33B). In contrast, there was no correlation for IBA1 in Cnr1-/- mice and only a tendency for a 
positive correlation for ICAM-1.  
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Figure 32. Hippocampal IBA1 and ICAM-1 immunoreactivity is increased by mild CSDS only in Cnr1+/+ mice. Coronal 
brain sections of 60 µm were stained for IBA1 (red) and ICAM-1 (cyan), nuclei were stained with DAPI (blue). Sections 
were imaged using confocal microscopy. (A) Left panels: representative images of the dentate gyrus (DG) of the 
hippocampus, acquired with a 20x objective. Z-stacks of 9 µm were taken with a step size of 3 µm. Maximum projections 
are shown. Scale bar = 200 µm. Right panel: higher magnification images of the inferior molecular layer (indicated by 
white boxes in overview) were acquired using the 63x objective. Z-stacks of 40 – 50 µm were acquired with a step size 
of 0.5 µm. Maximum projections of 5 µm depth are shown. Scale bar = 25 µm. (B) Quantification of IBA1+ area in the 
DG in 20x overview images (stress x genotype interaction: F(1,22) = 9.23, p = 0.006). (C) Microglia. (E) Quantification of 
ICAM-1 immunoreactivity on microglia, measured as ICAM-1 mean grey intensity within the IBA1+ area (no significant 
main effects). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects 
(compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to 
control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.   
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Figure 33. Changes in dentate gyrus IBA1 and ICAM-1 immunoreactivity are correlated with behavioural stress scores 
only in Cnr1+/+ mice. Results from immunohistochemical staining of IBA1 and ICAM-1 in the dentate gyrus (DG) of the 
hippocampus were correlated to behavioural stress scores of individual mice. (A) Spearman correlation of IBA1+ area 
vs. stress score (Cnr1+/+: r = 0.73, p = 0.014; Cnr1-/-: r = -0.04, p = 0.88; both genotypes: r = 0.16, p = 0.429). (B) 
Spearman correlation of ICAM-1+ area vs. stress score (Cnr1+/+: r = 0.86, p = 0.001; Cnr1-/-: r = 0.46, p = 0.085; both 
genotypes: r = 0.41, p = 0.04).  
 
Similar effects on IBA1 and ICAM-1 immunoreactivity were also observed in the CA1 region of the 
hippocampus (Figure 34). ICAM-1+ area was significantly increased by stress in Cnr1+/+, but not 
in Cnr1-/- mice (significant stress effect, tendency for stress x genotype interaction) (Figure 34C). 
For IBA1+ area, the directions of the effects were the same, but did not reach significance (Figure 
34B).  
 
 
Figure 34. Hippocampal CA1 neurovascular ICAM-1 immunoreactivity is increased by mild CSDS only in Cnr1+/+ mice. 
(A) Exemplary image of the CA1 region of the hippocampus of a stressed Cnr1+/+ mouse, stained for IBA1 (red) and 
ICAM-1 (cyan), nuclei were stained with DAPI (blue). Scale bar = 50 µm. (B) Quantification of IBA1+ area in the CA1 
region (no significant main effects). (D) Quantification of ICAM-1+ area in the CA1 region (stress: F(1,19) = 5.39, p = 
0.032; stress x genotype interaction: F(1,19) = 3.21, p = 0.089). Data was analysed by 2way ANOVA, followed by 
Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 
0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 
0.001. 
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3.2.12.2 Amygdala and mPFC 
Quantification of IBA1 immunoreactivity in the amygdala and mPFC revealed a similar pattern as 
observed in the hippocampus, although they were not as pronounced as in the DG (Figure 35). No 
difference was observed for the number of IBA1+ cells in the amygdala (Figure 35 C), but a 
significant stress x genotype interaction was found for IBA1+ area (Figure 35B). Stress slightly 
increased IBA1+ area in Cnr1+/+ mice and had the opposite effect in Cnr1-/- mice. In contrast, 
stress or genotype had no significant effect on IBA1+ area in the mPFC (Figure 35E), but stress 
slightly increased the number of IBA1+ cells (not significant in post-hoc comparisons) (Figure 35F). 
Quantification of neurovascular ICAM-1 in the amygdala and mPFC revealed very similar effects 
as those observed in the hippocampus, with a stress-induced increase in ICAM-1+ area in Cnr1+/+, 
but not in Cnr1-/- mice (Figure 35D and G). These effects reached statistical significance in the 
mPFC, but not in the amygdala.  
 
To verify that the observed changes were indeed caused by microglia and not by infiltrated 
monocytes (which are also IBA1+), brain sections were co-labelled for IBA1 and TMEM119, a 
recently identified marker that is specific for brain-resident microglia and is not expressed by 
peripheral, meningeal and perivascular macrophages (Bennett et al., 2016). In the DG, changes 
in TMEM119+ area were very similar to those observed for IBA1, with a stress-induced increase 
in Cnr1+/+, but not in Cnr1-/- mice (Figure 36B). However, the variance of the TMEM119 signal was 
rather high and the effects did not reach statistical significance (tendency for a stress x genotype 
interaction). Correlation analysis further showed a strong positive correlation between IBA1 and 
TMEM signals, supporting that the changes observed in IBA1+ area were caused by changes in 
brain-resident microglia (Figure 36C). Nonetheless, it should be noted that there were indeed a 
few IBA1+ TMEM119- cells. Mostly, those cells were found in proximity to blood vessels or 
meningeal regions and also displayed a round or rod-shaped morphology, rather different from 
the morphology of typical microglia (Figure 36A, white arrows). Only a very small number of IBA1+ 
TMEM119- cells with ramified morphology were found in the regions analysed. An interesting 
observation was that TMEM119 immunoreactivity was generally weaker in the granule cell layer 
and the subgranular zone of the DG, a region associated with neurogenesis. Although IBA1+ cells 
in this area had a faint TMEM119 signal, it was much weaker compared to other hippocampal 
regions (Figure 36A, arrow heads).  
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Figure 35. IBA1 and neurovascular ICAM-1 immunoreactivity in the amygdala and prefrontal cortex after mild CSDS.  
(A) Exemplary image of the amygdala (upper panel) and mPFC (lower panel) of a stressed Cnr1+/+ mouse, stained for 
IBA1 (red) and ICAM-1 (cyan), nuclei were stained with DAPI (blue). White dashed lines indicate the region analysed. 
Scale bar = 50 µm. (B) Quantification of IBA1+ area in the amygdala (stress x genotype interaction: F(1,20) = 9.37, p = 
0.006). (C) Number of microglia (IBA1+ cells) in the amygdala (no significant main effects). (D) Quantification of ICAM-
1+ area in the amygdala (stress: F(1,17) = 3.27, p = 0.088). (E) Quantification of IBA1+ area in the mPFC (no significant 
main effects). (F) Number of IBA1+ cells in the mPFC (stress: F(1,21) = 4.89, p = 0.038). (G) Quantification of ICAM-1+ 
area in the amygdala (stress: F(1,18) = 4.17, p = 0.056; stress x genotype interaction: F(1,18) = 3.72, p = 0.070). Data was 
analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of 
the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) 
+ p < 0.05, ++ p < 0.01, +++ p < 0.001. 
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Figure 36. Stress-induced changes in IBA1 immunoreactivity are driven by brain-resident microglia. Coronal brain 
sections of 60 µm were stained with antibodies against IBA1 (red) and TMEM119 (green), nuclei were stained with DAPI 
(blue). Sections were imaged using confocal microscopy. (A) Upper panels: representative image of the hippocampus 
of a Cnr1+/+ control mouse, acquired with a 20x objective, a single z-plane is shown. Scale bar = 200 µm. Bottom panel: 
higher magnification images of region of interest (indicated by white boxes in panel above). Arrows indicate IBA1+ 
TMEM119- cells, representing perivascular/meningeal macrophages, the arrow heads indicate IBA1+, TMEM119low 
cells with ramified morphology in the subgranular zone of the DG. Scale bar = 50 µm. (B) Quantification of TMEM119+ 
area in the DG in 20x overview images (stress x genotype interaction: F(1,20) = 3.06, p = 0.096). Data was analysed by 
2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same 
group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 
0.05, ++ p < 0.01, +++ p < 0.001. (C) Pearson correlation analysis of IBA1+ vs. TMEM119+ area in the DG (for both 
genotypes: R2 = 0.87, p < 0.0001).  
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3.2.13 Effects of mild CSDS on microglia morphology 
To determine the cause for the differences in IBA1+ area, microglia morphology was analysed in 
more detail. Therefore, high resolution z-stack images of 40 – 50 µm depth were acquired and 
analysed using an ImageJ-based analysis tool that automatically traces cells through the z-stack 
to generate 3D reconstructions and skeletons of individual cells. Thereby, different morphological 
parameters, such as cell volume, number of branches, and many more can be determined.  
 
3.2.13.1 Hippocampus: dentate gyrus 
Analysis of microglia in the inferior molecular layer of the DG revealed that microglia morphology 
was differently affected by stress in Cnr1+/+ and Cnr1-/- mice (Figure 37A). Firstly, IBA1 average 
intensity on individual microglia was significantly affected by both stress and genotype (Figure 
37B). In both genotypes, IBA1 intensity was significantly increased by stress. Microglia of stressed 
Cnr1+/+ mice showed highest IBA1 intensities, which were also significantly higher than those of 
stressed Cnr1-/- mice. For the cell soma size, a significant stress x genotype interaction was found, 
since microglial cell bodies were slightly enlarged after stress in Cnr1+/+, but not in Cnr1-/- mice 
(Figure 37C). In contrast, a significant stress effect was observed for the number of branches per 
microglial cell, which was based on a stress-induced reduction in Cnr1-/- mice, while no significant 
differences were observed for Cnr1+/+ mice (Figure 37D). Similar results were also observed for 
the number of junctions and the tree length, i.e. the total length of all processes (see Appendix). 
For both cell volume and cell surface area, significant stress effects and stress x genotype 
interactions were detected (Figure 37E - F). Under control conditions, microglia of Cnr1-/- mice had 
a slightly, albeit not significantly higher cell volume and surface than those of Cnr1+/+ mice. Stress 
lead to a significant reduction of cell volume and surface area in Cnr1-/- mice, while it had no effect 
in Cnr1+/+ mice. The ramification index, which is a measure for the complexity of the cellular shape, 
was also significantly affected by stress (Figure 37G). Although the effect was more pronounced 
in Cnr1-/- mice, stressed mice of both genotypes showed significantly lower ramification indexes 
compared to their respective control group. In Cnr1+/+ mice, this reduction was probably caused 
by the increase in cell body size, while in Cnr1-/- mice it was based on reduced branching.  
 
Overall, the results suggest that the stress-induced increase in IBA1+ area observed in the DG of 
Cnr1+/+ mice (see Figure 32) was caused by increased cell soma size and higher expression of 
IBA1 on microglia. Since IBA1+ area was measured by applying a threshold, increased IBA1 
expression would result in more particles falling within the IBA1+ threshold and thus increased 
IBA1+ area. In contrast, the lack of a stress effect on IBA1+ area in Cnr1-/- mice can be explained 
by morphological rearrangements of microglial processes. Microglia of stressed Cnr1-/- mice had 
less branches and were smaller than those of Cnr1-/- controls, which overall negated the increase 
in IBA1 expression.  
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Figure 37. Mild CSDS alters microglia branching in the dentate gyrus of the hippocampus only in Cnr1-/- mice. Microglia 
morphology after mild CSDS was analysed in the inferior molecular layer of the dentate gyrus (DG) of the hippocampus. 
Coronal brain sections of 60 µm were stained for IBA1 and images acquired using confocal microscopy. Z-stack images 
were analysed using an automated ImageJ-based analysis tool that traces cells through the z-stack to generate 3D 
reconstructions and cell skeletons. A total of 56 – 87 cells were analysed per group. (A) Representative images of traced 
microglia and resulting 3D reconstructions and cell skeletons. Scale bar = 5 µm. (B) Average intensity (mean grey) of 
IBA1 immunoreactivity on traced cells (stress: F(1,269) = 76.4, p < 0.0001; genotype: F(1,269) = 22.24, p < 0.0001). (C) 
Cell soma size, analysed manually in z-projections (stress: F(1,793) = 3.61, p = 0.058, stress x genotype interaction: 
F(1,793) = 6.66, p = 0.010). (D) Number of branches per cell, determined from skeletons (stress: F(1,269) = 8.465, p = 
0.0039). (E) Cell volume determined from 3D reconstructed cells (stress: F(1,265) = 5.712, p = 0.0175; stress x genotype 
interaction: F(1,265) = 7.282, p = 0.0074). (F) Cell surface area determined from 3D reconstructed cells (stress: F(1,266) = 
12.58, p = 0.0005, stress x genotype interaction: F(1,266) = 5.932, p = 0.0155). (G) Ramification index, determined from 
3D reconstructed cells. The ramification index is a unit-free parameter describing the complexity of the cellular shape, 
a value of one corresponds to a perfectly round cell without processes (stress: F(1,269) = 24.0, p < 0.0001). AU = arbitrary 
unit. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared 
to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the 
same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.  
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To test whether changes in microglial morphology were associated with behavioural stress-
susceptibility, mean values of each animal were correlated to the respective behavioural stress 
score (Figure 38). While IBA1 intensity and soma size were not correlated with stress scores in 
either genotype (Figure 38A - B), significant negative correlations were detected in Cnr1-/- mice for 
the number of branches (Figure 38C), cell volume (Figure 38D), surface area (Figure 38E), and 
the ramification index (Figure 38F). In contrast, these parameters were not correlated with the 
behaviour in Cnr1+/+ mice.  
 
 
Figure 38. Microglia morphology changes in the dentate gyrus are correlated with stress-related behaviour in Cnr1-/- 
mice. Microglia morphology after mild CSDS was analysed in the inferior molecular layer of the dentate gyrus (DG) of 
the hippocampus using an ImageJ-based analysis tool (see Figure 37 for details). Spearman correlation analysis was 
performed for mean morphological values of each animal and the respective behavioural stress score. (A) IBA1 mean 
intensity (Cnr1+/+: r = 0.07, p = 0.839; Cnr1-/-: r = 0.38, p = 0.166; both genotypes: r= 0.18, p = 0.371). (B) Microglia 
soma size (Cnr1+/+: r = -0.02, p = 0.959; Cnr1-/-: r = 0.09, p = 0.739; both genotypes: r = 0.09, p = 0.667). (C) Number 
of branches per cell (Cnr1+/+: r = -0.29, p = 0.38; Cnr1-/-: r = -0.72, p = 0.003; both genotypes: r = -0.40, p = 0.044). 
(D) Cell volume (Cnr1+/+: r = 0.59, p = 0.061; Cnr1-/-: r = -0.60, p = 0.019; both genotypes: r = -0.28, p = 0.168). (E) 
Cell surface area (Cnr1+/+: r = 0.30, p = 0.36; Cnr1-/-: r = -0.61, p = 0.017; both genotypes: r = -0.35, p = 0.083). (F) 
Ramification index (Cnr1+/+: r = -0.31, p = 0.357; Cnr1-/-: r = -0.72, p = 0.004; both genotypes: r = -0.48, p = 0.012). 
AU = arbitrary unit.  
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3.2.13.2 Hippocampus: CA1 region 
Analysis of microglial morphology in the stratum radiatum of the CA1 region revealed that 
compared to the DG, stress had a smaller effect on microglia morphology in this region (Figure 
39). Generally, the direction of morphological changes was similar to those observed in the DG, 
but did not reach significance in most cases. In part, this might be due to lower numbers of cells 
analysed and thus lower statistical power. Only for the soma size, a significant stress effect was 
detected, due to a slight increase in soma size in stressed mice (Figure 39B). For IBA1 intensity 
on microglia, significant stress and genotype effects as well as a stress x genotype interaction was 
found (Figure 39A). In the CA1 region, IBA1 intensity was increased by stress only in Cnr1+/+ mice.  
 
 
Figure 39. Mild CSDS does not significantly affect microglia morphology in the CA1 region of the hippocampus. 
Microglia morphology after mild CSDS was analysed in the stratum radiatum of the CA1 region of the hippocampus 
using an ImageJ-based analysis tool (see Figure 37 for details). A total of 37 - 68 cells were analysed per group. (A) 
Average intensity (mean grey) of IBA1 immunoreactivity on traced cells (stress: F(1,187) = 7.61, p < 0.006; genotype: 
F(1,187) = 17.35, p < 0.0001; stress x genotype interaction: F(1,187) = 5.78, p = 0.017). (B) Cell soma size (stress: F(1,465) 
= 5.21, p = 0.023). (C) Number of branches per cell (no significant main effects). (D) Cell volume (no significant main 
effects). (E) Cell surface area (no significant main effects). (F) Ramification index (no significant main effects). AU = 
arbitrary unit. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects 
(compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to 
control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.  
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3.2.13.3 Medial prefrontal cortex 
Compared to changes observed in the hippocampus, mild CSDS had opposite effects on microglia 
morphology in the mPFC, although they were not as pronounced as those in the DG (Figure 40). It 
should also be noted that it was shown that microglia in different cortical layers show different 
cell sizes and morphologies (Kongsui et al., 2014). Since the analysis in the mPFC was not 
performed in a specific layer, it thus cannot be excluded that the effects observed here might be 
distorted by different microglia subtypes being analysed together. Changes in IBA1 intensity and 
soma size were similar to those observed in the hippocampus – stress significantly increased IBA1 
expression (Figure 40A) and soma size (Figure 40B) of microglia in Cnr1+/+, but not Cnr1-/- mice 
(significant stress x genotype interaction). Opposite to the stress-induced reduction of microglia 
branching seen in the DG, stress significantly reduced branch numbers only in Cnr1+/+ mice 
(significant stress x genotype interaction) (Figure 40C). For cell volume and surface area, a 
tendency for a stress x genotype interaction and a significant interaction were detected, 
respectively (Figure 40D - E). However, the differences did not reach significance in post-hoc 
comparisons. Furthermore, microglia of control Cnr1-/- mice had a significantly lower ramification 
index than those of control Cnr1+/+ mice (significant stress x genotype interaction) (Figure 40F).  
 
Overall, morphological analysis of microglia indicates that stress effects on microglia are different 
between brain regions and are modulated by CB1 signalling. The strongest effects were observed 
in the DG of the hippocampus, suggesting that this region plays an important role during chronic 
stress exposure.  
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Figure 40. Mild CSDS slightly alters microglia morphology in the prefrontal cortex only in Cnr1+/+ mice. Microglia 
morphology after mild CSDS was analysed in the mPFC using an ImageJ-based analysis tool (see Figure 37 for details). 
A total of 63 – 87 cells were analysed per group. (A) Average intensity (mean grey) of IBA1 immunoreactivity on traced 
cells (stress: F(1,277) = 3.33, p < 0.069; stress x genotype interaction: F(1,277) = 12.17, p = 0.0006). (B) Cell soma size 
(stress: F(1,705) = 4.65, p = 0.032). (C) Number of branches per cell (stress x genotype interaction: F(1,277) = 5.55, p = 
0.019). (D) Cell volume (stress x genotype interaction: F(1,277) = 3.37, p = 0.067). (E) Cell surface area (stress x genotype 
interaction: F(1,277) = 4.65, p = 0.032). (F) Ramification index (stress x genotype interaction: F(1,277) = 5.43, p = 0.021). 
AU = arbitrary unit. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype 
effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared 
to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001.  
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3.2.13.4 Brain regional differences in microglia morphology 
In recent years, it has become evident that microglia within the brain are not a completely 
homogeneous population and show certain differences depending on their environment (Silvin 
and Ginhoux, 2018). Therefore, microglia morphology (using cell volume as an example) was 
compared between the different brain regions analysed in this study (Figure 41). Analysis of 
microglia from control mice revealed that microglia indeed show different volumes in different 
brain regions (significant brain region effect). In both Cnr1+/+ and Cnr1-/- mice, microglia within the 
DG were the largest, being significantly larger than those in the CA1 region and the mPFC. 
Furthermore, a significant brain region x genotype interaction was detected. Microglia in the mPFC 
were generally the smallest and in Cnr1-/- mice, the difference between CA1 region and mPFC 
reached significance in post-hoc comparisons. The same pattern of cell volume (DG > CA1 > 
mPFC) and a significant brain region effect was also observed in microglia of stressed mice, with 
microglia within the DG being significantly larger than those in the mPFC for both genotypes. In 
Cnr1+/+ mice, DG microglia were also significantly larger than those in the CA1 region, which in 
turn were larger than those in the mPFC.  
 
 
Figure 41. Microglia cell size shows brain-regional differences. Microglia morphology after mild CSDS was analysed in 
different hippocampal and cortical brain regions using an ImageJ-based analysis tool (see Figure 37 for details). Cell 
volume determined from 3D reconstructed cells (control group - brain region: F(1,309) = 41.43, p < 0.0001; brain regions 
x genotype interaction: F(1,309) = 3.33, p = 0.037; stress group -  brain region: F(1,419) = 29.79, p < 0.0001; brain regions 
x genotype interaction: F(1,419) = 2.44, p = 0.089). Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc 
comparisons. The analysis was performed separately for controls and for stressed mice. Significant differences between 
brain regions in post-hoc comparisons are indicated in the graph. * p < 0.05, ** p < 0.01, *** p < 0.001.  
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4 Discussion 
The overall objective of this study was to analyse how CB1 signalling modulates behavioural, 
neuroendocrine, and immunological responses during chronic social stress. Furthermore, the aim 
was to analyse whether the increased stress-susceptibility observed in the absence of CB1 
signalling is related to altered neuroimmune communication and altered myeloid cell function.  
 
In summary, this study strongly supports the finding that CB1 signalling protects the organism 
from the physical and emotional harms of stress. Upon exposure to a mild stressor, it dampens 
the severity of the behavioural responses and modulates HPA axis activity and possibly its 
adaptation during chronic stress exposure. Overall, the lack of CB1 signalling during chronic stress 
seems to cause insufficient GC signalling. With respect to immunological responses to stress, CB1 
signalling mainly modulates the function of brain-resident microglia, while effects on peripheral 
myeloid cells seem to be comparatively small. Finally, microglial parameter analysed in this study 
were correlated with the severity of the behavioural phenotype, thus implicating CB1-mediated 
modulation of microglia in the development of stress-related pathologies. The main findings of 
this study are further summarised in Figure 42.  
 
 
Figure 42. Summary of the effects of CB1 deficiency on neuroimmune communication systems after CSDS.  
Results of the present study are summarised in grey boxes, showing stress-induced changes observed in Cnr1-/- mice 
in comparison to stressed Cnr1+/+ mice. Grey text indicates uncertain or speculative findings. Abbreviations: CXCL12 = 
C-X-C motif chemokine 12, GC = glucocorticoid, GR = glucocorticoid receptor, HPA axis = hypothalamic-pituitary-adrenal 
axis, ICAM-1 = intracellular adhesion molecule 1, IL = interleukin, NE = noradrenaline (norepinephrine), SNS = 
sympathetic nervous system, TNFa = tumor necrosis factor alpha. 
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4.1 Stress-induced mortality in the absence of CB1 signalling  
Cnr1-/- mice are known to be highly stress-sensitive and prone to develop anxiety- and depressive-
like behaviours (Valverde and Torrens, 2012). One aim of this study was to confirm that this 
increased stress-susceptibility is also observed in a standard model of CSDS, which consists of 
daily defeat sessions of 5 - 10 minutes (Golden et al., 2011). A very severe phenotype of Cnr1-/- 
mice was detected in this model, with Cnr1-/- mice showing mortality rates of approximately 50% 
– compared to 10% in Cnr1+/+ mice. Similar, but slightly lower mortality rates (30%) were also 
observed during standard CSDS in mice that lack DAGLa, the main 2-AG synthesizing enzyme 
(Jenniches, 2016). This suggests that the protective effect of CB1 signalling during severe stress 
exposure is mainly, but not entirely, mediated by 2-AG. It is known that the Cnr1-/- line used in this 
study has an increased spontaneous mortality rate, however, the mechanisms are unknown 
(Zimmer et al., 1999). Based on the observations of the present study, it can be speculated that 
the increased spontaneous mortality is also linked to severe stress responses, for example during 
handling of the mice. Indeed, Cnr1-/- mice occasionally show handling-induced seizures or 
convulsions (unpublished observation) and have a lower threshold to develop chemically-induced 
epileptic seizures (Marsicano et al., 2003).  
 
Since social defeat models are associated with high incidence of cardiac arrhythmias (Sgoifo and 
Papi, 1995) and the death of Cnr1-/- mice during standard CSDS was reminiscent of sudden 
cardiac death, heart activity was analysed during CSDS using ECG recordings. Cnr1-/- mice did not 
show signs of myocardial infarction or ventricular fibrillation (the most common cause of sudden 
cardiac death), but were bradycardic and did develop total AV-block before death. The ECG traces 
further implied that mice might have had seizures or convulsions concomitant with the AV-block, 
indicated by high amplitude disturbances of the signal, possibly caused by muscle contractions. 
In fact, cardiovascular comorbidities are common in epilepsy patients (Shmuely et al., 2017) and 
there are several case reports of patients that develop bradycardia and AV-block during seizures 
(Leung, 2006).  
 
There are also several other possible explanations for the observed mortality under severe stress 
situations, that likely act in combination: direct cardiovascular effects of CB1 signalling via the 
SNS (Grzeda et al., 2015; Niederhoffer and Szabo, 1999; Varga et al., 1996); vagal over-activation 
in response to excessive SNS activity (“psycogenic death”), which has been associated with the 
occurence of AV-block (Alboni et al., 2013); or exacerbated inflammatory responses. Interestingly, 
stress-induced IL-6 levels were extremely high in one Cnr1-/- mouse that died shortly after the first 
defeat session. In humans, IL-6 is good predictor for mortality in cardiogenic shock patients 
(Andrié et al., 2012). IL-6 is released in response to stress (Zhou et al., 1993) and can further 
potentiate HPA axis activation by directly stimulating ACTH and GC production (Bethin et al., 
2000). The extremely high levels could thus result from an uncontrolled cycle of HPA axis 
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activation and IL-6-production. Additionally, a study showed that macrophages are present in the 
AV node of the heart, where they directly regulate electrical conduction of cardiomyocytes 
(Hulsmans et al., 2017). Interestingly, lack of these resident cardiac macrophages could delay or 
abolish atrial conduction to the ventricles, thus inducing 2nd or 3rd degree AV block. While cardiac 
cells were not analysed here, there were some changes in myeloid cell populations in Cnr1-/- mice 
and it might be worthwhile to investigate whether this also applies to cardiac macrophages.   
 
Overall, eCB signalling via CB1 appears to be extremely important for protecting the organism 
under severe stress exposure. In consequence, lack of CB1 signalling might impose a serious risk 
under these conditions, possibly related to cardiovascular complications. However, due to the 
substantial loss of Cnr1-/- mice during standard CSDS experiments, group sizes for subsequent 
behavioural and molecular analyses were very small and presumably the most stress-sensitive 
mice were underrepresented. Therefore, these results had to be interpreted with caution and will 
not be discussed in detail here. 
 
4.2 Stress-related behaviour  
Rodent models of social defeat stress are commonly used to model human psychiatric disorders, 
such as MDD or PTSD. The most common readout is the social avoidance test that is often used 
to differentiate between stress susceptible and resilient mice. In this test, typically two thirds of 
mice are classified as susceptible and the remaining one third is classified as resilient, meaning 
that they do not show reduced interaction with an unknown CD1 aggressor mouse (Golden et al., 
2011). In the standard CSDS paradigm applied here (5 - 10 minutes defeat sessions), all mice 
that survived the procedure classified as stress susceptible, suggesting that the magnitude of 
stress exposure was very severe. When defeat sessions were reduced to a maximum of 5 minutes, 
Cnr1+/+ mice showed the expected ratio of susceptible and resilient mice. However, this social 
avoidance behaviour was not correlated to any other behavioural readout, such as anxiety and 
anhedonia. This is in line with a study showing that mice can also be segregated into anxious and 
non-anxious groups after CSDS, independent from “stress susceptibility” (Bosch-Bouju et al., 
2016; Krishnan et al., 2007). And even though there were clear effects on social avoidance in 
each standard CSDS experiment, the effect on other anxiety- or depressive-like behaviours was 
still comparably small and varied between the experiments. This demonstrates that behavioural 
responses to stress are very complex and a single behavioural trait, such as social avoidance 
behaviour after CSDS, cannot be used to generally classify mice into stress “susceptible” versus 
“resilient” groups. While traits like anxiety, anhedonia, and social behaviour surely have certain 
underlying mechanisms in common, they do not necessarily overlap in the context of chronic 
stress.  
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In later experiments with mild CSDS, we therefore developed an overall behavioural stress scoring 
system that incorporates the performance in each of the behavioural tests instead of using just 
one readout. First of all, this might be more comparable to the clinical diagnosis of mental 
disorders, where patients have to fulfil several criteria listed in the DSM-V to be diagnosed. 
Secondly, there often is considerable variability between individual mice and some controls also 
displayed stress-related behaviour – especially in Cnr1-/- mice. This can possibly be explained by 
the control housing conditions used in this study (two unfamiliar mice separated by a perforated 
wall). Together with daily handling for body weight measurements, these conditions likely already 
inflicted a certain level of stress. The stress score thus allowed correlation analysis of behaviour 
to molecular parameters based on the individual stress level, independent of the actual group.  
 
Although Cnr1-/- mice already displayed symptoms of stress under control conditions, mild CSDS 
was still able to clearly increase stress-related behaviours in these mice. This was especially 
evident in the social avoidance and the nestlet test. In contrast, the stress effects in Cnr1+/+ mice 
neither reached statistical significance for any individual test nor for the overall stress score. 
Generally, mild CSDS and even standard CSDS did not have a strong influence on anxiety and 
anhedonia. Similar findings were also seen in previous experiments with DAGLa-/- mice, where 
standard CSDS only had minor effects on sucrose preference and anxiety in the open field or zero-
maze (Jenniches, 2016). These findings are in contrast to several studies that report anxiogenic 
effects of repeated social defeat (McKim et al., 2016, 2017; Wohleb et al., 2011, 2014b). These 
discrepancies might be due to slightly different social defeat protocols and different control 
conditions. In these studies, control mice were left undisturbed in established groups of three 
mice, which presumably imposes less baseline stress than the control housing conditions in the 
experiments described here. Additionally, behavioural tests in these studies were performed 
during the inactive phase of mice (lights on), while our tests were performed during the dark phase 
under illuminated, aversive conditions. This likely affects exploratory behaviour of mice and thus 
the overall outcome of behavioural analyses. For example, it was also demonstrated that the 
behavioural effects of environmental enrichment on locomotion and exploration are only obvious 
when mice are tested in the light, but not in the dark phase (Loss et al., 2015).  
 
In Cnr1-/- mice, the lack of a stress effect might further represent a ceiling effect, since they already 
showed increased anxiety and anhedonia at baseline. These results are in part inconsistent with 
another study using Cnr1-/- mice and a model of repeated social defeat (Dubreucq et al., 2012). 
In this study, pharmacologic blockade or constitutive deletion of CB1 did not affect anxiety or 
anhedonia, neither at baseline nor after social defeat. However, it should be noted that there are 
several differences in the experimental design that can explain the discrepancies. A different 
social defeat paradigm was applied, with seven days of stress, short-term sensory contact before 
and after the 10-minute defeat, and single-housing for the rest of the time. Stress exposure and 
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behavioural analysis was performed during the inactive phase of mice. Different behavioural tests 
were performed to evaluate emotional behaviour after stress (e.g. elevated plus maze for anxiety 
instead of open field in the current study). The authors further state that tests were performed 
under non-aversive conditions (dim illumination), in which the anxiogenic phenotype of Cnr1-/- 
mice is typically not detectable (Haller et al., 2004). Finally, a different Cnr1-/- mouse line was used 
(Marsicano et al., 2002), which was bred on a mixed, predominant C57BL/6N genetic 
background. There are several studies showing that different strains of mice and C57BL/6 sub-
strains show different phenotypes and that certain phenotypes (e.g. anxiety) are highly dependent 
on the laboratory and sometimes difficult to reproduce in a different environment (Bothe et al., 
2005; Crawley et al., 1997; Wahlsten et al., 2006). For example, it was shown that behavioural 
responses to chronic GC exposure are dependent on the genetic background and even vary 
between C57BL/6J and C57BL/6N sub-strains (Sturm et al., 2015).  
 
4.3 HPA axis regulation  
It is commonly assumed that persistently elevated GC signalling is detrimental and the cause of 
many chronic stress-related pathologies. However, stress-related neuropsychiatric disorders are 
in fact often associated with insufficient GC signalling (Raison and Miller, 2003). For example, 
patients suffering from PTSD often show low cortisol responses and overall blunted HPA axis 
activity (Miller et al., 2007). Chronically stressed subjects, such as caregivers of ill family members 
or victims or domestic violence, often display low cortisol output as well (Miller et al., 2002; Seedat 
et al., 2003; Vedhara et al., 2002). Another common observation in these chronically stressed 
populations is a flattening of diurnal cortisol patterns, with lower than normal morning secretion 
but higher levels during the rest of the day (Miller et al., 2007). Similar effects are also observed 
in rodent models of chronic stress, where CORT is consistently increased in the light but decreased 
in the dark phase (Bartlang et al., 2012; Koch et al., 2016; Reber et al., 2006, 2007). Results 
from Cnr1+/+ mice after mild CSDS recapitulate this phenomenon. While plasma CORT levels taken 
during the dark phase were slightly lower than in control mice, cumulative 24-hour faecal CORT 
concentrations were elevated after stress, possibly caused by increased levels during the light 
phase. In contrast, Cnr1-/- mice did not show any stress-induced changes in CORT levels. This 
could suggest that the HPA axis does not show the normal adaptation pattern over the course of 
chronic stress exposure in these mice. Indeed, there is strong evidence that eCB signalling via 
CB1 regulates GC signalling and is necessary for both the fast feedback inhibition of the HPA axis 
and its habituation to repeated stress exposure (Hillard et al., 2017; Morena et al., 2016).  
 
In several stress-responsive brain regions, GCs rapidly mobilise eCB/CB1 signalling, which 
contributes to the negative feedback inhibition of the HPA axis. In the PVN, acute stress or CORT 
administration induces 2-AG production by CRH neurons, which acts on CB1 receptors on 
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presynaptic glutamatergic neurons to suppress glutamate release and thereby inhibit the activity 
of CRH neurons (Di et al., 2003; Evanson et al., 2010). In contrast, CB1 receptors are mainly 
expressed on GABAergic interneurons in the mPFC and hippocampus. Thus, GC-induced 2-AG 
production in these regions would reduce GABA release and lead to disinhibition of excitatory 
projection neurons (Hill et al., 2011; Wang et al., 2012). These excitatory projections are thought 
to contribute to the cessation of the stress response via inhibitory relay neurons in the bed nucleus 
of the stria terminalis that in turn project to and inhibit CRH neurons in the PVN (Diorio et al., 
1993; Forray and Gysling, 2004). Thus, CB1 signalling contributes to the negative feedback 
inhibition of the HPA axis at several levels, at least under acute stress situations. In line with this, 
increased or prolonged GC secretion has been repeatedly reported in Cnr1-/- mice after acute 
stress exposure (Aso et al., 2008b; Barna et al., 2004; Hill et al., 2011; Patel et al., 2004). In 
contrast, until now it has not been analysed how GC signalling is altered in Cnr1-/- mice after 
chronic stress exposure.  
 
There is, however, evidence that CB1 signalling is involved in the habituation to repeated stress 
exposure, especially to homotypic stressors. Several studies showed that chronic stress alters 
CB1 expression and binding site density in a brain region-dependent manner. For example, 
chronic unpredictable stress increased gene expression and binding site densities of CB1 in the 
PFC (Hill et al., 2006, 2008), while both parameters were decreased in the hippocampus and 
hypothalamus (Hill et al., 2008). Chronic restraint stress decreased CB1 receptor binding in the 
DG, while there was no change in the CA1 region (Hill et al., 2009). In the present study, gene 
expression of Cnr1 and other ECS-related genes in the brain was not significantly changed after 
mild CSDS, likely due to the mild level of stress exposure (see Appendix). Furthermore, repeated 
homotypic stress increases 2-AG concentrations in several brain regions, including the 
hippocampus, hypothalamus, PFC, and amygdala (Dubreucq et al., 2012; Patel et al., 2005; 
Rademacher et al., 2008; Sumislawski et al., 2011). Accordingly, amygdala-specific DAGLa 
deletion (and thus 2-AG reduction) impairs adaptation to repeated stress and increases stress-
induced anxiety (Bluett et al., 2017). In contrast, brain AEA levels are consistently decreased in 
limbic brain regions after acute and repeated stress exposure (Hill et al., 2010a).  
 
It is suggested that this differential regulation of eCBs mediates different processes during stress 
adaptation. While the progressive increase of amygdalar 2-AG seems to suppress CORT 
production in response to the reencountered stressor, reduced AEA levels likely induce basal 
hypersecretion of CORT during the light phase (Hill et al., 2010a). These findings are in line with 
observations of CORT levels in Cnr1+/+ and Cnr1-/- mice after mild CSDS. Plasma CORT levels at 
the time point of expected stress exposure were higher in stressed Cnr1-/- mice compared to 
stressed Cnr1+/+ mice, since stress caused a slight downregulation of CORT in Cnr1+/+, but an 
upregulation in Cnr1-/- mice. The observed downregulation of plasma CORT in Cnr1+/+ mice might 
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represent the 2-AG-mediated suppression of the HPA axis in anticipation of another defeat 
session. In contrast, cumulative daily CORT levels were increased by stress in Cnr1+/+, but not in 
Cnr1-/- mice. This finding initially appears contrary to the common assumption that CB1 signalling 
inhibits the HPA axis. However, the overall increase in CORT in stressed Cnr1+/+ mice might be 
caused by the above mentioned AEA-mediated hypersecretion of CORT during the light phase. 
These adaptive changes cannot take place in the absence of CB1 signalling, which would explain 
the higher plasma CORT levels at the expected time of stress exposure and the absence of a 
stress effect on cumulative CORT in stressed Cnr1-/- mice. Nonetheless, a thorough analysis of 
circadian CORT fluctuations over the time course of CSDS would be necessary to confirm this.  
 
Another important factor that influences the outcome of GC signalling is the responsiveness of 
target organs. A consistent observation in depressed patients is GC resistance, meaning that the 
negative feedback inhibition of the HPA axis is not working properly, due to altered GR function in 
the brain (Anacker et al., 2011). The result is a hyperactive HPA axis and hypercorticolism. 
However, this does not necessarily translate into high downstream GC signalling. Since other GC 
targets (e.g. immune cells) can also develop GC resistance when repeatedly exposed to high levels 
of GCs during chronic stress, GCs do no longer provide their typical immunosuppressive function. 
Indeed, circulating monocytes of stressed humans show a transcriptional profile reminiscent of 
GC resistance (Miller et al., 2014). More precisely, expression of pro-inflammatory, NFkB-inducible 
genes is increased, while genes containing a glucocorticoid response element (GRE) are 
downregulated. Furthermore, the phenomenon of GC resistance has repeatedly been 
demonstrated in rodent models of chronic stress, where leukocytes isolated from stressed mice 
show exaggerated pro-inflammatory responses to subsequent stimulation and are less responsive 
to the suppressive effects of GCs (Avitsur et al., 2002; Stark et al., 2001, 2002; Wohleb et al., 
2014a). The development of GC resistance and the priming of leukocytes by stress were shown 
to be dependent on GC production during repeated stress (Niraula et al., 2018). While the present 
study did not directly asses GC-responsiveness after CSDS, stimulation of splenocytes isolated 
after standard CSDS confirmed that prior stress exposure caused a stronger pro-inflammatory 
response to LPS. This priming effect of stress was less pronounced in Cnr1-/- mice, indirectly 
supporting the finding of lower GC levels in these mice when chronically stressed. But since the 
experiments were performed after standard CSDS, where a large fraction of Cnr1-/- mice was lost 
due to mortality, it is possible that these results do not properly represent the effect of CSDS on 
Cnr1-/- splenocyte function. Nonetheless, results from mild CSDS also indicate at different levels 
that stressed Cnr1-/- mice likely develop insufficient GC signalling over the course of chronic stress. 
In contrast, stimulation of splenocytes from naive, non-stressed Cnr1+/+ and Cnr1-/- mice showed 
no difference in the anti-inflammatory effects of GCs on LPS-stimulated splenocytes (see 
Appendix). It can thus be excluded that splenocytes of Cnr1-/- mice already had an altered GC-
responsiveness at baseline.  
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4.4 Effects of stress on peripheral myeloid cells 
GCs produced during chronic stress are necessary for the egress of myeloid cells from the bone 
marrow into circulation, but are dispensable for increased myelopoiesis (Niraula et al., 2018). In 
contrast, the proliferation of HSCs and subsequent inflammatory monocyte and neutrophil 
production during chronic stress depends on adrenergic signalling (b3-adrenergic receptors) 
(Heidt et al., 2014). Both GCs and adrenergic signalling regulate expression of the chemokine 
retention factor CXCL12, which inhibits HSC proliferation and migration and retains cells within 
the bone marrow by interaction with its receptor CXCR4 (Ding and Morrison, 2013; Eash et al., 
2010). Mild CSDS slightly reduced Cxcl12 gene expression and this stress effect seemed a bit 
more pronounced in Cnr1+/+ mice, which could be related to the higher levels of CORT in these 
mice. TH staining intensity (an indirect measure of noradrenaline synthesis) in the bone marrow 
was also slightly increased by mild CSDS in both genotypes. TH intensity further appeared 
marginally higher in Cnr1-/- mice, although this difference did not reach statistical significance, 
possibly due to the small group size available for that analysis. Increased noradrenaline levels, 
however, would be expected in Cnr1-/- mice, since CB1 activation is known to inhibit noradrenaline-
release from sympathetic nerve terminals in the bone (Bab and Zimmer, 2008; Tam et al., 2008). 
Still, direct measurements of noradrenaline content in the bone marrow would be necessary to 
further validate the effect of mild CSDS and CB1 deficiency on adrenergic signalling.  
 
The rather subtle effects on bone marrow CXCL12 and TH correspond well to the moderate 
changes in peripheral myeloid cell populations observed after mild CSDS. For example, mild CSDS 
generally did not cause increased monocyte frequencies in the bone marrow or circulation. In 
Cnr1+/+ mice, circulating Ly6Chi monocytes were increased by stress in one cohort of mice, but 
this was not consistently observed in the second cohort. Only in the spleen, a significant stress 
effect with respect to Ly6Chi monocytes was observed. When looking at both bone marrow and 
circulating populations, it seemed like stressed Cnr1-/- mice showed higher Ly6Chi monocyte 
frequencies in the bone marrow but lower frequencies in the blood, compared to stressed Cnr1+/+ 
mice. Since monocyte egress during chronic stress is dependent on GCs, this could suggest that 
the lower GC levels in stressed Cnr1-/- mice prevented the release of these cells into circulation. 
Additionally, Ly6Chi monocytes require CCR2 for their egress from the bone marrow (Shi and 
Pamer, 2011). Cnr1-/- mice generally had reduced expression of CCR2 on monocytes, which could 
further inhibit their release into circulation. In contrast, neutrophil frequencies were increased by 
mild CSDS in the bone marrow of Cnr1-/- mice, but not in the circulation, also suggesting reduced 
egress of myeloid cells from the bone marrow. Neutrophils are the most abundant myeloid cell 
type in mammals and are very short-lived (Manz and Boettcher, 2014). With a lifespan of only 
approximately 12 hours, they need to be continuously generated from precursors in the bone 
marrow (Basu et al., 2002). Under non-inflammatory conditions, aged neutrophils are eliminated 
by macrophages in the spleen, liver, and the bone marrow (Furze and Rankin, 2008; Suratt et al., 
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2001). Aged neutrophils thus migrate back to the bone marrow to be phagocytosed by bone 
marrow macrophages. This elimination was shown to reduce CXCL12 expression and thereby 
regulate homeostatic release of new myeloid cells and HSCs (Casanova-Acebes et al., 2013). In 
peripheral blood macrophages, activation of CB1 receptors can induce phagocytosis (Mai et al., 
2015), suggesting that phagocytic elimination of neutrophils might be impaired in Cnr1-/- mice. 
However, neutrophil populations were not analysed in more detail in the present study. It thus 
remains unclear whether the increased neutrophil frequencies in the bone marrow of Cnr1-/- mice 
after mild CSDS were caused by increased production, reduced egress, or reduced elimination of 
aged neutrophils.  
 
According to the literature, peripheral monocytes are recruited to the brain neurovascular space 
after chronic stress and possibly enter into the brain parenchyma (Reader et al., 2015; Wohleb et 
al., 2015). This recruitment is mediated by interaction between integrins on monocytes and 
increased expression of cell adhesion molecules (CAMs) on brain endothelial cells. The increase 
of CAMs appears to be dependent on the number of social defeat cycles, since it was only detected 
after 6 days of social defeat – a time point that temporally correlated with the detection of 
peripheral monocytes in the brain (Sawicki et al., 2015). In Cnr1+/+ mice, stress indeed caused an 
increase in neurovascular ICAM-1 in stress-related brain regions (hippocampus, mPFC, amygdala). 
Nonetheless, here we did not detect increased numbers of monocytes or other myeloid cells in 
the brain after mild CSDS, neither by flow cytometry nor by immunohistochemistry. Since 
monocyte frequencies were also not increased in peripheral tissues in these mice, it is likely that 
the mild version of CSDS was not sufficient to induce pronounced myelopoiesis and consequently 
no monocyte trafficking to the brain. The induction of reactive brain endothelium and peripheral 
myelopoiesis therefore seem to be mediated by independent pathways. Indeed, stress-induced 
myelopoiesis in the bone marrow depends on adrenergic signalling (Heidt et al., 2014; Ramirez 
et al., 2016). In contrast, expression of ICAM-1 is dependent on GCs released during chronic 
stress, since its induction could be prevented by adrenalectomy and by inhibiting GC synthesis 
over the course of social stress (Niraula et al., 2018). Interestingly, neurovascular ICAM-1 
expression was only induced in Cnr1+/+, but not in Cnr1-/- mice, which further supports the finding 
of overall reduced GC signalling after chronic stress in the absence of CB1 signalling.  
 
The recruitment of inflammatory monocytes is suggested to play a causative role in the 
development of anxiety-like behaviour in response to chronic stress (Wohleb et al., 2015). In 
Cnr1+/+ mice, mild CSDS neither induced monocyte trafficking, nor a clear anxiety-like phenotype. 
Cnr1-/- mice already displayed increased baseline open field-anxiety and anhedonia that was not 
further affected by stress. It thus cannot be entirely excluded that the mild CSDS paradigm was 
simply not as anxiogenic as the repeated social defeat protocols that revealed the link between 
peripheral monocytes and stress-induced anxiety. However, if the baseline anxiety of Cnr1-/- mice 
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is considered a consequence of the mildly stressful control housing conditions (see chapter 4.2), 
we would still expect to find increased monocyte trafficking in these mice. Furthermore, Cnr1-/- 
mice showed clear changes in other stress-related behaviours after mild CSDS, but did not show 
any infiltration of monocytes to the brain. If anything, they even had less monocytes in the brain 
than stressed Cnr1+/+ mice. Thus, results from Cnr1-/- mice would argue against a crucial 
involvement of peripheral monocytes in mediating stress-related behaviour.  
 
4.5 Microglial responses to stress 
In contrast to the relatively weak effects on peripheral myeloid cell populations, mild CSDS did 
significantly affect brain-resident microglia and these changes were correlated to the degree of 
behavioural stress-susceptibility.  
 
Similar to ICAM-1, stress increased microglial staining (IBA1+ area) in the hippocampus of Cnr1+/+ 
mice, which has been reported in several other studies (Wohleb et al., 2011, 2014b). In contrast, 
this effect was not observed in Cnr1-/- mice. Again, these findings resemble those seen in mice 
treated with a GC antagonist during social defeat (Niraula et al., 2018). An increase in IBA1+ area 
is often considered a sign of microglial activation, although it can be the result of different factors, 
such as increased numbers of microglia, altered morphology, or increased IBA1 expression. 
Detailed analysis of hippocampal microglia after mild CSDS revealed that the different regulation 
of IBA1+ area between Cnr1+/+ and Cnr1-/- mice was in fact caused by different mechanisms. In 
Cnr1+/+ mice, the increase in IBA1+ area was a result of increased IBA1 expression and slightly 
enlarged cell bodies, which would be considered a sign of activation. In contrast, the absence of 
a stress-induced increase of IBA1+ area in Cnr1-/- mice was related to morphological 
rearrangements of microglia to a de-ramified state, which is also considered a sign of classical 
activation. Thus, analysis of IBA1+ area should always be complemented by a more detailed 
analysis of the underlying causes. Interestingly, only the morphological changes in Cnr1-/- mice 
(e.g. reduced number of branches) were correlated with the behavioural stress score. In contrast, 
stress-induced changes seen in Cnr1+/+ mice (e.g. increased soma size) were not related to the 
behavioural phenotype. 
 
In the literature, there is substantial controversy concerning the effects of stress on microglial 
morphology. Results range from either increased to decreased proliferation, IBA1 expression, cell 
size, and ramification (Bollinger et al., 2016; Hellwig et al., 2016; Hinwood et al., 2013; Kreisel et 
al., 2014; Lehmann et al., 2016; Wohleb et al., 2011, 2012). However, these discrepancies are 
not all together surprising when considering that different stress models, different brain regions, 
and different time points were analysed. For example, acute stress exposure (social or non-social) 
seems to induce proliferation of microglia in several brain regions, but this effect is no longer seen 
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or even reversed after prolonged stress (Kreisel et al., 2014; Lehmann et al., 2016). By now it is 
also recognised that microglia morphology and function show brain region-dependent 
heterogeneity (Ayata et al., 2018; Bollinger et al., 2016; De Biase et al., 2017; Masuda et al., 
2019). Consistent with that, microglia displayed different morphologies under control conditions 
and in response to stress in the different regions analysed here. Microglia in the DG were generally 
larger and more ramified than those in the CA1 region and the mPFC. Furthermore, stress effects 
on microglia morphology were most pronounced in the DG.   
 
The subgranular zone of the DG is one of the brain’s neurogenic niches – a region where new 
neurons are generated from progenitor cells. Adult neurogenesis has been implicated in a range 
of psychiatric disorders and was also shown to be altered in several mouse models of chronic 
stress (Lucassen et al., 2016). Microglia can regulate neurogenesis via different mechanisms, 
including the release of substances that either stimulate or suppress neurogenesis (Sato, 2015; 
Sierra et al., 2014). For example, pro-inflammatory cytokines like IL-1b inhibit neural precursor 
cell proliferation and neuronal differentiation in the DG (Wu et al., 2013). On the other hand, 
microglia also produce BDNF, a neurotrophin that supports survival of newly generated neuronal 
cells (Ferrini and De Koninck, 2013). Microglia within the DG might therefore have a distinct 
function compared to other brain regions, which could also be reflected in their morphology. Since 
CB1 signalling is also known to regulate neurogenesis (Prenderville et al., 2015), it would be 
worthwhile to investigate whether the stress-induced microglial changes observed in the DG of 
Cnr1-/- mice are also related to changes in neurogenesis.  
 
Control Cnr1-/- microglia in the DG were also slightly larger and hyper-ramified. Microglia hyper-
ramification in the DG was previously shown to be induced by models of repeated stress (Hellwig 
et al., 2016). It therefore seems likely that the control housing conditions were indeed already 
stressful to highly sensitive Cnr1-/- mice. Microglia hyper-ramification is sometimes considered a 
first step in microglial responses to injury or a consequence of intense neuronal activity (Hinwood 
et al., 2012). For example, activation of neurons by NMDA and subsequent release of adenosine 
triphosphate (ATP) from neurons was shown to induce microglial process outgrowth via purinergic 
receptors in acute hippocampal slices (Dissing-Olesen et al., 2014). Similarly, blocking or 
stimulating glutamatergic signalling in an ex vivo retinal explant system induced a rapid retraction 
or outgrowth of microglial processes, respectively (Fontainhas et al., 2011). These morphological 
changes were also related to functional changes, since increased branching in response to 
glutamatergic signalling was also associated with increased motility of those branches. A role for 
neuronal activity in regulating microglia process dynamics was recently also demonstrated in 
longitudinal in vivo imaging studies the hippocampus, where motility of microglial processes was 
strongly influenced by the activity of local neurons (Nebeling et al., 2019). Furthermore, the study 
demonstrated a connection between microglia motility with the plasticity of dendritic spines, since 
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both the new formation and elimination of spines were associated with increased contact rates 
by microglia. So far, it is not known which signalling molecules mediate this interaction and what 
the functional role for the contacts are. Since CB1 receptor signalling limits excessive neuronal 
transmission, it will be important to analyse whether the differences in microglia morphology 
observed in Cnr1-/- mice are caused by altered neuronal activity at baseline and in response to 
stress. Importantly, it was also shown that the effects of GC signalling on monocyte trafficking and 
neurovascular ICAM-1 in response to repeated social defeat are active downstream of neuronal 
activation in stress-responsive brain regions (Niraula et al., 2018). Thus, dysregulated neuronal 
activity in response to stress could still directly and locally alter microglial function without the 
involvement of peripheral cells. The ECS is well-situated to provide an interaction pathway 
between microglia and neurons (and astrocytes), since eCBs are produced on-demand in 
response to high neuronal activity. While the typical retrograde feedback signalling of eCBs acts 
via CB1 receptors on presynaptic neurons, the eCBs released by an active synapse could also be 
sensed by nearby microglia – possibly by microglial CB2 receptors. By this, microglial processes 
could be attracted to the synapse, since 2-AG has been shown to induce microglial migration via 
CB2 in vitro. Additionally, ATP stimulation of microglia (simulating excessive neuronal activity or 
neuronal injury) induced the production of 2-AG, which in turn would limit synaptic activity via CB1 
and thereby provide neuroprotection (Walter et al., 2003).  
 
As a second readout for microglia function, surface expression of activation markers CD11b, 
CD40, and MHCII was analysed using flow cytometry and found upregulated after mild CSDS. 
Interestingly, expression of all three markers was positively correlated with behavioural stress 
scores and accordingly was highest on stressed Cnr1-/- mice. In comparison to microglial 
morphology changes – which were different between Cnr1-/- and Cnr1+/+ mice – the direction of 
effects was similar in both genotypes, albeit more pronounced in Cnr1-/- mice. Since microglia 
were isolated from whole brain homogenates, it cannot be excluded that there are regional 
differences in these parameters as well. Together with CD18, CD11b forms the complement 
receptor 3 (CR3) – a pattern-recognition receptor and part of the complement cascade (Ehlers, 
2000). In the brain, CR3 is expressed by microglia and is involved in microglia-mediated synaptic 
pruning (Schafer et al., 2012; Stevens et al., 2007). Synapses (e.g. immature or dysfunctional) 
are tagged by complement components C1q and C3, which targets them for elimination by 
microglia via C3-CR3 signalling. Mice deficient for either of the complement components have 
deficits in synaptic connectivity, pointing to a crucial role for this process during neuronal 
development. On the other hand, overexpression of complement components and increased or 
uncontrolled phagocytosis of synaptic terminals is observed in several neurodegenerative 
disorders (Morgan, 2018; Sekar et al., 2016). Increased CD11b expression, as observed in 
stressed Cnr1-/- mice, would thus point to an increased phagocytic activity of microglia. In line with 
this, a study using social defeat demonstrated that microglia of stress susceptible mice have an 
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increased capability of phagocyting neuronal debris (Lehmann et al., 2016, 2018). It was further 
demonstrated that acute stress causes a long-lasting increase in C1q in the hippocampus, that 
was associated with dendritic spine loss and microglial hyper-ramification (Smith et al., 2019). 
Similar to microglia morphology, also phagocytic activity of microglia shows great variability 
between brain regions and is especially high in regions with high neuronal death rates, such as 
the cerebellum. In brain regions with a rather stable neuronal population, like the striatum, 
microglial clearance activity seems to be inhibited via epigenetic suppression of clearance-related 
genes (Ayata et al., 2018). Intriguingly, induction of aberrant phagocytic activity in this region 
causes neuronal spine loss, thigmotaxis (reduced locomotion), increased anxiety, and the 
development of seizures with age – a phenotype very similar to that of Cnr1-/- mice. Notably, this 
clearance phenotype of microglia was not associated with an overall pro-inflammatory phenotype. 
These findings are supported by another study describing microglial heterogeneity in different 
basal ganglia nuclei with respect to morphology, metabolism, mitochondrial function, and 
phagocytic activity, but without substantial differences in typical immune functions (De Biase et 
al., 2017). Similarly, gene expression of pro-inflammatory cytokines in the brain was not affected 
by mild CSDS (see Appendix) and microglia did not show the very typical amoeboid morphology of 
classical pro-inflammatory activation. It is thus possible that mild CSDS did not induce profound 
neuroinflammation, but did affect other microglial functions.  
 
In summary, while there were clear changes in microglia, there was no infiltration of peripheral 
myeloid cells into the brain after stress, which has been reported in several other studies (Lisboa 
et al., 2018; McKim et al., 2016, 2017; Niraula et al., 2018; Sawicki et al., 2015; Wohleb et al., 
2013, 2014a, 2014b). On the one hand, this could be due to the very mild version of CSDS applied 
in this study. This would suggest that the response of microglia precedes the infiltration of 
monocytes, which is supported by the finding that activated microglia release CCL2 to recruit 
monocytes to the brain endothelium after chronic stress (McKim et al., 2017). On the other hand, 
also other groups reported that microglia activation alone was sufficient to induce depressive-like 
states after chronic stress, without the infiltration of peripheral cells (Lehmann et al., 2016, 2018) 
and that monocytes do not infiltrate into brain parenchyma, but only accumulate in brain vessels 
(Menard et al., 2017). Similar to the experiments described here, these studies performed stress 
exposure and tissue collection during the dark phase, while those that observed monocyte 
infiltration performed the experiments during the light phase or did not specify the time of day. It 
should also be noted that slightly different protocols were used in each study (e.g. setup of defeat 
sessions, control housing conditions). This suggests that the neuroinflammatory responses to 
chronic social stress are highly specific and probably time of day-dependent. Indeed, many of the 
aspects analysed in this context are under circadian control, prompting the need for clearly 
defined experimental setups. The following section will therefore discuss the possible influence 
of circadian rhythms and the time of stress exposure on some parameters analysed in this study. 
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4.6 Stress effects and their dependence on circadian rhythms  
GCs follow a well-described circadian rhythm, peaking at the onset of the organism's active phase. 
Accordingly, the reactivity of the HPA axis (e.g. sensitivity of adrenal cells to ACTH) and the 
amplitude of a stress response to an acute stressor strongly depends on the time of stress 
exposure (Leliavski et al. 2014). Similarly, also responses to chronic stress and adaptation of the 
HPA axis to it depend on when the stressors are presented (Aslani et al., 2014; Koch et al., 2016). 
Furthermore, the ability of an organism to adapt to chronic stress exposure is not mediated by a 
universal mechanism, but seems to depend on the type of stressor (homotypic versus heterotypic 
stressors, social versus non-social stressors, etc.). This complexity is illustrated by several studies 
that analysed time of day effects in different rodent models of stress. In a model of acute predator 
scent stress, it was shown that rats are more vulnerable to the effects of traumatic stress when 
exposed at the beginning of the light phase – when baseline GCs levels are low (Cohen et al., 
2015). The detrimental effects of chronic mild stress (heterotypic, non-social) on behaviour and 
neuronal structures were also more pronounced when animals were stressed during the light 
phase (Aslani et al., 2014). In contrast, it was shown that the effects of chronic social defeat 
(homotypic, social) on behaviour, immune function, and HPA axis adaption were more prominent 
when mice were stressed during the dark phase (Bartlang et al., 2012, 2014, 2015). In most 
cases, these time-dependent differences in susceptibility were mediated by altered 
responsiveness of adrenal cells to ACTH and thus altered circadian GC secretion (Bartlang et al., 
2012; Reber et al., 2006, 2007; Ulrich-Lai et al., 2006).  
 
Catecholamines show a diurnal pattern as well, which peaks at the beginning of an organism’s 
active phase – similar to GCs. As described above, the bone marrow is one of the targets 
innervated by sympathetic nerves and accordingly, bone marrow noradrenaline also shows diurnal 
fluctuations with a peak during the active phase (Cosentino et al., 1998). The changes in 
noradrenaline are paralleled by fluctuations in the release of HSCs and myeloid cells into 
circulation (Méndez-Ferrer et al., 2008). Circulating and splenic Ly6Chi monocytes peak during the 
inactive phase and also their recruitment to sites of inflammation is dependent on the time of day 
(Nguyen et al., 2013). In a model of virus-induced encephalitis, CCL2-mediated recruitment of 
Ly6Chi monocytes to the CNS was higher when the infection was elicited at the beginning of the 
inactive phase (Gagnidze et al., 2016). It is thus possible that also stress-induced myeloid cell 
trafficking is different depending on the time of stress exposure and/or time point of the analysis.  
 
Another factor that is likely influenced by the time of day is blood-brain-barrier integrity and 
endothelial cell function. It was shown that the blood-brain-barrier permeability is regulated by 
clock genes and thus different dependent on the time of day (Nakazato et al., 2017). Furthermore, 
ICAM-1 expression by vascular endothelial cells showed a rhythmic expression pattern in mouse 
bone marrow and skeletal muscle (Scheiermann et al., 2012). Consequently, leukocyte adhesion 
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to the tissue also showed a diurnal rhythm (high at night onset, low during the day). While this 
study did not analyse neurovascular ICAM-1 expression, it is possible that similar patterns are also 
observed in brain endothelial cells. Therefore, the ability to detect peripheral monocytes in the 
brain or brain vessels after chronic stress might also depend on the time point of analysis.  
 
Microglia have an intrinsic circadian clock as well, which influences their response to inflammatory 
stimuli, both at baseline and in the context of acute stress (Fonken et al., 2015, 2016). Stress-
induced inflammatory priming of microglia to a subsequent inflammatory stimulus was stronger 
when animals were stressed during the inactive phase, possibly mediated by different GC 
signalling in microglia (Fonken et al., 2016). This time-dependent microglial reactivity to stress 
might in turn also affect interaction of microglia with synapses and thereby affect stress-related 
neuronal function. Indeed, also synaptic plasticity, i.e. the formation and elimination of synapses, 
is dependent on the time-of-day. As such, it was demonstrated that circadian CORT oscillations 
promote learning-dependent synapse formation and maintenance (Liston et al., 2013). Formation 
of new spines after a motor-learning task was more frequent and spines were more stable when 
training was performed at the circadian CORT peak (beginning of dark phase). Although this study 
did not directly analyse stress effects, it can be assumed that the effect of stress-induced CORT 
on synapses is also dependent on the time of stress exposure. Adult neurogenesis, another form 
of neuronal plasticity, is regulated by the circadian rhythm as well. In the DG, the generation of 
newborn neurons increases during the dark phase (Tamai et al., 2008). It is thus also possible 
that those newly generated cells are differently affected by stress, depending on the time of stress 
exposure.  
 
Finally, it is being recognised that the activity of the ECS follows a circadian rhythm as well. There 
is evidence that the number of CB1 receptors, eCB tissue content, and the activity of eCB 
synthesising and degrading enzymes show diurnal variations (Vaughn et al., 2010). For example, 
plasma levels of 2-AG show a nadir during sleep and a peak during the afternoon in healthy human 
adults (Hanlon et al., 2015). In the rodent brain, 2-AG levels are higher during the inactive phase 
in several brain regions, including PFC and hippocampus (Valenti et al., 2004). In the 
hippocampus, also CB1 receptor density is higher in the inactive phase (Rueda-Orozco et al., 
2008). Interestingly, AEA exhibits an opposite diurnal pattern as 2-AG and CB1 in those regions, 
with higher levels measured during the active phase (Valenti et al., 2004). These results suggest 
that different phases of the day are accompanied by a different ECS tone, which will influence 
many downstream targets. Although speculative, this different ECS tone or different CB1 signalling 
might also contribute to the differences in stress-susceptibility observed at different times of the 
day.   
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4.7 Brain region- and cell type-specific effects of CB1 signalling  
One limitation of this study is the use of constitutive Cnr1-/- mice, which lack CB1 receptors on all 
cells throughout development and might therefore show some adaptations in neuronal, endocrine 
and immune system activity. Although Cnr1-/- mice have no gross anatomical or neuronal defects, 
it is known that CB1 receptors are involved in embryonic neuronal development. CB1 signalling 
was shown to regulate neural progenitor proliferation, migration of pyramidal cortical neurons and 
interneurons, axonal guidance, and synaptogenesis (Berghuis et al., 2005, 2007; Díaz-Alonso et 
al., 2012; Mulder et al., 2008; Trazzi et al., 2010; Wu et al., 2010). It thus cannot be excluded 
that some of the phenotypes observed in Cnr1-/- mice are not due to the acute lack of CB1 
signalling, but due to developmental adaptations (e.g. miswiring of neuronal circuits).  
 
A second drawback of constitutive Cnr1-/- mice is the lack of CB1 on various cell types. CB1 
receptors are expressed on virtually all neuronal subtypes, including glutamatergic, GABAergic, 
noradrenergic, dopaminergic, and serotonergic neurons (Marsicano and Kuner, 2008). The 
retrograde inhibition of synaptic activity of these neurons naturally has very different outcomes 
for the overall network activity and thus also the functional output (Busquets-Garcia et al., 2018). 
In a study using a slightly different repeated social defeat protocol, it was shown that CB1 
receptors on different neuronal populations regulate different aspects of the behavioural 
consequences of stress (Dubreucq et al., 2012). CB1 receptors on cortical glutamatergic neurons 
were responsible for mediating fear responses after stress, while those on GABAergic neurons 
were involved in mediating stress-induced changes in locomotor activity, and CB1 on serotonergic 
neurons modulated hedonic behaviour. Additionally, CB1 receptors on adrenergic and 
noradrenergic cells in the hippocampus and the periphery were found necessary for mediating 
memory impairments induced by acute stress (Busquets-Garcia et al., 2016). Anxiogenic effects 
of central CB1 antagonism were also dependent on peripheral adrenergic transmission 
(Bellocchio et al., 2013), suggesting that CB1 signalling in the adrenergic system provides an 
essential communication pathway between the brain and periphery.  
 
Furthermore, CB1 receptors and eCBs are differentially expressed between brain regions and 
accordingly can have different effects on stress-related brain circuits. For example, it was 
demonstrated that 2-AG signalling specifically in the BLA is both necessary and sufficient for 
promoting resilience to traumatic stress exposure in the form of foot shocks (Bluett et al., 2017). 
The resilient phenotype, determined by anxiety-related behaviour, was associated with higher 
2-AG-mediated suppression of glutamate release from hippocampal projections to the BLA. In 
contrast, PFC-BLA synapses were not involved. Thus, CB1 receptors expressed by hippocampal 
glutamatergic projection neurons and their activation by amygdala-derived 2-AG might play an 
essential role in mediating stress resilience.  
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With respect to stress-related inflammation, there is generally not much information on the role 
of CB1 signalling, let alone CB1 signalling on different neuronal populations. In a model of 
repeated stress exposure (four days), constitutive Cnr1-/- mice showed exaggerated excitotoxicity 
and inflammation in the mPFC, but this was in part also already seen at baseline (Zoppi et al., 
2011). Ageing is also associated with chronic low-grade neuroinflammation, which is aggravated 
in mice lacking CB1 on GABAergic, but not on glutamatergic neurons (Albayram et al., 2011). 
GABA-CB1 knockout mice further show some baseline changes in hippocampal microglial 
morphology and an altered microglial response to peripheral LPS injections (Ativie et al., 2018). 
Since these changes were also associated with altered expression of proteins involved in 
microglia-neuron communication (e.g. CX3CL1 on neurons), it is suggested that CB1 receptors on 
GABAergic neurons could play an important role in mediating neuronal control over microglial 
function. Whether this is also true for stress-related microglial responses, is however not known 
so far.  
 
Finally, CB1 receptors are also expressed by non-neuronal cells both in the periphery and the 
brain, including adipocytes (Ruiz de Azua et al., 2017), pancreatic cells (Bermudez-Silva et al., 
2008), astrocytes (Navarrete et al., 2014), oligodendrocytes (Molina-Holgado et al., 2002), and 
possibly microglia – albeit at very low levels (Walter et al., 2003). Another layer of complexity is 
added by the findings that CB1 receptors are not only located on the plasma membrane of cells, 
but also on intracellular membranes, for example on mitochondria (Bénard et al., 2012). So far, 
the presence of mtCB1 has been demonstrated on sperm and muscle cells (Aquila et al., 2010; 
Mendizabal-Zubiaga et al., 2016) as well as neurons and possibly astrocytes in the brain (Hebert-
Chatelain et al., 2014, 2016), where it regulates mitochondrial respiration and thus cellular 
energy supply. In recent years, the concept of immunometabolism – the role of mitochondria and 
cellular metabolism in regulating immune cell function – has received a lot of interest (O’Neill et 
al., 2016). Although not analysed so far, the presence of mtCB1 in immune cells, including 
microglia, would provide an intriguing mechanism of how CB1 signalling could also directly 
regulate immune function.  
 
It will therefore be important to clearly dissect the contribution of CB1 receptors on different cell 
types and in different brain regions to the increased stress-susceptibility that is clearly observed 
in constitutive Cnr1-/- mice. The availability of various cell type-specific CB1 knockout lines and 
viral vectors for site-specific manipulation of CB1 signalling provides a promising basis for 
accomplishing that.  
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4.8 Conclusions  
In summary, this study provides clear evidence that CB1 signalling protects the body from the 
physical and emotional harms of social stress. CB1 signalling seems especially indispensable in 
situations of severe stress and lack of it may impose a serious risk, possibly related to 
cardiovascular complications. But even under mildly stressful conditions, which do not result in 
the development of maladaptive behaviours in most wild type mice, CB1 deficiency greatly 
increases the proportion of mice that do show a stress-related behavioural phenotype. This is in 
agreement with the view that the ECS generally acts as a buffering system and lack of its function 
reduces the capacity to cope with situations in which homeostasis is disturbed – as it is the case 
during stress. Differences in ECS signalling might thus also underlie some of the natural variance 
in stress-susceptibility/resilience observed in laboratory rodents and humans. 
 
Surprisingly, the results described here indicate that the lack of CB1 signalling on the long run 
leads to insufficient GC signalling. Although this is in contradiction to the common believe that 
CB1 signalling mediates negative feedback of the HPA axis, it does support the idea that CB1 
signalling is necessary for adaptation of the stress response under chronic stress conditions. In 
Cnr1+/+ mice, this adaptation likely involves flattening of the circadian GC rhythm, which overall 
increases GC levels. Although GCs are often considered detrimental and the cause of stress-
related pathologies, this shift in GC signalling might in fact be protective under chronic stress 
conditions.  
 
Interestingly, the stress effects on myeloid cells and inflammatory signalling described in the 
literature (e.g. neurovascular ICAM-1, microglial IBA1, increase in circulating monocytes) were 
rather observed in Cnr1+/+ mice, although these mice did not develop a clear behavioural 
phenotype after mild CSDS. It is thus possible that these changes are also somehow adaptive and 
not the cause for the development of behavioural deficits. Indeed, the fact that stressed Cnr1-/- 
mice showed a clear behavioural phenotype without strong changes in peripheral myeloid cells 
and no recruitment of monocytes to the brain argues against a crucial involvement of those cells. 
In contrast, different parameters of microglial function (morphology and surface marker 
expression) were changed after mild CSDS and correlated with the behavioural susceptibility – 
especially in Cnr1-/- mice. While this study cannot provide evidence for a causal relationship of 
microglial function to behaviour, it strongly suggests that microglia play an important role in stress-
related pathologies. Whether microglia actively shape behaviour or rather respond to other 
(neuronal) changes that occur during chronic stress and how CB1 signalling can regulate 
microglial function remains to be analysed in future studies.  
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Appendix 
A1. Behavioural analysis after standard CSDS (first cohort) 
 
 
Supplementary Figure 1. Detailed behavioural analysis of Cnr1+/+ and Cnr1-/- mice after standard CSDS (first cohort).  
See next page for continuation of figure and figure legend.  
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Supplementary Figure 1. Detailed behavioural analysis of Cnr1+/+ and Cnr1-/- mice after standard CSDS (first cohort).  
(A) Experimental timeline of standard CSDS and subsequent behavioural tests. (B - C) Standard CSDS induced strong 
social avoidance, indicated by reduced interaction with a novel CD1 mouse (D) and increased time spent in corner areas 
(C) in both genotypes. In Cnr1-/- mice, stress effects on interaction time did not reach significance in post-hoc 
comparisons, due to low baseline interaction in control mice and small group sizes.  (D - E) CB1 deficiency (and stress) 
increases anxiety in the open field test. (D) Time spent in the centre of the open field was reduced in Cnr1-/- mice, 
especially in stressed mice. (E) Both stress and CB1-deficiencty reduced locomotion in the open field. (F - G) CB1 
deficiency increases anxiety in the elevated zero-maze (O-maze). (F) Time spent in the open (brightly illuminated) area 
of the O-maze was reduced in Cnr1-/- mice. (G) Velocity in the open area was slightly increased in Cnr1-/- mice. (H) Stress 
reduced sucrose preference (thus induced anhedonia) in Cnr1+/+- mice. In contrast, Cnr1-/- mice showed reduced 
sucrose preference in control conditions, which was not further affected by stress. (I) Cnr1-/- mice showed reduced 
immobility time in the Porsolt forced swim test, usually a sign for lower depressive-like behaviour. However, in this test 
Cnr1-/- mice appeared very nervous and hyperactive. Stress had no effect on immobility time. (J - K) Home cage activity 
was not significantly affected by stress in neither Cnr1+/+ (J), nor in Cnr1-/- mice (K). (L) Mean activity during the active 
phase was not affected by stress or CB1 deficiency. (M) Mean activity in the inactive phase was slightly lower in Cnr1-/- 
mice, independent from stress. Home cage activity data was analysed separately for Cnr1+/+ and Cnr1-/- mice by 
repeated measure (RM) 2way ANOVA, followed by Bonferroni post-hoc comparisons. Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, 
** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, 
+++ p < 0.001. 
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A2. Behavioural analysis after standard CSDS (second cohort) 
 
 
Supplementary Figure 2. Behavioural analysis of Cnr1+/+ and Cnr1-/- mice after standard CSDS (second cohort).  
(A) Experimental timeline of standard CSDS and subsequent behavioural tests. (B - C) Standard CSDS induced strong 
social avoidance, indicated by reduced interaction with a novel CD1 mouse (D) and increased time spent in corner areas 
(C). In Cnr1-/- mice, stress effects on interaction time did not reach significance in post-hoc comparisons, due to low 
baseline interaction in control mice and small group sizes. (D - E) CB1 deficiency and stress did not affect anxiety in the 
open field test in this cohort. (D) Time spent in the centre of the open field was not significantly different between the 
groups. (E) Stress reduced locomotion in the open field in Cnr1-/- mice. (F) Sucrose preference was not affected by 
stress or genotype in this cohort. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For 
genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects 
(compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
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A3. Immunosuppressive function of CORT in LPS-treated splenocytes 
 
 
Supplementary Figure 3. In vitro analysis of immunosuppressive function of CORT in LPS-stimulated splenocytes. 
Splenocytes were isolated from naive, non-stressed male Cnr1+/+ and Cnr1-/- mice and cultured overnight. Cells were 
stimulated with LPS from E. coli 0127:B8, with or without co-treatment with different concentrations of CORT. After 
stimulation, IL-6 secretion was analysed in the supernatant using ELISA. LPS treatment alone induced secretion of IL-
6, which was dose-dependently reduced by increasing concentrations of CORT. Neither the pro-inflammatory response 
to LPS, nor the immunosuppressive action of CORT was affected by the genotype. Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons.  
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A4. Expression of ECS-related genes after mild CSDS 
 
 
Supplementary Figure 4. Gene expression analysis of ECS-related genes after mild CSDS. Brain regions were isolated 
approximately 24 h after the last stress exposure in one cohort of mice. RNA was isolated, reverse transcribed into 
cDNA and gene expression analysed by qPCR. Expression of target genes was normalised to the expression of reference 
gene Hprt and is presented as 2-DCp. (A - B) Hippocampus: mild CSDS had no effect on Cnr1 or Dagla gene expression. 
(C - E) Amygdala: stress had no effect on Cnr1, DAGLa (Dagla), or MAGL (Mgll) gene expression. (F - H) PVN: stress had 
no effect on Cnr1, DAGLa (Dagla), or MAGL (Mgll) gene expression. Control Cnr1-/- mice showed slightly higher Dagla 
and Mgll expression. (A, C, F) Analysis of Cnr1 expression confirms the absence of Cnr1 mRNA in Cnr1-/- mice. Data was 
analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of 
the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) 
+ p < 0.05, ++ p < 0.01, +++ p < 0.001.  
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A5. Expression of inflammatory genes after mild CSDS 
 
 
Supplementary Figure 5. Gene expression analysis of immune-related genes after mild CSDS. Brain regions were 
isolated approximately 24 h after the last stress exposure in one cohort of mice. RNA was isolated, reverse transcribed 
into cDNA and gene expression analysed by qPCR. Expression of target genes was normalised to the expression of 
reference gene Hprt and is presented as 2-DCp. (A - B) Hippocampus: mild CSDS had no effect on COX-2 (Ptgs2) or IL-6 
(Il6) gene expression. (C - D) Amygdala: mild CSDS had no effect on COX-2 (Ptgs2) or IL-6 (Il6) gene expression. (E - F) 
PVN: mild CSDS had no effect on COX-2 (Ptgs2) or IL-6 (Il6) gene expression. In all regions, expression of IL-1b (Il1b) 
and TNFa (Tnf) were below the detection limit of the qPCR (all Cp values > 35). Data was analysed by 2way ANOVA, 
followed by Bonferroni post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, 
** p < 0.01, *** p < 0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, 
+++ p < 0.001. 
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A6. Microglia morphology after mild CSDS 
 
 
Supplementary Figure 6. Extended data on microglia morphology in the dentate gyrus after mild CSDS. Microglia 
morphology was analysed in the inferior molecular layer of the dentate gyrus (DG) of the hippocampus after mild CSDS. 
Coronal brain sections of 60 µm were stained for IBA1 and images acquired using confocal microscopy. Z-stack images 
were analysed using an automated ImageJ-based analysis tool that traces cells through the z-stack to generate 3D 
reconstructions and cell skeletons. A total of 56 – 87 cells were analysed per group. (A) Stress reduced the spanned 
volume (determined from the convex hull of the reconstructed cell) of Cnr1-/- microglia. (B) Stress reduced the number 
of junctions (determined from the skeleton of the reconstructed cell) of Cnr1-/- microglia. (C) Stress reduced the tree 
length, i.e. the total length of all branches (determined from the skeleton) of Cnr1-/- microglia. (D) The average branch 
length was not affected by stress or genotype. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc 
comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 0.001. 
For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001. 
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Supplementary Figure 7. Extended data on microglia morphology in the CA1 region after mild CSDS. Microglia 
morphology was analysed in the stratum radiatum of the CA1 region of the hippocampus after mild CSDS. A total of 37 
- 68 cells were analysed per group. (A - D) Stress or genotype did not significantly affect microglia morphology in this 
region. Data was analysed by 2way ANOVA, followed by Bonferroni post-hoc comparisons.  
 
 
Supplementary Figure 8. Extended data on microglia morphology in the prefrontal cortex after mild CSDS. Microglia 
morphology was analysed in the medial prefrontal cortex (mPFC) after mild CSDS. A total of 63 – 87 cells were analysed 
per group. (A) Stress or genotype did not affect the spanned volume of microglia. (B) Stress reduced the number of 
junctions of Cnr1+/+ microglia. (C) Stress or genotype did not affect the total tree length of microglia. (D) Stress increased 
the number of junctions of Cnr1+/+, but not Cnr1-/- microglia. Data was analysed by 2way ANOVA, followed by Bonferroni 
post-hoc comparisons. For genotype effects (compared to Cnr1+/+ of the same group) * p < 0.05, ** p < 0.01, *** p < 
0.001. For stress effects (compared to control of the same genotype) + p < 0.05, ++ p < 0.01, +++ p < 0.001 
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